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CHAPTER 1- STUDY DESIGN 
 
1.1 Setting the scene: Physical activity, health and ageing 
 
Physical activity and physical fitness are said to have long been linked with 
health; the earliest records of exercise for health promotion stem from 
DQFLHQW &KLQD LQ ¶ %& (Hardman & Stensel, 2003;Grunfeld & 
Feingold, 1991). A modern trend with chronic health and economic 
implications is that of the worldwide demographic change, of increased life 
expectancy and an ageing population. Although this trend cannot be altered 
by physical activity, being more active may go some way to alleviate a 
number of age-associated problems. More than 580 million people 
worldwide are older than 60 years and this number is expected to rise to 
1000 million by 2020 (Knoops et al., 2004). The UK, like many other 
developed countries has an ageing population, with the median age of the 
UK population having risen from 34.1 years to 38.6 years in the last three 
decades (http://www.statistics.gov.uk). 
 
There is much controversy regarding the cost of both clinical and social 
care for elderly individuals when they can no longer maintain the 
necessary functions to survive independently or need care as they age. 
Ageing is one of the most important social and financial problems facing 
western society- it is both intransient and associated with considerable 
morbidity (Greiwe et al., 2001). In the UK, hip fractures alone, in the 
HOGHUO\FRVW DSSUR[LPDWHO\ǧPLOOLRQSHUDQQXP (Hollingworth et al., 
1995). Consensus has been reached supporting any method which may 
prevent this decline in independence maintenance (a state of health and 
well-being that allows individuals to sustain normal daily activity and 
functional independence (Sumukadas et al., 2006)), thus having economic, 
social and health benefits both for the elderly individuals involved and for 
society as a whole. 
 
Regardless of other predisposing factors, diet and lifestyle influence 
mortality and morbidity during the course of life. Because of the 
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cumulative effect of factors throughout life, it is particularly important for 
older persons to adapt to and adopt diet and lifestyle practices that will 
minimize their risk of premature death and maximize their chances of 
healthy, active ageing (Knoops et al., 2004). 
 
One of the most significant and visually apparent changes with ageing is 
that of reduced muscle mass and historical observations of this loss are 
common (Evans, 1995b; Narici & Maffulli, 2010). This undesirable loss of 
muscle mass with ageing is called sarcopenia (Rosenberg, 1997) with the 
WHUPGHULYHGIURPWKH*UHHNZRUGV³VDUFRV´IOHVKDQG³SHQLD´ODFNRI).  
Interest in sarcopenia has been widely DSSDUHQWVLQFHWKH¶VEXWPRUH
recently evidence is emerging that dynapenia; the lack of strength with 
ageing, is a more consistent factor in compromised well-being with age 
and in some cases the term sarcopenia is now being used to describe losses 
of both size and strength (Morley et al., 2001). Both the US NIH and the 
European Working Group on Sarcopenia now recognize sarcopenia as 
changes in body composition and function, with the latter suggesting that 
three stages of sarcopenia should be recognized: 1. Presarcopenia ± the loss 
of muscle mass, 2. Sarcopenia ± the loss of muscle mass accompanied by a 
loss of either strength or physical performance and 3. Severe Sarcopenia ± 
when all three of the above features are present (Cruz-Jentoft et al., 2010). 
Not all are in agreement that one term should be used to describe both 
losses though as it implies proportionality between losses of mass and 
function which are not always apparent (Narici & Maffulli, 2010) and the 
term dynapenia as a separate concept has been proposed to refer to 
functional compromise of the entire neuromuscular apparatus (Clark & 
Manini, 2008). 
 
If the concepts of dynapenia or staged sarcopenia are to be believed then it 
is muscle quality, and not just quantity that impacts on quality of life with 
ageing and force generating capacity per unit cross-sectional area must be 
key to these declines. With this belief comes even more uncertainty as to 
the underlying mechanisms of sarcopenia with a raft of mechanisms 
proposed to be at play, although which if any of these is the most 
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significant is still to be determined. One suggestion is that there may be 
genetic determinants of sarcopenia (Gonzalez-Freire et al., 2010), although 
FXUUHQWUHYLHZVVXJJHVWWKDW³VDUFRSHQLFJHQH´NQRZOHGJe is tentative and 
inconsistent (Tan et al., 2012; Garatachea & Lucia, 2011). A second, and 
much more accepted mechanism is that of alterations in muscle protein 
turnover. This has been shown by numerous research groups (Rennie, 
2009; Kumar et al., 2009; Rasmussen et al., 2006; Cuthbertson et al., 
2005; Guillet et al., 2004) and it is not a question of whether this 
mechanism contributes to sarcopenia and/ or dynapenia, but more a 
question of the underlying changes causing this dysregultion. A third 
proposed mechanism is that of changes in hormone (Lamberts et al., 1997; 
Haren et al., 2008) and cytokine (Yende et al., 2006; Roubenoff et al., 
1998) milieu, especially involving androgens, growth hormone, insulin-
like growth factor 1 (IGF-1) and interleukin (IL)-6. Loss of innervation is 
another proposed mechanism and this in itself can be attributed to a 
number of age-related changes including: 1. ³JURXSHG GHQQHUYDWLRQ
DWURSK\´ (Tomlinson et al., 1969), 2. a progressive loss of motor units 
(Brown, 1972) and 3. a compromised potential for terminal sprouting and 
reinnervation of muscle fibres (Einsiedel & Luff, 1992). The fifth proposed 
potential mechanism is that of compromised vascularisation (DeSouza et 
al., 2002) which may expose ageing muscles to hypoxia and impaired 
nutrient delivery. The sixth proposed mechanism is increased oxidative 
stress. With age there is a reduction in cellular anti-oxidant buffering and 
an increase in free radicals due to dysfunction in the mitochondrial 
respiratory chain (Barreiro et al., 2006). This increased exposure to 
oxidative stress may damage the muscles DNA, myofibrillar proteins, 
myocellular proteins, the neuromuscular junction, elements of the 
sarcoplasmic reticulum which are responsible for Ca+ release and also 
contribute to motor unit atrophy and the reduced number and function of 
satellite cells seen in old age (Bornemann et al., 1999). The penultimate 
proposed mechanism is that of poor nutrition, where despite the increases 
in body fat seen in old age, there is a decrease in food intake with age. The 
reasons for the anorexia of ageing are complex but are thought to include 
visceral, hormonal, neurological, pharmacological and psychological 
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factors (Morley, 1997), with many older adults failing to meet 
recommended protein requirements (Roubenoff & Hughes, 2000), which 
along with Vitamin D deficiency (Visser et al., 2003) has been shown to 
significantly increase the risk of sarcopenia (Solerte et al., 2008). The final 
proposed mechanism is that of physical inactivity. There is much evidence 
to support various modalities of exercise in older people, with 
improvements reported in muscle volume and torque (Morse et al., 2005), 
physical performance of activities of daily living (Liu & Latham, 2009) 
and in the promotion of muscle protein synthesis (MPS) and suppression of 
the expression of genes related to muscle protein breakdown (MPB) 
(Harber et al., 2009). Masters athletes have also been found to have 
protection against the age-related loss of motor unit number (Power et al., 
2012) and vascular responsiveness to vasodilatory stimuli (Ebeling et al., 
1993), the implications of which are outlined above.   
 
Continuing the theme of physical activity, evidence that resistance-exercise 
training (RET) is of benefit to older adults has been long documented, with 
different training types and methods instigating various responses and 
adaptations. It is well established that RET interventions can partially 
reverse losses in 1. strength (Fiatarone et al., 1990; Vandervoort, 2002; 
Porter et al., 1995; Frontera et al., 1988), 2. muscle mass (Hurley & Roth, 
2000; Tracy et al., 1999) and 3. power, thus reducing the difficulty in 
performing daily tasks, enhancing energy expenditure, improving body 
composition and promoting participation in spontaneous physical activity 
(Hunter et al., 2004).  
 
RET can be defined as movements performed against a specific external 
force and has benefits not only for the elderly but for people of all ages, be 
they performance, health-related or relative to desired changes in body 
composition. Using RET, both muscular strength and endurance are 
developed on the principle of overload; this is increasing the frequency, 
intensity or duration, to above that normally experienced. Every activity, 
including activities performed in everyday life, requires some degree of 
strength, power and endurance. The enhancement of muscular strength 
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and/ or endurance will enable individuals to perform these tasks with less 
physiological stress and will aid in maintaining functional independence 
(Franklin, 2000). For the elderly, it is believed that maintenance of muscle 
mass and strength as we age leads to much improved functional capacity 
and quality of life (Tipton, 2001), with exercise seeming more effective at 
preventing muscle loss than restoring lost muscle mass (Wolfe, 2006). 
 
With the exclusion of H2O, protein is the major component of muscle, so 
over a given period of time muscle loss will only occur if muscle protein 
breakdown (MBP) exceeds muscle protein synthesis (MPS). Acute RET 
has been shown to stimulate MPS, both absolutely and relative to MPB 
(Phillips et al., 1997); following a resistance training bout or session, with 
changes in MPS of a much greater magnitude than changes in MPB 
(Phillips et al., 1999). It has also been frequently suggested in the literature 
that muscle hypertrophy following chronic RET results from an increase in 
the basal level of MPS, such that during much of the day following 
training, muscle is in a more positive net protein balance. Studies have 
concluded that RET, for as little as two weeks results in an increase in the 
basal levels of MPS in both the young and the elderly (Yarasheski et al., 
1992; Hasten et al., 2000). 
 
Research has shown that short term RET may reverse 2-3 decades of 
muscle loss (Hikida et al., 2000; Yarasheski et al., 1999; Welle et al., 
1995) and in the elderly RET improved their performance of activities 
required for daily living (Fiatarone et al., 1990; Hunter et al., 2001; 
Skelton et al., 1995), both those based around strength and aerobic 
capabilities; as less activation is required to stimulate a stronger muscle, 
hence delaying fatigue (Frontera et al., 1990). Even in the frail elderly, 
progressive RET has been shown to increase muscle strength, gait velocity 
and power and although these improvements in muscular performance 
were paired with only a modest 2.7% increase in muscle cross-sectional 
area, the frail elderly did retain the ability to increase their rate of MPS in 
response to RET, with increases of up to 48% following a 16 week RET 
program (Yarasheski et al., 1999).  
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The smaller than expected increase in muscle cross-sectional area observed 
by Yarasheski and colleagues (Yarasheski et al., 1999) suggests that 
contractile proteins within the muscle cells of physically frail elderly 
people have a reduced capacity to hypertrophy in response to RET. This 
suggestion in combination with the work of others, who observed that RET 
increased the MPS in healthy elderly to a similar magnitude as it did in 
healthy younger subjects (50-180%) (Hasten et al., 2000), leads one to 
suggest that for optimal benefits and to promote healthy ageing, RET 
should where possible, begin before frailty occurs (Greig et al., 2011).  
 
In this work we aimed to collectively assess the impact of 20 weeks RET 
on muscle structure and function (focus of chapter 2), body composition 
(focus of chapter 3) and risk factors for chronic disease (focus of chapter 4) 
in young, middle-aged and older individuals.  
 
1.2 Study design 
 
1.2.1 Screening and participant inclusion 
Recruitment for this study resulted in the inclusion of 51 subjects who 
formed 3 groups and underwent the complete study protocol (Table 1.1). 
We recruited 9 males and 5 females aged 18-28 y who are referred to as 
µ\RXQJ¶ :H UHFUXLWHG 10 µPLGGOH-DJHG¶ PDOHV DQG 10 µPLGGOH-DJHG¶
females aged 45-55 y and we also recruited 10 males and 7 females aged 
65-75 y, WKHµROG¶DJHJURXS5ecruitment targeted healthy volunteers, who 
in the opinion of a clinician were capable of participating. Healthy 
volunteers were recruited from the community by poster advertisements, 
radio and newspaper coverage, internet advertisements and recruitment 
talks at targeted interest groups.  
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Table 1.1 Subject characteristics 
 
Age-Group Males: Females Age (y) ±SEM BMI (kg·m2) ±SEM 
Young 9:5 24.9±3.5 23.5±2.3 
Middle-aged 10:10 49.5±3.7 26.7±3.0 
Older 10:7 69.6±3.2 26.9±1.9 
 
Subjects were excluded from study recruitment if they showed evidence of: 
x Overt muscle wasting .i.e. more than one standard deviation below 
normal muscle or fat-free mass (FFM) for age (Fuller et al, 1992). 
x A body mass index (BMI) <18 or >28, or a BMI >30 with a waist 
circumference >102cm (males) or >88cm (females). 
x Active cardiovascular disease: uncontrolled hypertension (blood 
pressure (BP) >160/100), angina, heart failure or arrhythmia. 
x Cerebrovascular disease: previous stroke, large vessel or 
intracranial aneurysm. 
x Respiratory disease including chronic obstructive pulmonary 
disease (COPD) and severe asthma. 
x Metabolic disease: hyper and hypo parathyroidism, untreated hyper 
DQGK\SRWK\URLGLVP&XVKLQJ¶VGLVHDVHW\SHV,RU,,GLDEHWHV 
x Active inflammatory bowel disease, renal disease or malignancy 
x Recent (within 6 months) steroid treatment or hormone replacement 
therapy. 
x Clotting dysfunction e.g. DVT, pulmonary embolus, warfarin 
therapy and/ or haemophilia. 
x Pregnancy: all pre-menopausal women were tested prior to both 
acute studies. 
x Musculoskeletal or neurological disorders. 
 
Ethical approval for all aspects of this study was granted by The University 
of Nottingham Medical School Ethical Advisory Committee and was 
received on the 21/03/2006 (Appendix 1).  
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Prior to their baseline acute study and after reading the volunteer 
information sheet (Appendix 2) subjects underwent a screening session in 
which they were asked to provide written consent for participation in the 
study (Appendix 3). They underwent a medical examination; including 
medical history, a physical examination, physical strength tests, an 
electrocardiogram (ECG) and blood tests (FBC, U&E, Glucose, LFT and 
TFT) to ensure they fulfilled all inclusion criteria. Body composition was 
measured by dual energy X-ray absorptiometry (DEXA) (Lunar Prodigy II, 
GE Medical Systems). 
 
At their screening session subjects performed a 1-RM assessment on a leg-
extension RET machine (ISO Leg Extension, Leisure Lines (GB) Ltd) to 
be used for the calculation of the exercise to be performed during the 
VXEMHFW¶VDFXWHVWXGLHV 
 
1.2.2 Baseline acute study prior to RET 
Following their screening visit subjects underwent a baseline acute study. 
They were required to fast for 12 hours prior to this study commencing.  
 
Under local anesthetic (1% lignocaine) a cannula was introduced into a 
forearm vein for infusion of stable tracer amino acids, a hand vein for 
arterialized blood sampling and the femoral vein of each leg for venous 
EORRGVDPSOLQJ7KH³KRW-KDQG´WHFKQLTXHZDVXVHGWRREWDLQDUWHULDOized-
venous blood samples, as a less invasive alternative to direct arterial 
sampling. A well-established WHFKQLTXH GHYHORSHG LQ WKH ¶V WKLV
method involved placing the hand in a heated box, at ~55°C to create an 
arterio-venous shunt of blood by vasodilation of veins in the fingers, 
allowing arterialized-venous blood sampling from a retrograde catheter in 
the dorsum of the hand (Abumrad et al., 1981). 
 
Primed constant infusions of stable isotope amino acids were continued for 
the duration of the study and blood samples taken as illustrated (Figure 
1.1). Plasma samples were collected and processed for the quantification of 
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insulin, cytokines, serum cholesterol and glucose and for use in measures 
of muscle protein synthesis. 
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Figure 1.1 Schematic representation of baseline acute study protocol. 
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During the first two hours of the acute study, subjects were given tracer 
infusions only and studied in the postabsorptive state.  
 
At two hours the subjects were asked to perform one leg resistance 
exercise; unilateral leg extensions at 75% 1-RM on a free weight leg 
extension machine (ISO Leg Extension, Leisure Lines (GB) Ltd). All 
subjects performed 6 sets of 8 repetitions followed by 2 sets of 10 calf-
raises on the exercising leg to ensure blood flow to the lower leg muscles 
(i.e. Soleus and Gastrocnemius).  
 
After the exercise the subjects received small intermittent meals, every 30 
minutes, consisting of a clinical liquid nutritional supplement (Fortisip, 
Nutricia Clinical Care), supplying energy at 4.25 times the subjects basal 
metabolic rate (BMR), calculated by standard equations (Schofield, 1985) 
and with 15% of the total energy being supplied as protein: 
 
7RWDOGRVH >ɯ%05NFDO24 h-1@ɯ 
 
Biopsies (~150 mg) of Vastus Lateralis muscle (Figure 1.2) were taken 
from WKH µUHVW OHJ¶ at 0 hours, from both legs immediately following the 
exercise bout, and from both legs 2.5 hours after the exercise. Biopsies 
were taken using the conchotome technique (Dietrichson et al., 1987) after 
skin and fascia incisions were made under local anesthesia (1% 
lignocaine). Subsequent biopsies after the initial biopsy at 0 hours were 
taken at least 2cm proximal to the last. At each time point three ~50 mg 
tissue samples were collected from the same biopsy site; a sample for RNA 
extraction was immediately snap-frozen in liquid nitrogen and the other 
two, for tracer analysis and protein extraction were washed in ice-cold 
phosphate buffered saline (PBS) before snap freezing in liquid nitrogen 
and then being stored at -80oC prior to analysis (Figure 1.3). The biopsy 
sites were closed with synthetic sutures and covered with shower-proof 
dressings. Sutures were removed and biopsy sites checked at 7 days 
following the acute study. 
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Taken from: www.orgs.jmu.edu/strength/images/male_muscles_quadriceps.htm 
Figure 1.2 Superficial muscles of the upper right leg, anterior surface. 
 
 
 
 
 
   
A.                                                         B.
 
 Figure 1.3 Muscle biopsy extraction and collection. 
A. Muscle biopsy extraction by clinician 
B. Muscle biopsy preparation by technician prior to storage 
 
Measurements of leg blood flow using Doppler ultrasound were obtained 
from both legs at three time points nearing the end of both the fasted and 
fed phases.  
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1.2.3 Repeat acute study after RET 
More than three but less than seven days after the final exercise session of 
RET, subjects underwent a repeat acute study. Protocol for this was 
identical to the baseline acute study with the exception of it being preceded 
by a DEXA (GE LUNAR II) scan, as previously performed at the 
screening session. 
 
1.2.4 Diet diaries 
At the first acute study, at least one week before RET began all subjects 
were asked to complete a 3-day diet diary recording all food and drink 
taken during that three day period. Subjects were advised how to record 
their intake accurately and diet diaries based on those used by The Royal 
Derby Hospital dietetic department were issued, including instructions for 
completion of the diary (Appendix 4). Subjects were asked to complete a 
second diet diary mid-way through their RET program (week ten or 
eleven). 
 
1.2.5 Resistance-exercise training program 
The aim of the RET program was to improve muscular strength and 
endurance, and achieve skeletal muscle growth (muscular hypertrophy). 
Muscular strength is defined as the maximal force that a muscle or muscle 
group can generate (Wilmore & Costill, 1999) and this is often assessed 
using the one repetition maximum test (1-RM). Muscular strength is 
achieved using resistance that requires maximal or near maximal muscle 
tension over relatively few repetitions, while muscular endurance is 
developed using lesser resistance but performing a greater number of 
repetitions. Current guidelines advise 8-12 repetitions resulting in near 
failure on the final repetition to elicit improvement in both muscular 
strength and endurance in healthy individuals (Franklin, 2000). Based on 
this all subjects trained three times a week (Kraemer et al., 2002), with 
each session lasting approximately 60 minutes. Training intensity 
(following four weeks of initiation sessions) was 70% 1-RM (Evans, 1999; 
Rhea et al., 2003) based on single sets (Carpinelli & Otto, 1998) of 12 
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repetitions (Kraemer et al., 2002; Pollock et al., 1994) with 2 minutes rest 
between sets. To ensure equipment familiarity and correct technique was 
adhered to, the first 4 weeks of each subjects RET was at 40-60% 1-RM. 
Throughout the RET program a trained gym instructor verbally encouraged 
the subjects and ensured proper form and technique was performed. 
 
1-RM assessments were performed by each subject every four weeks to 
ensure that the intensity of their training remained relative to their 1-RM 
regardless of any strength changes that occurred with blood pressure and 
resting heart rate also measured at four-weekly intervals. 
 
To ensure uniformity between the amounts of training performed by each 
subject they were excluded from the study in the event of non-compliance, 
defined as: 
x Non-attendance for >6 consecutive sessions 
x Less than 75% attendance (< 36/48 sessions) 
x Failure to complete the set exercise regime on >15% attendance (> 
7 sessions)  
 
Although the order and number of multiple sets per exercise varied 
between the three sessions each week to prevent boredom and drop-out, the 
same total numbers of repetitions were performed each session over a total 
of 8 exercises as detailed below (Table 1.2). A full training log was 
provided for each subject (Appendix 5), with weight lifted the only 
variable between subjects according to their 1-RM. 
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Table 1.2 Resistance-exercise training program. 
Exercise Primary muscles 
trained 
Workout 1 
(sets) 
Workout 2 
(sets) 
Workout 3 
(sets) 
Seated Chest 
Press 
Pectorals, Deltoids, 
Triceps 
2 4 1 
Lat Pull 
Down 
Latissimus Dorsi, 
Trapezius, Biceps 
2 4 1 
Seated Lever 
Row 
Latissimus Dorsi, 
Biceps 
2  4 
Leg 
Extension 
Quadriceps 2 4 1 
Seated Leg 
Curl 
Hamstrings 2 4 1 
Seated Leg 
Press 
Quadriceps, 
Hamstrings, Gluteals 
2  4 
Back 
Extension 
Erector Spinae 2  2 
Abdominal 
Curl 
Abdominals 2  2 
Number of 
sets 
 16 16 16 
 
1.3 Statistical analysis 
Statistical analyses were performed using Graph Pad Prism (Version 5.02). 
All data are reported as means ± SEM with significance set at P<0.05, 
unless otherwise stated. 
   
Two-way ANOVA with Bonferroni post-hoc analysis was used to compare 
age-group differences before and after RET in basal, fed and fed-plus-
exercised conditions for measures of MPS, leg blood flow (LBF), leg 
vascular conductance (LVC) and leg peripheral resistance (LPR). Protein 
concentrations/ phosphorylation for measures that were made in all three 
conditions were also measured using 2-way ANOVA and Bonferroni post-
hoc analysis after data had been LOG transformed for normality. 
 
Strength, body composition (BC), blood pressure (BP), resting heart rate 
(RHR) and diet diary analysis were analysed using ANOVA with 
Bonferroni or Newman-Kelus post-hoc analysis. Basal protein 
concentrations were also analysed using ANOVA with Bonferroni post-
hoc analysis again after LOG transformation. 
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Correlations between strength and lean mass, body fat % and BMI or LBF 
and age were displayed using linear regression and analysed using 
3HDUVRQ¶VFRUUHODWLRQ 
 
Myosin heavy chain distribution, RNA: DNA: Protein ratios, Glucose 
concentrations, insulin concentrations, HOMA, glucose: insulin ratios, 
cholesterol profiles and cytokine concentrations were analysed using 
ANOVA with Bonferroni post-hoc analysis between groups and students t-
test between paired samples before and after RET. 
 
Glucose and insulin handling were analysed using ANOVA with 
Bonferroni post-hoc analysis on area-under-the-curve values generated for 
each individual subject. 
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CHAPTER 2- INDICATORS OF FRAILTY 
 
2.1 Introduction to frailty 
 
Progressive sarcopenia, the age-related loss of skeletal muscle mass, is 
ultimately central to frailty (Wolfe, 2006a), a condition that is highly 
prevalent in old age and is associated with an increased risk of falls, 
disability, hospitalization and morbidity (Fried et al., 2001). For many 
years frailty was considered synonymous with disability and co-morbidity 
but is now being recognized as an independent, distinct clinical syndrome 
(Fried et al., 2001).  
 
2.1.1 Cycle of frailty 
Based on the cycle of frailty (Fried & Watson, 1998) (Figure 2.1) Fried 
identified the phenotype of frailty as the presence of three or more of the 
following factors  (Fried et al., 2001): 
 
1. Unintentional weight loss of >5% body weight in one prior year. 
2. Grip Strength weakness: Grip Strength ability in the lowest 20% of 
the population, adjusted for gender and BMI. 
3. Poor endurance and energy as indicated by self-report of 
exhaustion. 
CHAPTER HYPOTHESES: 
i. There are age-related declines in muscle strength that are associated 
with lower dietary protein intake in older individuals. 
ii. Resistance-exercise training will improve muscle strength but the 
gains will be less in older individuals. 
iii. Age-related declines in muscle strength are associated with a 
difference in muscle fibre composition.  
iv. Resistance-exercise training will alleviate age-related declines in 
muscle protein synthesis in the basal condition and in response to 
feeding. 
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4. Slowness: Time to walk 15 feet in the slowest 20% of the 
population, adjusted for age and height. 
5. Low Physical Activity: A Physical Activity score in the lowest 
TXLQWLOHEDVHGRQ0(7¶VDGMXVWHGIRUDJHDQGJHQGHU 
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Adapted from: Fried and Watson, 1998 (Fried & Watson, 1998) 
Figure 2.1 Cycle of Frailty 
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A reduction in physical activity is one component of the cycle of frailty 
(Figure 2.1) and it is commonly believed that disuse accounts for as much 
as 50% of the decline in work capacity with ageing. Losses of muscle due 
to ageing are very similar to losses of muscle due to inactivity (Bortz, 
1982). Inactivity has a depressive effect on muscle protein metabolism 
which may influence muscle protein balance and result in muscle mass loss 
(Ferrando et al., 1996), although a relatively small volume of RET seems 
to be enough to alleviate this decrease in MPS (Klitgaard et al., 1990). As 
well as deleterious effects on muscle protein metabolism disuse is also 
associated with a decreased capacity to utilize substrates such as fatty 
acids, glucose and pyruvate.  
 
A combination of decreased levels of physical activity with age and 
physiological changes (Roth et al., 2000; Voorrips et al., 1993) may go 
some way to explaining the extent of sarcopenia (which can progressively 
lead to frailty) in elderly individuals, although it is still unknown if the 
primary cause is the physiology of ageing RU WKH ³SK\VLRORJ\ RI GLVXVH´
(Wilmore, 1991). 
 
2.1.2 Muscular changes and frailty 
2.1.2.1 Sarcopenia 
Skeletal muscle is required for a large range of functions including the 
preservation of posture, mobility and strength, as well as metabolic 
functions such as glucoses homeostasis. The term sarcopenia was coined to 
describe age related losses of skeletal muscle (Rosenberg, 1997), which 
according to cross-sectional and longitudinal studies has already started in 
the third decade of life, with a marked acceleration by the fifth (Larsson et 
al., 1979; Melton, III et al., 2000; Janssen et al., 2004). There are some 
factors which have been shown to be correlated to adult lean body mass 
(LBM) that we can do very little about, such as the positive correlation 
between birth weight and LBM (Gale et al., 2001). We can however 
mediate a number of lifestyle factors to reduce the risk of sarcopenia, for 
example both smoking and excessive alcohol consumption have been 
shown to increase this risk (Szulc et al., 2004; Lang et al., 2003). 
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Sarcopenia, is associated with muscle weakness, increased fatigue and a 
loss of independent function; all characteristics of physical frailty 
(Yarasheski et al., 1999). Current definitions of sarcopenia use a 
comparison of LBM or skeletal muscle mass of the subject, with that of a 
height and weight matched young adult. Baumgartner and others take 2 
standard deviations (SD) below the mean muscle mass for age as defining 
significant sarcopenia, (Baumgartner et al., 1998) which results in 
prevalence estimates of 13-24% for those 65-70 y and greater than 50% in 
those aged 80 y or older. OWKHUVXVHWKUHVKROGVLQUHODWLRQWRWKHµVNHOHWDO
PDVV LQGH[ UDWLR¶ OHDQERG\PDVV NJKHLJKW P2)) where sarcopenia is 
denoted as values below 5.75 kg/m2 for women and 8.5 kg/m2 for men 
(Janssen et al., 2004). Another index has come into use recently to 
characterize the muscle mass of the limbs, the appendicular lean-tissue 
body mass (ALBM) score, which is also used in relation to height (Kim et 
al., 2002). 
 
Sarcopenia is a widespread syndrome that can have a devastating effect on 
quality of life (Wolfe, 2006b) and causes considerable morbidity 
(Baumgartner et al., 1998). As skeletal muscle is the primary site for 
glucose and triglyceride oxidation and the most predominant determinant 
for resting metabolic rate (Zurlo et al., 1994) sarcopenia may contribute to 
negative conditions of peripheral insulin resistance, dyslipidaemia and 
increased adiposity (Greiwe et al., 2001), all of which are known to be 
detrimental to human health. 
 
The average person spends 15% of their lifespan in an unhealthy state 
requiring hospitalization or care, due to disability, injury or disease 
occurring in old age (Hunter et al., 2004). Age-associated losses of skeletal 
muscle mass and strength are widely documented in the current literature 
and it is estimated that by 80 years of age humans generally lose 30-40% 
of skeletal muscle fibres (Dirks & Leeuwenburgh, 2005) and voluntary 
contractile strength is decreased, on average, by up to 40% (Doherty, 
2003). The most notable strength reductions are reported in the weight 
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bearing lower limb muscle groups (Hunter et al., 2004), with decreased 
strength during both flexion and extension (Evans, 1992). Power output 
also declines with ageing and may be important in the incidence of falls 
(Caserotti et al., 2001) and the inability to perform weight bearing tasks 
(Samson et al., 2000).  
 
Sarcopenia is associated with many important outcomes, both social and 
clinical, such as: 
  
x Mobility impairments (Melton, III et al., 2000; Sternfeld et al., 
2002; Davison et al., 2002) 
x Disability (Baumgartner et al., 1998; Visser et al., 1998)  
x Falls (Baumgartner et al., 1998) 
x Fractures, (Melton, III et al., 2000b)  
x Increased body fat; which can in itself cause functional difficulties 
(Weinsier et al., 2000) and is also associated with increased 
dyslipidaemia and reduced insulin sensitivity (Hunter et al., 2004) 
x Frailty (Puts et al., 2005) 
x Loss of independence (Baumgartner et al., 1998; Janssen et al., 
2002).  
 
Sarcopenia has been associated with substantial increases in morbidity and 
premature mortality (Janssen et al., 2004). Severe sarcopenia increases the 
likelihood of developing a disability by 2-fold in men and by 3-fold in 
women (Janssen et al., 2002) and doubles the chances of premature death 
(Cawthon et al., 2007). Sarcopenia also poses a major problem for those 
admitted to hospital, with post operative hospitalization time and 
complication rate increased in patients with evidence of muscle wasting 
(Windsor & Hill, 1988). Diminished hand-grip strength, which is 
associated with lean tissue losses (Heimburger et al., 2000) is associated 
with increased mortality due to stroke, pneumonia, heart disease and 
cancer (Sasaki et al., 2007; Gale et al., 2007). 
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It is not just the loss of muscle mass that is detrimental to human health 
and well-being with age. Losses of strength and power are reportedly up to 
3-fold greater than losses of mass (Goodpaster et al., 2006), with suggested 
losses of 1-2% per year in isometric strength (Hughes et al., 2001; 
Rantanen et al., 1998).  These are not however consistent in all individuals 
as biological variability, lifestyle choices and nutritional status can all have 
an impact. In fact, in some older individuals strength is maintained over a 
number of decades (Rantanen et al., 1998), holding back frailty and losses 
of independence maintenance. 
 
The impaired functional capacity often associated with ageing (Evans & 
Cyr-Campbell, 1997) and the associated diminished muscle mass and 
reduced strength (Bassey et al., 1992; Rantanen et al., 1999) can lead to 
both reduced independence, quality of life (Daley & Spinks, 2000; 
Winograd et al., 1991) and potentially contribute to falls (Reeves et al., 
2004). Whipple and colleagues found that the strength of elderly people 
who suffered falls was significantly lower than in elderly people who did 
not fall.  
 
With the detrimental effects of sarcopenia well established, methods by 
which it may be limited or countered are always welcome and may be 
sought from the list of established risk factors based on current findings 
(Whipple et al., 1987), although some are pre-determined and inevitable 
(Table 2.1). 
 
Table 2.1 Risk factors for sarcopenia 
Established risk factors for sarcopenia 
 
Advancing age 
Low body weight 
Physical inactivity 
Female sex 
Low birth weight 
Impaired lower limb function 
  
 
 44 
Any condition associated with relative anorexia, low physical activity or 
inflammation increases the risk of muscle wasting and is therefore a 
significant risk factor for sarcopenia (Poehlman et al., 1995; Kyle et al., 
2002). 
 
Muscle contains ~35% of all total body protein (Cohn et al., 1980) which 
is maintained by a continual process of protein synthesis and breakdown. A 
negative balance in muscle protein metabolism, where MPB exceeds MPS 
is required for muscle loss. Skeletal muscle mitochondrial and contractile 
protein synthetic rates decline with age (Rooyackers et al., 1996; 
Yarasheski et al., 1993) and are associated with reduced muscle mass, 
decreased muscle strength and decreased endurance capacity (Balagopal et 
al., 1997; Yarasheski et al., 1993; Welle et al., 1995; Rooyackers et al., 
1996; Nair, 1995), although it is not known if the change in net MPS that 
occurs with ageing is due to change in basal muscle protein metabolism or 
the result of changing levels of physical activity and/ or nutritional status. 
Either way, this association suggests that an increase in muscle protein 
synthesis should result in an improvement in muscle strength and function, 
and modulate the disability associated with physical frailty and ageing 
(Yarasheski et al., 1999). 
 
It has been suggested that the basal level of MPS is reduced by ageing 
(Hasten et al., 2000; Balagopal et al., 1997) therefore leading to a constant 
decrement in net muscle protein balance and ultimately, may go some way 
to explain muscle loss with ageing. However, there is great inconsistency 
in the literature surrounding this concept, with some authors reporting no 
difference between the FSR of mixed muscle proteins between the young 
and the elderly (Volpi et al., 2001). 
 
Alternative proposed mechanisms for the cause of sarcopenia in the elderly 
include a decline in serum anabolic hormones (Morales et al., 1998; Urban 
et al., 1995), increased myostatin (Thomas et al., 2000; Welle et al., 2002; 
Corsi et al., 2002), higher levels of TNF-Į(Argiles et al., 2000; Langen et 
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al., 2001), an inability to repair fibres, apoptosis and/ or a reduced capacity 
for satellite cell activation (Bornemann et al., 1999). 
 
Satellite cells are the committed stem cells of adult skeletal muscle, located 
at the surface of the basal lamina of the myofibre. Their major function is 
to repair, revitalize and mediate skeletal muscle growth by differentiating 
into myocytes. Satellite cells are normally non-proliferative, they do 
however become active when skeletal muscle tissue is injured or heavily 
used, for example when performing RET. It has been proposed that a 
reduced capacity for satellite cell activation in the elderly occurs because 
negative regulators of satellite cell activation, such as myostatin, could 
possibly down-regulate satellite cell activation by inhibiting the G1 to S-
phase transition (McCroskery et al., 2003). For satellite cell division 
quiescent cells need to enter the S-phase of the cell cycle from either the 
G1or G0 phase (Figure 2.2).  
 
Adapted from: www.nobelprize.org/medicine/laureates/2001/press.html 
Figure 2.2 Satellite cell cycle 
³*´UHSUHVHQWV*DS³6´UHSUHVHQWV6\QWKHVLV³0´UHSUHVHQWV
Mitosis 
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Although the definitive mechanism behind sarcopenia remains unclear, the 
negative impact it can cause is well established. It is likely a combination 
of factors interact to contribute to age-related physiological changes which 
lend themselves to muscle mass losses. 
 
2.1.2.2 Muscle protein metabolism  
Although the pathophysiology of sarcopenia is complex and not yet fully 
understood, it is known that changes in muscle protein turnover are 
required for alterations in muscle mass to occur. Muscle mass is 
maintained by a dynamic equilibrium in protein turnover in which net 
efflux of amino acids during fasting periods is offset by net influx (and 
incorporation into protein) during fed periods. Both ageing and exercise 
(topics explored in this project) may modulate the capacity for muscles to 
incorporate amino acids into protein; the key aspect for the regulation of 
hypertrophy and atrophy. 
 
There are 20 Amino acids (AA) which are incorporated into protein; 8 are 
essential (EAA), 10 are non-essential as they are synthesised endogenously 
DQG  DUH µFRQGLWLRQDOO\ HVVHQWLDO¶ LQ FHUWDLQ FLUFXPVWDQFHV ,W LV WKH $$
sequence which directly determines protein formation, which in turn 
determines structure and function (Table 2.2). 
 
Table 2.2 Amino Acid Classifications 
Essential 
 
Non-Essential 
 
Conditionally Essential 
Isoleucine Alanine Arginine 
Leucine Asparagine Histidine 
Lysine Aspartate  
Methionine Cysteine  
Phenylalanine Glutamate  
Threonine Glutamine  
Tryptophan Glycine  
Valine Proline  
 Serine  
 Tyrosine  
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The functions of protein include: 
 
1. Maintaining the structure of muscles and connective tissue 
2. Acting as messengers for hormones 
3. Acting as enzyme catalysts 
4. Acting as transporters  
5. Genetic regulation roles 
6. Fluid and pH balance 
 
Protein regulation accounts for about 20% of daily energy needs and this 
can increase during times of starvation or trauma when as well as 
LQFUHDVLQJ HQHUJ\ GHPDQGV PXVFOH SURYLGHV $$¶V WR VXVWDLQ SURWHLQ
synthesis in other tissues.  
 
Unlike carbohydrates and fatty acids, protein is not stored in the body, 
DOWKRXJKPXVFOHFDQSURYLGH$$¶VGXULQJ IDVWLQJ  After feeding MPS is 
LQFUHDVHGLQUHVSRQVHWRWKHLQFUHDVHGDYDLODELOLW\RI$$¶VEXWWKHGXUDWLRQ
of this increased response is limited to ~2 hours, even if the increased AA 
availability is maintained (Atherton et al., 2010). During fasting/ starvation 
MPB is increased to meet the demand, but there is a limit to how much 
protein can be catabolised to sustain the resultant negative nitrogen 
balance. 
 
The balance between protein synthesis and protein breakdown is closely 
regulated. Feeding HVSHFLDOO\LI($$¶VDUHLQFRUSRUDWHGDQGH[HUFLVHDUH
the most potent stimulators of protein anabolism and act synergistically to 
promote muscle mass via an increase in MPS and a decrease in MPB. 
Starvation and immobilization promote protein catabolism (Phillips et al., 
2009) though it appears that synthesis decreases under these conditions 
before a smaller increase in breakdown, which results in a net loss of 
muscle protein. Only in advanced stages of disease or sepsis does protein 
breakdown increase greatly, although the rate of synthesis is also increased 
to preserve protein mass.  
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It is understanding WKHPHFKDQLVPVRI036DQG03%DQGWKHµSDWWHUQV¶IRU
the loss and gain of protein that is essential to design effective therapies to 
prevent wasting and restore muscle mass. 
 
2.1.2.3 Muscle protein synthesis 
Protein synthesis requires the transfer of genetic information from 
deoxyribonucleic acid (DNA) into protein which involves the transcription 
of mRNA and subsequent translation on ULERVRPH¶V involving tRNA. 
Three nucleotides (bases) in the mRNA are required to specify particular 
$$¶VIRULQFOXVLRQ 
 
The translation process consists of three stages: Initiation, elongation and 
termination. The initiation and termination stages can be regulated to affect 
the rate of protein synthesis. The initiation complex is formed when the 
ribosome assembles on the mRNA in the presence of various initiation 
factors. The ribosome moves down the mRNA to the start AUG codon and 
forms the 70-S initiation complex. Each AA has a specific aminoacyl-
tRNA synthetase, which catalyzes the binding of the AA to an acceptor site 
on the t-RNA forming aminoacyl-tRNA. This carries the AA to the 
ribosome where it binds and is committed for protein synthesis.    
 
Elongation involves the binding of subsequent aminoacyl-tRNA 
complexes. The ribosome moves one complex down the mRNA and the 
initiation process is repeated. The protein is released when a stop codon is 
reached; this is termination. 
 
Post-translation proteins may be modified or spliced, further increasing the 
number of proteins. A single protein may also have many interactive 
domains allowing it to simultaneously have multiple functions. Although 
the AA constituents of a protein do not necessarily indicate the role of that 
protein in a cell they can suggest a common function between proteins. 
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2.1.2.4 Muscle protein breakdown 
There are three main systems of protein breakdown: i. Proteolytic systems, 
ii. Metabolism of the amino-nitrogen and iii. Metabolism of the carbon 
backbone. 
 
1.  There are three proteolytic pathways used. i. The lysosomal 
proteolytic pathway effects surface membrane proteins and 
extracellular proteins. These proteins are taken up by endocytosis 
and degraded within the lysosomes by proteases. ii. The calcium-
ion activated calpains pathway is activated in response to cell 
injury. The resultant rise in calcium concentration leads to 
increased proteolytic activity within the damaged tissue and/ or 
DNA damage leads to the activation of caspases and results in 
apoptosis within the mitochondrion. iii. The ubiquitin-proteasine-
dependent pathway degrades most intracellular protein. This system 
catalyzes the degradation of long-lived proteins and short-lived 
regulatory proteins. It is this pathway that causes atrophy in times 
of trauma, fasting or immobilisation, although this pathway does 
result in amino acid release which can be re-used as incorporation 
into new proteins.  
 
2. The metabolism of the amino-nitrogen system of degradation is 
initialised by the removal of the amino group, which may be 
accomplished by oxidative deamination, transamination or 
dehydration all of which result in different paths to amino acid 
degradation.  
 
3. Metabolism of the carbon backbone contributes to protein 
breakdown as there is continual oxidatioQ RI $$¶V DV PHWDEROLF
fuel.     
 
2.1.2.5 Muscle protein balance 
As previously mentioned, skeletal muscle contains ~35% of all total body 
protein (Cohn et al., 1980), which is maintained by the continual processes 
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of MPS and MPB outlined above. Skeletal muscle accounts for between 25 
and 50% of all protein turnover in the body, dependent upon feeding status 
(i.e. postabsorptive or postprandial) (Tessari et al., 1996). Amino-acids 
which are released during protein turnover can be used for cell growth and 
repair, or branched-chain amino acids (%&$$¶V) can be used as a fuel for 
skeletal muscle, although they contribute no more than 15% of total energy 
during exercise (Rennie et al., 2006). Different stimuli, both metabolic and 
physical can influence MPS and MPB. In general, MPS is responsible for 
gradual changes in muscle mass and MPB adapts to preserve tissue 
(Rennie & Millward, 1983).  
 
In healthy adults, in postabsorptive (PA) conditions MPB exceeds MPS, 
whereas in the postprandial condition both MPS and MPB increase, but 
increases in MPS are greater than increases in MPB resulting in a net gain. 
Typical in the PA condition varies between 0.04 and 0.08%.h-1, although 
this is dependent upon the stable isotope tracer and analysis/interpretation 
techniques used (Smith et al., 2007b). For example, measurements taken 
with leucine are approximately 20% greater than those taken using 
phenylalanine. 
 
2.1.2.5.1 Regulation of muscle protein synthesis by nutrients  
The anabolic effects of feeding are driven through two principal 
mechanisms: first, FSR of muscle proteins increase ~300% (Atherton et 
al., 2010) and second, MPB rates are depressed ~50% (Wilkes et al., 
2009). As the magnitude of change in MPS is greater than those of MPB, 
increases in MPS are the main driver of anabolic responses to feeding.  
 
Amino acids (Rennie et al., 1982), specifically EAA (Smith et al., 
1992;Volpi et al., 2003;Tipton et al., 1999) are the most significant 
anabolic stimulants of muscle protein turnover, with EAA required for 
sustained muscle growth. Of course, teleologically, the anabolic effects of 
EAA must be short-lived otherwise one could achieve hypertrophy through 
overfeeding.  
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The anabolic effect of EAA on FSR correlates with extracellular 
availability (Bohe et al., 2003), although there appears to be a delay of 
approximately 30 min before MPS is increased (Bohe et al., 2001). A 2-3 
fold increase in MPS has been observed following a 50% rise in EAA 
availability (Smith & Rennie, 1996), but MPS returns to baseline levels 
after ~150 min, even in the presence of continued EAA availability (both 
muscle and plasma AA) (Bohe et al., 2001;Atherton et al., 2010) 
suggesting DQ LQQDWH µPXVFOH-fuOO¶ UHVSRQVH FRQILUPLQJ WKH SUHPLVH WKDW
anabolic effects of EAA must be short-lived and discounting the possibility 
of MPS being driven by plasma/intracellular amino acid bioavailability per 
se. This µZLQGRZ¶ of ~150 min is similar to the response shown after a 
mixed meal, where physiological increases in AA typically return to 
baseline within 180 min (Bergstrom et al., 1990). The time-lapse required 
before a repeated increase in EAA availability can again increase MPS is 
not yet known. 
 
We are now beginning to understand the mechanisms of increased MPS in 
response to EAA. Confirmation of a role for mammalian target of 
rapamycin complex 1 (mTORc1) signalling was recently provided in a 
study in which administration of rapamycin (a specific inhibitor of 
mTORc1) blocked increases in mTORc1 signalling and MPS after oral 
EAA ingestion in humans (Dickinson et al., 2011). Work from our own 
group is also in agreement with this as after a feed of 48g whey protein 
rising MPS rates were matched closely with increases in mTORc1 
substrate phosphorylation (Atherton et al., 2010). There is however a 
caveat to this seemingly straight forward association, in the latter study by 
our group MPS returned to baseline 90 min after feeding despite continued 
up regulation of mTORc1 signalling, thus revealing some level of 
dissociation between MPS and mTORc1 .  
 
Another possible mechanism involves amino acid transporters which may 
serve as more sophisticated import mechanisms than first thought. For 
instance, it was recently shown that the anabolic effects of leucine require 
glutamine efflux via sodium-coupled neutral amino-acid transporter 
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member 2 (SNAT2) so the system-L amino-acid transporter 1 (LAT1) 
heteroexchange system can import leucine (Nicklin et al., 2009). 
Importantly, these transporters have been demonstrated to be acutely 
regulated by oral EAA intake in humans, with reported increases in mRNA 
and protein for both LAT1 and SNAT2 (Drummond et al., 2010).       
 
Insulin is another (postulated) feeding-based anabolic stimulus when 
accompanying other nutrients or after resistance exercise. Insulin promotes 
muscle gains primarily by inhibition of MPB (Louard et al., 1992), 
although it has been suggested that insulin also has a role to play in 
increasing MPS (Newman et al., 1994), a concept that some disagree with 
after demonstrating no effect of insulin-alone on MPS (Chow et al., 2006) 
or no additional effect of insulin/ carbohydrate on EAA promoted MPS 
(Greenhaff et al., 2008; Staples et al., 2011). 
 
2.1.2.5.2 Regulation of muscle protein synthesis by exercise 
It is now well established that nutrient sufficiency represents a necessary 
component of muscle remodeling and hypertrophy (Moore et al., 2009a) 
and that EAA potentiate acute anabolic responses to exercise. Recent work 
has however, provided new information surrounding the independent and 
synergistic anabolic effects of exercise and nutrients. 
 
It is not only bodybuilders and recreational weight-lifters who aim to 
increase muscle mass through RET, it also represents the most popular and 
accepted method in offsetting declines in muscle mass in both ageing and 
other muscle wasting conditions. An emerging theme in trying to 
understand the mechanisms of muscle hypertrophy is that of an intrinsic 
capacity of muscle to respond to RET. This concept is supported by a study 
from West and colleagues (West et al., 2009) ZKHUHE\ µKLJK¶ DQG µORZ¶
hormone environments were created through varying muscle recruitment 
YROXPH6\VWHPLFFRQFHQWUDWLRQVRIµDQDEROLF¶KRUPRQHVJURZWKKRUPRQH
(GH) and testosterone) did not impact on acute MPS responses to exercise 
or adaptive responses to RET. This concept is also supported by a study in 
which 14 days recombinant GH administration did not affect MPS despite 
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increases in serum GH, insulin-like growth factor (IGF-1) and IGF-1 
mRNA expression (Doessing et al., 2010). Support for this notion leads to 
the suggestion that anabolic hormones do not drive MPS or loading-
induced adaptations in humans and that these must instead be controlled by 
intrinsic autocrine/ paracrine factors and mechanotransduction processes.  
 
Not only do muscle cells appear to have an intrinsic signal to increase MPS 
but also selectivity over which proteins are to be synthesized; explaining 
how RET increases myofibre size, whereas endurance training increases 
fatigue resistance. This diversity in response to different training modes 
can be seen when MPS is measured in distinct muscle fractions. Wilkinson 
and colleagues reported that RET upregulated myofibrillar protein 
synthesis whereas endurance training specifically upregulated 
mitochondrial protein synthesis (Wilkinson et al., 2008). Additional work 
also shows that RET induced sustained increases in myofibrillar but not 
sarcoplasmic MPS (Moore et al., 2009b). Taken together, these results 
support the notion that myofibrillar protein accretion is the most important 
muscle fraction for muscle hypertrophy.  
 
Contractile exercise, like EAA intake is an important anabolic stimulus for 
MPS in skeletal muscle. High force contractions increase MPS by 50-
100% compared to basal rates, although this is accompanied by a 50% 
increase in MPB (Biolo et al., 1995). The response to acute exercise is 
seemingly determined by the duration and intensity of the exercise and 
whether the muscle is trained in that mode of exercise. i.e., heavily 
resistance-trained muscle does not appear to increase FSR in response to 
an acute bout of that type of exercise (Tipton et al., 1996);(Roy et al., 
1997). Following resistance exercise, the increased FSR has been reported 
to last ~48 h (Phillips et al., 1997). 
 
The combination of exercise and EAA feeding may have an important role 
in MPS. Fujita and colleagues suggested that a combination of AA and 
CHO feeding 60 min before a resistance exercise bout attenuates the FSR 
reduction that occurs during exercise compared to unfed controls (Fujita et 
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al., 2009) and when looking at possible mechanisms for the heightened 
synergistic response to these stimuli Moore et al, reported that 
phosphorylation of mTORc1 and mitogen-activated protein kinase 
(MAPK) were shown to be greater following the combination of exercise-
plus-feeding compared to exercise alone which may explain additive 
effects on MPS (Moore et al., 2011a).  
 
The question of optimal timing for nutrient intake in combination with 
exercise has long been a hotly debated topic and recent findings from Burd 
et al. demonstrate good reason to question the importance of timing. Burd 
et al. demonstrated that even 24 h after a single bout of resistance exercise, 
provision of EAA caused a much greater increase in MPS in the exercised 
leg compared to the rest leg (Burd et al., 2011a), suggesting that the 
additive effects of exercise to EAA ingestion are long-lived, and lead to the 
speculation that consuming adequate dietary EAA is more important than 
timing per se. 
 
As with feeding, there appears to be a latency period after an acute 
resistance exercise bout; of which the time is still not yet confirmed.  Some 
authors report 2 (Kumar et al., 2009) to 4 h (Tang et al., 2008);(Biolo et 
al., 1997) as the time before maximum increases in MPS are reached and 
others have described no MPS changes at 3 h but maximal responses 6 and 
24 h after exercise (Cuthbertson et al., 2005). This inconsistency suggests 
that the latency period prior to maximal responses may be due to 
differences in exercise intensity. This inconsistency may also explain the 
lack of change in FSR in resistance-trained individuals mentioned earlier in 
this section; it may not be that they do not have the ability to respond, but 
rather they may have a much longer latency that was not accounted for 
when final measurements were taken at 5 (Tipton et al., 1996) and 10 h 
(Roy et al., 1997) post-exercise.   
 
Taken together, AA¶V and acute exercise increase MPS by 2-3 fold, 
compared to baseline values (Cuthbertson et al., 2006), with no increase is 
MPB (Biolo et al., 1997), possibly due to the increased blood insulin 
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concentrations, and therefore result in a positive net balance and allow for 
the accretion of muscle. Data about the optimum timing of AA intake post-
exercise to elicit the best increases in MPS has been inconsistent, and this 
may be due to the number of variables in these studies, including AA 
source, exercise intensity and duration and the training status of the 
subjects involved. There are however suggestions that early feeding post-
exercise increases the maximal rate of MPS after exercise (Levenhagen et 
al., 2001) and recent data from Moore and colleagues (Moore et al., 2009a) 
shows a dose-response relationship between MPS and post-exercise 
protein, up to a maximum of 20g of protein. This synthesis date is 
supported by data from a recent training study, showing that protein 
supplementation immediately after exercise results in greater gains in 
LBM, than in those who received delayed feeding (Hartman et al., 2007). 
 
In summary, high-force contractions can increase MPS rates increase by 
~100% (Chesley et al., 1992; Biolo et al., 1995) but MPB rates increase by 
~50% (Biolo et al., 1995) and as MPB is greater that MPS in the PA 
condition these changes only result in neutral net balance. Therefore, to 
form a positive net balance a combination of these two anabolic stimuli; 
exercise and EAA feeding are essential.  
 
2.1.2.5.3 Regulation of muscle protein synthesis in catabolic conditions 
Causes of muscle atrophy may be broadly separated into wasting-
associated diseases, disuse and sarcopenia. The latter two of these 
categories are often entwined with levels of physical activity decreasing 
with advancing age. Although it has long been known that declines in PA 
MPS and/or increases in MPB are a catalyst for muscle atrophy, recent 
work has uncovereG D QHZ OD\HU RI G\VUHJXODWLRQ WHUPHG ³DQDEROLF
UHVLVWDQFH´WKDWVHHPVWRWUDQVFHQGWKHFDXVHVRIDWURSK\,QEULHIDQDEROLF
resistance is a deficit in the capacity to mount anabolic responses to 
activity and nutrients (Rennie & Wilkes, 2005; Fry & Rasmussen, 2011); 
the key influences of muscle mass maintenance. Anabolic resistance may 
UHSUHVHQWDSUHPDWXUH³PXVFOH-IXOO´VWDWHWKDWXQGHUOLHVDQGRUH[DFHUEDWHV
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atrophy and perhaps contributes to maladaption to exercise as seen in 
ageing (Figure 2.3). 
 
 
Figure 2.3 Schematic showing muscle protein synthesis responses in 
normal (²), catabolic (- -) and anabolic states (···). 
$UURZV LQGLFDWH WKH µPXVFOH-IXOO¶ VHW SRLQW ZKLFK FDQ EH PRGXODWHG LQ
terms of amplitude and/ or duration of MPS.   
 
2.1.2.5.4 Anabolic resistance to feeding in ageing muscles 
Although sarcopenia must involve an imbalance between MPS and MPB, 
rates of MPS and MPB during PA periods are unchanged with age (Volpi 
et al., 2000; Cuthbertson et al., 2005; Yarasheski et al., 1999; Katsanos et 
al., 2006) and this has been reported consistently for all fractions of muscle 
with only a few groups reporting diminished synthesis rates in the 
sarcoplasmic fractions of older muscle (Hasten et al., 2000; Balagopal et 
al., 1997). 
 
With this in mind, other mechanisms for sarcopenia have been sought; one 
of which is the concept of anabolic resistance. In support of this concept 
Cuthbertson et al. compared responses in MPS to oral EAA over a wide 
availability (2.5-40 g) and found that above 5 g EAA, older men exhibited 
smaller increases in MPS to those seen in young people, work which is 
also supported by others (Cuthbertson et al., 2005; Paddon-Jones et al., 
2004). In these studies demonstrating anabolic-blunting with advancing 
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age it appears to be related to reduced activation of the AA induced 
signalling pathways that promote MPS (Cuthbertson et al., 2005) and 
suggests that in response to AA older individuals are less likely to 
accumulate muscle protein. This blunted signalling response has been cited 
as having a role in the progression of sarcopenia (Paddon-Jones et al., 
2008). 
 
In contrast to this work, others have reported anabolic resistance but only 
at lower doses of EAA (Volpi et al., 2000) and Symons et al. found that 
administration of 113 g of lean beef (~30 g protein) raised MPS by 
approximately 50% in both young and old healthy subjects (Symons et al., 
2009). Similarly, Chevalier et al. (Chevalier et al., 2011) found no blunting 
in  the anabolic response under hyperglycaemic, hyperinsulinaemic, 
hyperaminoacidaemic conditions in which blood concentrations of insulin, 
total amino acids and glucose were maintained at ~300-400 pmol.l-1, 
~3300 µmol.l-1 and ~8 mmol.l-1, respectively. Taken together these 
findings support the notion that overcoming anabolic resistance is simply a 
matter of increasing total amino acid load; although remain at odds to 
reports of anabolic resistance at 20-40 g EAA (Cuthbertson et al., 2005) 
DQGWKHFRQFHSWRIDSUHPDWXUH³PXVFOH-IXOO´VLJQDOAtherton (Atherton et 
al., 2010). 
 
Consequently, perhaps it is the quality rather than the quantity of AA that 
is important for overcoming anabolic resistance. Pennings et al. (Pennings 
et al., 2011) compared acute anabolic responses of old men to casein, 
casein hydrolysate and whey protein. MPS rates were significantly higher 
following whey ingestion (0.15%.h-1) than casein (0.08%.h-1) or casein 
hydrolysate (0.10%.h-1); a result which the authors explained as being due 
to the faster absorption rates and a higher peak plasma concentration of 
leucine. These findings in combination ZLWKGDWDIURPWKH3KLOOLSV¶ODELQ
which MPS in young males was more effectively stimulated by a large 
single bolus of protein that by the sum of quantitatively equivalent smaller 
boluses (West et al., 2011) support the concept that rapid exposure of 
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muscle to amino acids and/ or peak leucine concentration may be 
important in determining anabolic sensitivity.  
 
The addition of novel dietary interventions have also proved efficacious 
and suggest that overcoming anabolic resistance may not be simply due to 
AA quantity/ quality. For example, 8 weeks supplementation of omega-3 
fish oils ameliorated anabolic resistance in elderly men smith (Smith et al., 
2011). Although consensus still needs to be reached on optimal feeding 
strategies to overcome anabolic blunting with age, this initial work is 
promising.    
 
2.1.2.5.5 Anabolic resistance to exercise in ageing muscles 
It is not only the anabolic responses to feeding that appear blunted in the 
elderly but also their responses to exercise. Young individuals have been 
shown to double their FSR after an acute bout of resistance exercise, while 
this does not appear to be so in older individuals, with a deficit in MPS 
responses of approximately 30% reported over a wide-span of exercise 
intensities (20-90% 1-RM) (Kumar et al., 2009). These findings were 
further corroborated by Fry et al. (Fry et al., 2011) who showed that ageing 
impairs contraction-induced human skeletal muscle mTORc1 signalling 
and MPS when sampling up to 24 h after exercise. Collectively these data 
may explain age-related reductions in trainability (i.e. muscle hypertrophy) 
with RET (Bickel et al., 2011). These findings of anabolic resistance with 
age are not restricted to RET, Durham et al. (Durham et al., 2010) reported 
age-related decline in MPS responses to walking in the fed state. 
Therefore, it may be that anabolic insensitivity even to mild, habitual 
activity may exacerbate the catabolic effects of sedentarism associated with 
ageing.  
 
As with feeding there is conflicting data that casts doubt on the existence 
and/ or severity of anabolic resistance to exercise with age. For example, 
Symons et al. (Symons et al., 2011) found that when a bout of resistance 
exercise was combined with a high protein meal there was no difference in 
MPS responses between young and older individuals. Drummond et al. 
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(Drummond et al., 2008) UHSRUWHGWKDWWKHµFXPXODWLYH¶DQDEROLFUHVSRQVH
to resistance exercise and EAA is similar between young and old but that 
the response is simply delayed with ageing. Based on this proposition 
shorter-duration post exercise studies must be read with caution as they 
may not be able to capture the complete long-term anabolic effects of 
exercise (Burd et al., 2011). A study design which encompasses a longer 
post-exercise measurement period (Fry et al., 2011) is more likely to 
identify potentially important differences that could be masked under 
short-study formats (Phillips et al., 2012). 
 
For those supporting the notion of anabolic blunting with age suggestions 
have been made that these blunted responses in the elderly can be 
improved after a relatively short period of RET (of as little as 2 wk) 
(Hasten et al., 2000), while others report that even after 3 months of high 
intensity RET anabolic blunting was still apparent in older individuals 
(Welle et al., 1995). The data from Hasten was measured 3 h after acute 
exercise, compared to 24 h after by Welle and colleagues and this 
discrepancy renders these results difficult to compare as explained above.  
 
It is clear to see the benefits of exercise and/ or activity on anabolic status 
when you examine the situation of disuse, something which becomes much 
more likely with age. Consider the following: 
 
x Normal turnover is 0.05%.h-1 (or 1.2%.day-1) in which MPS and 
MPB are equal and opposite 
x MPS increases three-fold for 1.5 h with feeding 
x Approximately 5 h per day is spent in fed periods (Atherton et al., 
2010) 
 
Based on conservative assumptions from previous findings MPS is 
suppressed ~50% in both PA and fed periods with disuse which would 
equate to: 
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Protein accretion = (0.025 x 19 (PA hours)) + (0.025 x 1.5 x 5 (fed)) = 
0.66%.day-1 
 
Thus, if MPB remained constant: 
 
Muscle loss = 1.2-0.66 = 0.54%.day-1 
 
a figure entirely consistent with that measured (0.6%.day-1) over the first 
30 days of immobilization (Phillips et al., 2009).   
  
It is not only exercise training but also changes to the format of an acute 
exercise bout that may improve anabolic responses in the elderly. 
Following on from their study in which anabolic blunting with age to 
resistance exercise over a range of intensities (20-90% 10RM) was 
demonstrated (Kumar et al., 2009), Kumar and colleagues doubled work 
by increasing the number repetitions performed  which significantly 
increased FSR in the older men, this time regardless of the intensity (40 or 
75% 1-RM) and bought the FSR of the older men to a level not 
significantly different to that of the younger men who performed the 
RULJLQDOµVLQJOH¶ZRUNORDGDWWKHVDPHLQWHQVLW\Kumar et al, Gerontology, 
in press), effectively restoring their anabolic response. 
 
2.1.2.3 Muscle fibre type 
A muscle fibre is linked to a single motor neuron and expresses 
characteristic molecules to determine its contractile function, namely 
different myosin heavy chain (MHC) isoforms and metabolic enzymes. 
The mechanisms of how different contractile functions are determined are 
still not fully understood although both the motor neuron and muscle fibre 
type have been implicated to play a role in this process. Diversity within 
human muscle is based on genetic predisposition and future differential 
expression and gene regulation is regulated by the two mechanisms 
outlined below (Bottinelli & Reggiani, 2000): 
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1. A qualitative mechanism whereby many muscle proteins exist in 
forms that are similar but not identical, these are known as 
isoforms. Isoforms can derive from the same gene through 
alternative splicing or from different genes of the same family 
(isogenes). Isoform generation is the first mechanism in generating 
diversity within muscle fibres. 
 
2. Differential expression of the same gene is a quantitative 
mechanism whereby the proportion of up and down-regulating 
products such as neural discharge, mechanical load and hormones 
differ between the same gene modifying and/or promoting new 
functional or structural features. 
 
The number of possible combinations and therefore variations as a result of 
the combination of the above two mechanisms is limited by constraints set 
either by structural requirements or by rules of expression which set 
preferential associations between isoforms (Bottinelli & Reggiani, 2000). It 
is for this reason that some combinations diminish and more frequent 
phenotypes of muscle fibres appear.  
 
Although the above mechanisms were not then understood, the diversity of 
VNHOHWDO PXVFOH KDV EHHQ UHFRJQL]HG VLQFH DV HDUO\ DV WKH ¶V
(Spangenburg & Booth, 2003). In 1873, Ranvier categorized muscles as 
red with slow muscle contraction and white with fast contraction, based 
upon appearance and stimulation of the muscles with electrical current. In 
1970, Brooke and Kaiser recognized more than one type of fast/ white 
fibre (Type II), labeling the fibre types: Type I, Type IIa and Type IIb 
(Brooke & Kaiser, 1970). This terminology was altered in 1972 by Peter 
and colleagues who devised a dual-functioning naming system based on 
both contractile properties and oxidative capacity. Type I became slow-
twitch oxidative red (SO), Type IIa became fast-twitch oxidative white 
(FOG) and Type IIb became fast-twitch glycotic white (FG) (Peter et al., 
1972). By the mid-¶V JURXSV KDG EHJXQ WR LGHQWLI\ WKH FRUUHODWLRQV
between myosin heavy chain isoform expression (via electrophoresis), 
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contraction speeds and myosin ATPase activity (Reiser et al., 1985; Staron 
& Pette, 1986). In 1989, Schiaffino et al, described a third possible fibre 
type in fast twitch muscle when they discovered IIx MHC protein 
(Schiaffino et al., 1989). 
 
Current classifications of human muscle fibre types commonly refer to 
three types based on histochemical staining of MHC, these being: type I 
µVORZ-UHG¶ W\SH ,,D µIDVW-UHG¶ DQG W\SH ,,[ µIDVW-ZKLWH¶(Smerdu et al., 
1994), with type IIb identified mainly in non-human species such as mice, 
rats, rabbits and sheep, although some type IIb fibres can be found in the 
facial and eye muscles of humans. Type I, IIa and IIx  fibres all differ in 
contractile and energetic properties that are known to be associated with 
their MHC isoform content (Bottinelli & Reggiani, 2000).  
 
A summary of the characteristics of these fibre types is given below (Table 
2.3): 
 
Table 2.3 Summary of skeletal muscle fibre type characteristics 
Classification Scheme Fibre Type 
Contractile speed Slow-twitch Fast-twitch Fast-twitch 
Myosin heavy chain  I IIa IIx 
Metabolic function Oxidative Oxidative Glycotic 
Average % in human vastus 
lateralis (Andersen & Aagaard, 2000)  
 
40 
 
30 
 
30 
Adapted from: (Spangenburg & Booth, 2003) 
 
It must be acknowledged that the majority of these characteristics are 
based on the idea of a continuum with much individual variation. Type I 
fibres contain the MHC 1 isoform and have lower maximum shortening 
velocity, maximum power and ATPase activity and slower kinetics of 
stretch than type IIx fibres. Type IIx fibres contain MHC 2x and have a 
higher specific force than type I. Type IIa fibres are an intermediate 
classification containing MHC 2a isoforms, they have shortening velocity, 
maximum power, ATPase activity and kinetic stretch speed that is in 
between that of type I and type IIx fibres, although specific force which is 
the same as that seen in type IIx fibres (Hilber et al., 1999). 
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Within a single human, fibre type distribution and ratio will vary greatly, 
even among the large limb and trunk muscles. Not all of DQ LQGLYLGXDO¶V 
skeletal muscles will have the same fibre type distribution. Johnson and 
colleagues (Johnson et al., 1973) demonstrated this when he found that in 6 
male autopsied cadavers the soleus muscle contained 75-98% type I fibres 
while the vastus lateralis contained only 20-46% type I fibres. These 
significant differences may be explained by the different functionality of 
these muscles and therefore the related differences in the firing patterns of 
the innervating motor neurons.  
 
The soleus muscle is situated inferior to the gastrocnemius in the calf (see 
Figure 2.4). It originates from the posterior surface of the head of the fibula 
and the internal border of the tibia. At the other end it forms a tendon with 
the gastrocnemius; commonly known as the Achilles tendon, this inserts 
onto the posterior surface of the calcaneus. The soleus is for the majority of 
the time in steady tension. This is required for posture, without the constant 
pull of the soleus the body would fall forward. When activated the soleus 
also aids in plantar flexion of the foot. 
 
In comparison, the vastus lateralis, the largest muscle in the quadriceps 
femoris, situated in an anterior position in the upper leg (see Figure 2.4) is 
more active without postural need for steady tension. Attached to the 
anterior and inferior borders of the greater trochanter, to the lateral aspect 
of the gluteal tuberosity and to the lateral aspect of the linea aspera, three 
quarters of this muscle is attached. Inserting at the patella and the tibial 
tuberosity via the patellar ligament, the vastus lateralis is involved in the 
extension and stabilization of the knee joint- an action required for 
running, jumping, dancing and walking, for example, and therefore plays a 
very different role to that of the fore mentioned soleus.    
 64 
 
Adapted from: www.orgs.jmu.edu/strength/images/male_muscles 
Figure 2.4 Anatomical positions of soleus and vastus lateralis 
 
)LQGLQJV RI KHWHURJHQHRXV H[SUHVVLRQ RI 0+&¶V ZLWKLQ D VLQJOH ILEUH
(Pette & Staron, 2000) in combination with new screening methods such as 
2D-gels and micro-arrays have made evident the fact that there are many 
more than three types of protein expressed in human skeletal muscle. In 
2001 it was suggested that the co-expression of MHC isoforms with the 
same muscle fibre may form a sub-population of hybrid fibres with high 
adaptive potential; able to switch phenotype to meet new functional 
demands (Baldwin & Haddad, 2001).  
 
The cadaver samples used by Johnson (Johnson et al., 1973) were from 
healthy but relatively sedentary individuals. Among sportspeople the range 
RI PXVFOH ILEUH W\SH GLVWULEXWLRQ YDULDWLRQ ZLWKLQ LQGLYLGXDOV¶ PXVFOHV LV
greater still. Exercise training (both resistance and endurance type) is a 
major factor in determining muscle phenotype. RET is well known to elicit 
both muscle hypertrophy and a shift of fibre type distribution (Bottinelli & 
Reggiani, 2000; Schiaffino & Reggiani, 1996; Fluck & Hoppeler, 2003). 
With regard to fibre type distribution and training, longitudinal studies 
have often shown a small and surprisingly similar training-induced shift for 
endurance and RET (Adams et al., 1993; Liu et al., 2003; Andersen et al., 
1994). Despite the differences in muscle mass and metabolism induced by 
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the two forms of training DW\SH,,[ĺ,,DVKLIWLVPRVWFRPPRQO\ observed 
(Fluck & Hoppeler, 2003; Jansson & Kaijser, 1977) with little evidence to 
suggest that type I fibres may be increased through training.  
 
An increase in the number of type I fibres has been observed in animal 
studies, although 24 hour a day muscle stimulation was required, 
something that is near impossible to achieve in humans (Trumble et al., 
2001). In 2000 Thayer and colleagues (Thayer et al., 2000) reported an 
increase in type I fibre number after 10 years of endurance training, 
however the cross-sectional design of this study raises the question of 
whether this was an age or training effect. This question also followed a 
study by Trappe five years earlier where after 20 years the same increase in 
type I fibres was seen in both endurance trained and untrained males 
(Trappe et al., 1995). 
 
There is some disagreement in the literature as to what happens to fibre 
type distribution with ageing. In 1983, Larsson and colleagues reported a 
slight increase in relative proportions of Type I fibres with age (Larsson, 
1983). This increase however, was not confirmed by other later cross-
sectional studies (Porter et al., 1995). Indeed when Frontera and colleagues 
studies the muscle of the same subjects at aged 65 y and then 12 y later, 
they observed a decrease of Type I fibres from ~60% to 40% (Frontera et 
al., 2000). 
 
With regard to RET, Booth and Pette both found that sprint and power 
training caused some shift of type IIx to type I and type IIa fibres which 
can be attributable to increased activity levels but the most noticeable 
difference was the increased size (cross-sectional area) of type IIx fibres 
(Booth et al., 1998; Pette, 1998). Howald and more recently Putman, both 
reported a significant increase in the size of type IIx fibres following RET 
(Howald, 1982; Putman et al., 2004). One potential mechanism proposed 
for this increase in size is stretch as a stimulus to growth (Goldspink et al., 
1992). It has also been proposed that the increase in type I and IIa fibres 
following training, including that of a resistance/ power variety may be due 
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to the elevated levels of human growth hormone (HGH) and testosterone 
following RET which in turn has the capacity to increase oxidative 
metabolism as favored by muscle fibre types I and IIa (Kraemer, 1992).   
 
In contrast to longitudinal studies, cross-sectional studies have shown a 
strong bias in fibre type distribution towards fast-twitch fibres in elite 
sprinters (~70% type IIa and IIx fibres) and slow-twitch fibres in elite 
marathon runners (60-90% type I fibres) (Sjostrom et al., 1988; Andersen 
et al., 2000) (see Figure 2.5). The inconsistency between these two types of 
study may be explained by either the longer or more intense training of 
elite athletes, or by a genetically determined bias of fibre type distribution 
(D'Antona et al., 2006), or both. 
 
 
Adapted from: Spurway, 2006 (Spurway, 2006) 
Figure 2.5 Relative percentages of type I fibres in different athletes and 
untrained people 
Red horizontal lines = means; Green vertical lines = ranges. This figure is 
representative of fibre number and not size. 
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2.1.3 Nutrition and frailty 
As people age a loss of muscle mass, strength and declines in metabolic 
function begin to occur. This must be considered when developing 
programs to change diet and lifestyle. 
 
When trying to maintain or improve muscle mass and/ or strength at any 
stage of life it must be acknowledged that muscle protein is directly 
affected by protein in the diet. A high dietary protein intake increases MPS 
by increasing systemic amino acid availability (Motil et al., 1981) and the 
amino acids absorbed as a result of protein digestion stimulates MPS in a 
dose-dependent way. Several studies indicate that healthy older adults may 
need more protein than the dietary recommended intake (DRI) to increase 
muscle mass and strength (Campbell et al., 1994; Campbell et al., 2001), 
although studies involving commercial nutritional protein supplements or 
high protein diets in the elderly have mainly reported negative results 
(Campbell et al., 1995; Welle & Thornton, 1998; Fiatarone et al., 1994).  
These negative results may be in part due to a calorie-for-calorie reduction 
in other food intake if a supplement is involved (Fiatarone et al., 1994), or 
the absence of exercise training in these studies. 
 
Rates of MPS are responsive to RET and also to feeding. RET in the 
absence of nutrients will not result in optimal gains. The anabolic effects of 
exercise are amplified by protein intake. Protein intake above the EAR of 
0.66g.kg.day-1 stimulates the fractional synthetic rate (FSR) of muscle 
protein which has been shown to be positively correlated with muscle 
strength (Balagopal et al., 1997). FSR can be defined as a parameter which 
can estimate protein turnover from kinetic tracer data using validated 
formulae. Stimulation of muscle via RET should interact with nutrients in 
any meals consumed in the 24 hours following and result in muscle 
growth. Interaction of nutrient intake and RET has been demonstrated to 
increase MPS without a concomitant increase in MPB, thus resulting in a 
positive net muscle protein balance (Biolo et al., 1997; Tipton et al., 1999; 
Rasmussen et al., 2000). The ingestion of amino acids post exercise has 
been shown to further stimulate muscle protein synthesis (Tipton et al., 
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1999; Borsheim et al., 2002), ultimately resulting in greater muscle fibre 
hypertrophy (Kim et al., 2005). 
 
The need for exercising individuals to consume greater dietary protein than 
sedentary people is because those exercising will need to off-set the 
oxidation of amino acids during exercise with protein intake. This 
oxidation can account for ~ 1-5% of the total energy cost of exercise, plus 
there will be a need for protein to repair any exercise induced muscle 
damage and to provide substrate for the synthesis of lean tissue 
(Tarnopolsky, 2004). Research has shown that this increased need for 
protein in exercising individuals is true regardless of training mode (i.e. 
resistance or endurance based) or indeed training status (Friedman & 
Lemon, 1989). Risks in consuming insufficient amounts of protein, 
especially for exercising individuals include the creation of a negative 
nitrogen balance leading to muscle catabolism and impaired recovery 
(Campbell et al., 2007). This extra protein requirement is thought to be 
even more so for those undertaking RET, especially during the initial 
stages of training or if sharp increases in volume occur (Campbell et al., 
2007). There is however evidence that training over time can lead to 
biological adaptations that may improve net protein retention (Rennie & 
Tipton, 2000). 
 
The additional protein requirements of exercising individuals may be 
consumed in dietary foods or by the use of supplementation, which in 
some circumstances can prove to be convenient (Tipton & Wolfe, 2004). 
Common sources of protein include meat, milk, whey, casein and soy-
based products, all of which provide different protein bioavailability; 
explained as the amount and variety of amino acids that are digested and 
absorbed into the blood stream after protein ingestion (Campbell et al., 
2007). The quality of a protein source is often determined by the protein 
digestibility corrected amino acid score (PDCAAS), established by the 
Food and Agriculture Organization. Milk-derived whey protein isolate 
presents the highest PDCAAS of all the common protein sources, thought 
WR EH GXH WR LWV KLJK FRQWHQW RI HVVHQWLDO DQG %&$$¶V (Campbell et al., 
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2007)%&$$¶VOHXFLQHLVROHXFLQHDQGYDOLQHPDNHXSaRIVNHOHWDO
muscle protein and current literature VXJJHVWV WKDW RI WKH WKUHH %&$$¶V
leucine is most significant in stimulating MPS (Rennie et al., 2006). 
Research has shown that whey protein elicits a sharp, rapid rise of plasma 
amino acids following ingestion (Boirie et al., 1997) and induces a greater 
protein gain than the common alternative supplement, casein (Dangin et 
al., 2003).  
 
The timing of protein intake can prove integral in preserving muscle mass, 
eliciting hypertrophy and/ or ensuring successful recovery from exercise. 
There is much research advocating the positive role of protein intake post 
RET on increases in muscle mass (Willoughby et al., 2007; Esmarck et al., 
2001; Tipton et al., 2003; Cribb et al., 2007) and high levels of blood 
amino acids following RET have found to be significant in promoting MPS 
(Biolo et al., 1997). Protein intake when combined with exercise may also 
have a role in sustaining optimal immune function (Campbell et al., 2007). 
A study by Flakoll and colleagues showed that the ingestion of a mixed 
(carbohydrate, fat and protein) nutritional supplement, rich in protein, 
immediately after exercise resulted in 33% less medical visits, 28% less 
infection-related visits, and 37 % less orthopedic-related visits. Self-
reported post-exercise muscle soreness was also significantly reduced, 
compared to those who had ingested a placebo supplement of no 
nutritional value (Flakoll et al., 2004). 
 
Overall, the muscular growth, recovery aid and health benefits that can be 
achieved by adequate protein intake all lead to the conclusion that protein 
UHTXLUHPHQWV HTXDO WR RU DERYH WKH '5,¶V VKRXOG UHDFKHG E\ DOO WKURXJK
healthy whole-food intake. It is however safe and may prove very 
convenient for exercising individuals with a higher protein requirement to 
ingest some high quality protein in the form of supplementation. Claims 
that high protein diets can be detrimental to health due to metabolic strain 
on the kidneys and increased calcium excretion are unfounded with no 
substantive evidence to support these reports in healthy individuals 
(Campbell et al., 2007). On the contrary preliminary clinical studies have 
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suggested benefits of high-protein diets on major risk factors for chronic 
diseases, such as kidney disease, hypertension, diabetes, obesity and the 
metabolic syndrome (Martin et al., 2005) and data is now showing that 
those most susceptible to osteoporosis should consume dietary protein 
above current recommended levels to optimize bone mass by increasing 
circulating levels if IGF-1 (Dawson-Hughes et al., 2004).  
 
2.1.4 Implications of frailty 
Frailty is a common and important syndrome that is increasingly prevalent 
with advancing age. Associated with adverse health outcomes such as 
disability and admission to hospital or long-term care (Clegg et al., 2011), 
frailty is often responsible for reduced quality of life, reduced 
independence maintenance and increased health-care costs for an ageing 
population.   Frailty is characterised by cumulative physiological decline, 
which results in a vulnerability to sudden changes in health status that can 
be triggered by relatively minor stressor events (Walston et al., 2006). The 
frailty phenotype includes weight loss, reduced energy expenditure, slower 
gait speed, losses of strength and power and sarcopenia (as outlined in 
Figure 2.1). A recent study reported a frailty prevalence rate of 8.5% for 
women, and 4.1% for men in 638 people aged 64-74 years (Syddall et al., 
2010). Frailty is cyclic; its development results in a situation that leads to 
worsening frailty and increased risk of adverse health consequences.  
 
Because of the associated adverse health consequences, frailty impacts 
directly on quality of life, well-being and independence maintenance and 
has important economic implications. Any intervention therefore, that has 
the potential to attenuate prevalence or severity of frailty is likely to have 
benefits for not only the individual in question but also for their families 
and society as a whole (Clegg et al., 2011). 
 
2.1.5 Frailty and resistance-exercise training 
As one of the key components of frailty, sarcopenia is characterised by loss 
of muscle mass and strength reflective of a progressive withdrawal of 
anabolism and increased catabolism. Sarcopenia is mediated by multiple 
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factors including alpha-motor neuron death, altered hormone 
concentrations, inflammation and inactivity (Jones et al., 2009). 
Sarcopenia is a potential target for frailty prevention initiatives as 
interventions to increase muscle mass and strength through exercise have 
been shown to improve basic mobility skills such as getting up from a 
chair, climbing stairs and walking to the toilet. These mobility skills, which 
most people would take for granted are critical for maintenance of 
independence in older age and loss of these skills can lead to increased 
care requirements (Clegg et al., 2011). RET has been shown in numerous 
studies to improve the strength and muscle mass of divergent training 
groups (Benton & Schlairet, 2012; Macdonald et al., 2012; Geirsdottir et 
al., 2012), including very old geriatric patients already classed as frail 
(Binder et al., 2005), although strength increments are typically much 
larger than hypertrophic responses (Strasser et al., 2009).  
 
Age-related declines in skeletal muscle mass may also contribute to other 
age-associated changes such as reductions in BMD, insulin insensitivity 
and decreased aerobic capacity. This association suggests that elderly 
people gaining both muscle mass and strength with adequate RET may not 
only improve functional independence but may also decrease the 
prevalence of many age-associated chronic diseases that have links with 
declines in skeletal muscle mass (Evans, 1992).  
 
2.2 Methodology 
 
2.2.1 Muscle protein synthesis 
In order to determine AA kinetics a primed constant infusion of trace 
quantities of stable isotope amino acids; ³the WUDFHU´, were administered 
through a forearm vein to minimise changes in plasma AA profiles. The 
tracer infusion contained [1, 2-13C2]- Leucine, (Cambridge Isotopes, 
Cambridge, MA, USA) which was quality assessed for purity and sterility 
prior to tracer manufacture, and which were then aseptically dissolved in 
250 ml of 0.9% at the Clinical Trials Sterile Production Unit, Pharmacy, 
Queens Medical Centre, Nottingham. The desired tracer infusion rate for 
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each subject was calculated by subject body weight to obtain a constant 
level of pre-cursor labeling at ~6% (Table 2.4) and was administered via an 
infusion pump (Volumed µVP5005) at a prime dose of 0.7 mg·kg-1, 
followed by a constant infusion rate of 1 mg·kg-1.  During the fed phase of 
the study the tracer infusion rate was increased to ~1.6 mg·kg·hr-1 to ensure 
a constant level of labeling, accounting for the 6% increase in leucine from 
the feed.  
 
Table 2.4 Calculations of tracer infusion rate 
Amino acid Prime Fasted Infusion Fed Infusion 
[1,2-13C2]- Leucine 0.66 mg·kg-1 1 mg·kg·hr-1 1.6 mg·kg·hr-1 
 
The tracer infusion of [1,2-13C2]- Leucine coupled with the sampling of 
venous blood and the muscle biopsies allowed us to measure muscle 
specific protein synthesis by measuring directly and indirectly the uptake 
of tracer by the muscle (Figure 2.6). 
 
Figure 2.6 Principle of tracer uptake by skeletal muscle 
1. Injection of labelled and unlabelled tracer amino acids 
2. Uptake of amino acids into tissue 
3. Incorporation into tissue protein 
4. Unlabelled amino acid release 
5. Venous concentration 
 
The primed constant infusion method that we used relies on the assumption 
that steady state aminoacyl-tRNA (the immediate pre-cursor for protein 
synthesis) is attained, however as this is extremely difficult to measure, 
ODEHOOLQJLQWKHĮ-keto acid of leucine was used as a surrogate measure as it 
 73 
is metabolized intracellularly and closely reflects the labelling of the true 
leucyl-tRNA (Watt et al., 1991). 
 
To determine the labelling of Į-NHWRLVRFDSURDWH Į-KIC), plasma was 
deproteinised with 100% ethanol and dried. Lipids were removed by ethyl 
acetate extraction and then samples were converted to their tert-
butyldimethylsilyl (t-BDMS) derivatives. Enrichments were determined by 
gas-chromatography-mass spectrometry using a Trace DSQ GC-MS 
(Thermo Fisher Scientific, Hemel Hempstead, UK) and the use of 
appropriate internal standards. 
  
The rate of muscle protein synthesis between the biopsies was calculated 
using standard equations: 
 
FSR (%·h-1) = (¨Em/Ep ɯ1/t) ɯ 
 
:KHUHǻ(m is the change in labelling of muscle protein leucine between 
the two biopsy samples, Ep is the mean enrichment over time of the 
SUHFXUVRUIRUSURWHLQV\QWKHVLVYHQRXVĮ-KIC 13C2 labelling), and t is time 
EHWZHHQ WKH ELRSVLHV ZLWK YHQRXV Į-KIC representing the immediate 
precursor for protein synthesis, i.e. leucyl-tRNA as discussed above (Nair 
et al., 1988). 
 
To determine the change in labelling of muscle protein leucine between the 
two biopsy samples it was required that we isolated the myofibrillar 
protein from our muscle biopsy samples. Myofibrillar protein isolation was 
achieved using the following method:  
 
Muscle sample was snipped using fine point scissors in cold extraction 
buffer (0.02 M Tris, 0.15 M NaCl, 0.1 M EDTA, 0.1 M Triton-X) using 
10µl per mg of tissue. The homogenate was centrifuged at 1¶ɯg for 20 
min, the supernatant removed and the myofibrillar/ collagen pellet re-
suspended in 0.3 M NaOH. 7KHVXSHUQDWDQWZDVFHQWULIXJHGIXUWKHU¶
g for 15 min) and the sarcoplasmic fraction was precipitated by bringing 
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WKHVXSHUQDWDQWWRZLWKHWKDQRODQGFHQWULIXJLQJDJDLQ¶J7KH
pellet containing the myofibrillar and collagen protein fractions was twice 
washed with 0.7 M KCl and the soluble myofibrillar protein and the 
insoluble collagen were separated by centrifugation at ¶JIRUPLQ  
 
The myofibrillar fraction was precipitated using 1 M perchloric acid and 
the pellet washed twice with 70% ethanol. Myofibrillar protein was 
hydrolysed in 0.05 M HCl/Dowex 50W-X8-200 at 110°C overnight 
(Balagopal et al., 1994), and the liberated amino acids purified then eluted 
in 2 M NH42+7KH$$¶VZHUHWKHQGHULYDWL]HGDVWKHLU N-acetyl-n-propyl 
(NAP) ester (Meier-Augenstein, 1999).  
 
The incorporation of [1,2-13C2] leucine into protein was then analysed by 
gas chromatography combustion-isotope ratio mass spectrometry (GC-C-
IRMS; Delta-plus XL, Thermo Fisher Scientific, Hemel Hempstead, UK). 
Separation ZDV DFKLHYHG RQ D P ɯ  PP ɯ ȝ ILOP '%-1 
capillary column (Agilent Technologies, West Lothian, UK) (Bohe et al., 
2001; Moore et al., 2005).  
 
2.2.2 Muscle protein concentrations by immunoblotting   
Muscle biopsies (~10-20 mg) were homogenized with scissors in ice-cold 
extraction buffer (10 Pl/mg-1) containing 50 mM Tris-HCl (pH 7.4), 0.1% 
Triton X-100, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 0.5 mM activated 
sodium orthovanadate (all Sigma Aldrich, Poole, UK) and a complete 
protease inhibitor cocktail tablet (Roche, West Sussex, UK). Homogenates 
were rotated on a Vibramax for 10 min at 4°C and centrifugeGDW¶J
for 10 min at 4°C before recovery of supernatants representing 
sarcoplasmic fractions. Bradford assays were used to determine 
sarcoplasmic protein concentrations after which samples were standardized 
to 1 mg/ml-1 by dilution with Laemmli loading buffer in order to measure 
relative protein concentrations of our proteins of interest. Samples were 
mixed and heated at 95°C for 5 min before fifteen Pg of protein/lane was 
loaded on to Criterion XT Bis-Tris 12% SDS-PAGE gels (Bio-Rad, Hemel 
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Hempstead, UK) for electrophoresis at 200 V for ~60 min. Gels were 
equilibrated in transfer buffer (25 mM Tris, 192 mM glycine, 10% 
methanol) for 30 min before proteins were electroblotted on to 0.2 Pm 
PVDF membranes (Bio-Rad) at 100 V for 30 min. After blocking with 5% 
low-fat milk in TBS-T (Tris Buffered Saline and 0.1% Tween-20; both 
Sigma-Aldrich, Poole, UK) for 1 h, membranes were rotated overnight 
with primary antibody (all AbCam, Cambridge, UK) against our target 
proteins at a concentration of 1:2000 at 4°C. Membranes were washed 
(3×5 min) with TBS-T and incubated for 1 h at room temperature with 
HRP-conjugated anti-rabbit secondary antibody (New England Biolabs, 
UK), before further washing (3×5 min) with TBS-T and incubation for 5 
min with ECL reagents (enhanced chemiluminescence kit, Immunstar; 
Bio-Rad). Blots were imaged and quantified by assessing peak density 
after ensuring bands were within the linear range of detection using the 
Chemidoc XRS system (Bio-Rad, Hemel Hempstead, UK). Where 
required, phosphorylation of signalling proteins was corrected for loading 
anomalies to an appropriate loading control.  
 
2.2.3 Whole body strength 
Whole-body strength was measured as the sum of 6 1-RM assessments 
performed at the beginning of the RET and every four weeks throughout. 
The 1-RM assessments were on 6 resistance training machines (Cybex 
International UK Ltd, Derbyshire, UK) with the assessments carried out by 
a fully qualified exercise professional following a standard operating 
procedure that included a pre-determined warm up set of 10 repetitions, 3 
min rest between warm-up and assessment beginning and 2 min rest in-
between each 1-RM attempt. The final 1-RM was to be determined within 
5 attempts, or the assessment was declared void and was performed again 
~48h later. The exercises assessed were three using the upper-body; 
latissimus pull-down, seated chest press and seated lever row and three for 
the lower body; leg extension, seated leg curl and leg press. 
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2.2.4 Diet diary analysis 
Analysis of the subjects three-day diet diaries from prior to and during the 
exercise training program were analyzed using Microdiet diet analysis 
software, version 5 (Downlee Systems Ltd) to assess the subjects dietary 
habits, macro and micro-nutrient composition. This data was then assessed 
to determine if there were differences in the habitual diets of our three age 
groups or if they altered in response to RET. 
 
2.2.5 Muscle fibre typing 
Taking 25 mg of basal muscle sample from before and after RET, 
myofibrillar protein was extracted as described earlier in this chapter. The 
pellet containing myofibrillar and collagen fractions was then snipped 
using fine point scissors in  250 µl of lysing buffer (10% Glycerol, 5% 2-
Mercaptoethanol, 2.3% Sodium dodecyl sulphate (SDS), dissolved in 62.5 
mM Tris-HCl-solution (pH 6.8)). Samples were mixed and heated at 90°C 
for 3 min and then diluted 1:20 with lysing buffer (as above) before 1 µl of 
sample was loaded on to self-cast 6% SDS-PAGE gels (separation gel: 
13.4 ml Acrylamide/ Bis-acrylamide buffer (30 ml 2% bis-solution, 150 ml 
40% Acrylamide solution bought to 200 ml with ddH2O), 6.7 ml Lower-
Tris solution (36.34 g Tris-base, 8 ml 10% SDS bought to 200 ml with 
ddH2O (pH 8.8)), 15.0 ml Glycerol, 2.0 ml 10% SDS, 5.0 ml 1M Glycine, 
7.5 ml ddH2O, 750 µl 10% Ammonium persulfate, 60 µl TEMED; stacking 
gel: 3.72 ml 30% Acrylamide solution, 4.71 ml 2M Tris-HCl-solution (pH 
6.8), 10 ml Glycerol, 250 µl 10% SDS, 6.24 ml ddH2O, 125 µl 10% 
Ammonium persulfate, 20 µl TEMED), alongside a protein ladder to 
confirm isoform size at analysis.  
 
The gels were placed into a mini-system electrophoresis tank (Bio-Rad, 
Hemel Hempstead, UK) filled with 1 litre running buffer (3.02 g Tris-Base, 
14.41 g Glycine, 1.01 g SDS bought to 1 litre with ddH2O) and 400 µl of 
mercaptoethanol in the upper chamber. An electrical current was passed 
through the tank at 50 V for 30 hours. Gels were then silver stained 
DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVProteosilver Silver Stain Kit, 
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Sigma Life Sciences, UK). Gels were imaged and the proportion of 
identified type I, IIa and IIx bands quantified by assessing peak density 
after ensuring bands were within the linear range of detection using the 
Chemidoc XRS system (Bio-Rad, Hemel Hempstead, UK) (Figure 2.7). 
 
 
MHC-IIx - top, MHC-IIa ± middle, MHC-I - bottom. 
 
Figure 2.7 Image of a bis-acrylamide gel after electrophoresis to 
identify MHC isoforms.  
 
2.2.6 RNA: DNA: Protein ratios 
Taking 15 mg of basal muscle sample from before and after RET; the 
sample was snipped using fine point scissors in 1ml 0.2M percholric acid 
(PCA; BDH Laboratories) before vortexing and centrifugation at 4°C at 
¶ USP IRU  PLQXWHV WR IRUP D SHOOHW 7KH SHOOHW ZDs then washed 
twice in 1ml 0.2M PCA before 800µl of 0.3M sodium hydroxide (NaOH; 
Sigma Aldrich, Poole, UK) was added to the pellet before they were placed 
in a hot block at 37°C for 30 min to allow the pellet to dissolve.  
 
Once dissolved 20µl of sample was removed to measure total protein using 
the Bradford assay. In brief, 967µl of Bradford reagent (Sigma Aldrich, 
Poole, UK) was mixed with 26.4µl 0.3M NaOH and 6.6µl of sample 
before reading on a spectrophotometer (Bichrom WPA Lightwave, UK) at 
595nm after 10 minutes at room temperature. 
 
400µl of 1M PCA was added to the remaining dissolved samples and they 
were cooled at 4°C for 10 min before vortexing and centrifugation at 4°C 
DW ¶ USP IRU  minutes to form a pellet. The supernatant was then 
removed and stored in new vials before 300µl 0.2M PCA was added to the 
SHOOHWEHIRUHYRUWH[LQJDQGFHQWULIXJDWLRQDW&DW¶USPIRUPLQ
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The supernatant from this was then added to the new vials giving a volume 
of 1.5ml which was used to measure RNA. 
 
In brief, RNA measurements were made on a spectrophotometer at 260 and 
270nm with 0.2M PCA as the blank. The equation used to calculate RNA 
taking account of peptide material was: 
 
RNA µg/ml-1 = (abs260nm × 11.87) ± (abs275nm × 10.4) × (100/9.7) 
 
1ml 2M PCA was then added to the pellet and the samples were placed in a 
heated block at 70°C for 60 min. Samples were then vortexed and 
FHQWULIXJHGDW&DW¶USPIRUPLQWRIRUPDSHOOHW7KHVXSHUQDWDQW
was then removed and stored in new vials. 300µl 2M PCA was added to 
WKH SHOOHW EHIRUH YRUWH[LQJ DQG FHQWULIXJDWLRQ DW & DW ¶ USP IRU 
min. The supernatant from this was then added to the new vials giving a 
volume of 1.3ml which was used to measure DNA. 
 
In brief, DNA measurements were made on a spectrophotometer at 268 
and 274nm with 2M PCA as the blank. The equation used to calculate 
RNA taking account of peptide material was: 
 
DNA µg/ml-1 = (abs268nm ± abs284nm) × (100/9.7) 
 
2.3 Results 
 
2.3.1 Effect of resistance-exercise training on muscle protein synthesis 
There was no effect of age on basal MPS either before or after RET and 
RET had no effect on basal MPS in any of the age-groups.  
 
All groups demonstrated increased MPS in response to feeding before RET 
(Y: 0.044±0.004 vs. 0.082±0.010, P<0.001; M: 0.041±0.004 vs. 
0.064±0.005, P<0.01; O: 0.042±0.003 vs. 0.065±0.006%·h-1, P<0.01) but 
there was no difference in fed MPS between the age-groups before RET, 
although there was a trend for it to be higher in the young than in the 
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middle-aged group (P=0.08). After RET, the young and the middle-aged 
groups still demonstrated increased MPS in response to feeding compared 
to basal values (Y: 0.053±0.006 vs. 0.085±0.011, P<0.01; M: 0.047±0.003 
vs. 0.061±0.004 %·h-1, P<0.05). Surprisingly, the old did not demonstrate a 
significant increase in MPS in response to feeding alone after RET 
(0.045±0.006 vs. 0.061±0.006%·h-1, P>0.05) and this may be due to the 
slightly increased (but not significant) basal value observed after RET 
(0.042±0.003 vs. 0.045±0.006%·h-1, P>0.05). This unusual finding may 
also be due to the statistical analysis used as when comparing the old 
groups basal MPS to their fed MPS after RET with a paired t-test there was 
a significant difference (P=0.02).  
 
Both before (Y: 0.044±0.004 vs. 0.081±0.008; M: 0.041±0.004 vs. 
0.081±0.005; O: 0.042±0.003 vs. 0.083±0.006%·h-1, all P<0.001) and after 
RET (Y: 0.053±0.006 vs. 0.105±0.011; M: 0.047±0.003 vs. 0.085; O: 
0.045±0.006 vs. 0.090±0.008%·h-1, all P<0.001) all three groups responded 
to the dual stimuli of exercise-plus-feeding when compared to basal values. 
In the young, MPS in response to exercise-plus-feeding was significantly 
higher after RET compared to before (0.081±0.008 vs. 0.105±0.011%·h-1, 
P<0.05). The old group demonstrated an additional response of exercise-
plus-feeding compared to feeding alone only after RET (0.61±0.006 vs. 
0.90±0.008, P<0.001).  
 
The only difference between the age-groups either before or after RET was 
that the MPS in response to exercise-plus-feeding was significantly lower 
in the middle-aged group compared to the young after RET (0.105±0.011 
vs. 0.085±0.007, P<0.05) (Figure 2.8).  
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Figure 2.8 Myofibrillar fractional synthetic rates in young, middle-aged 
and older subjects before and after RET. Values are means±SEM. 
Statistical analysis via 2-way ANOVA with Bonferroni post-analysis. **= 
P<0.01 vs. basal pre-training; ***= P<0.001 vs. basal pre-training; #= 
P<0.05 vs. basal post-training; ##= P<0.01 vs. basal post-training; ###= 
P<0.001 vs. basal post-training; = P<0.001 vs. feeding post-training; ¶= 
P<0.05 vs. exercise-plus-feeding pre-training; a= P<0.05 vs. young in the 
same condition. 
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2.3.1.1 Molecular markers of muscle protein synthesis 
Before RET the young did not increase p70S6K  (p70) phosphorylation in 
response to any of the anabolic stimuli. After RET, the young had 
increased phosphorylation in response to exercise-plus-feeding (0.91±0.05 
vs. 1.25±0.05, P<0.001). The middle-aged group demonstrated increases 
phosphorylation in response to exercise-plus-feeding both before 
(1.00±0.00 vs. 1.19±0.03, P<0.001) and after (0.96±0.03 vs. 1.17±0.05, 
P<0.001) RET with phosphorylation after exercise-plus-feeding higher that 
after exercise alone both before (1.19±0.03 vs. 1.04±0.04, P<0.01) and 
after RET (1.17±0.05 vs. 1.04±0.04, P<0.05) and also higher than after 
feeding alone before RET (1.19±0.03 vs. 1.07±0.04, P<0.05). The old 
group displayed increased p70 phosphorylation after exercise-plus-feeding 
both before (1.00±0.00 vs. 1.19±0.04, P<0.01) and after RET (0.97±0.04 
vs. 1.25±0.04, P<0.001) with phosphorylation in response to exercise-
plus-feeding higher than after exercise alone before RET (1.19±0.04 vs. 
1.00±0.04, P<0.05). The old group also demonstrated increased 
phosphorylation in response to feeding alone after RET (0.97±0.04 vs. 
1.21±0.04, P<0.001). At no time point was there a significant difference 
between the age groups (Figure 2.9). 
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Figure 2.9 P70 phosphorylation in young, middle-aged and old subjects, in basal, fed, exercised and fed-plus-exercised conditions, before and 
after RET. Analysis by ANOVA with Tukey post-hoc analysis. **= P<0.01 vs. basal pre;***= P<0.001 vs. basal pre; ###= P<0.001 vs. basal 
SRVW 3YVIHGSUH= P=<0.05 vs. exercise pre; = P= <0.01 vs. exercise pre; = P<0.05 vs. exercise post. 
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The young did not increase 4EBP1 in response to any of the anabolic 
stimuli either before or after RET, although both before and after RET the 
phosphorylation in response to feeding alone (before: 1.27±0.05 vs. 
0.82±0.06, P<0.001, after: 1.19±0.06 vs. 0.83±0.05, P<0.01) and exercise-
plus-feeding (before: 1.15±0.09 vs. 0.82±0.06, after: 1.21±0.05 vs. 
0.83±0.05, both P<0.01) was significantly higher than after exercise alone. 
The middle-aged group also showed that exercise suppressed 
phosphorylation compared to feeding alone (1.13±0.05 vs. 0.86±0.04, 
P<0.001) and exercise-plus-feeding (1.15±0.05 vs. 0.86±0.04, P<0.001) 
before RET but this was not apparent after RET. The old group showed 
increases in 4EBP1 phosphorylation before and after RET in response to 
both feeding alone (before: 1.00±0.00 vs. 1.20±0.03, after: 1.04±0.04 vs. 
1.23±0.05, both P<0.01) and exercise-plus-feeding (before: 1.00±0.00 vs. 
1.24±0.04, P<0.001, after: 1.04±0.04 vs. 1.22±0.06, P<0.01). The old 
group also showed significantly higher phosphorylation after feeding alone 
and exercise-plus-feeding compared to after exercise alone both before 
(1.20±0.03 and 1.24±0.04 vs. 0.87±0.04 respectively, P<0.001) and after 
(1.23±0.05 and 1.22±0.06 vs. 0.94±0.05 respectively, P<0.001) RET. At 
no time point was there a significant difference between the age groups 
(Figure 2.10). 
 84 
Figure 2.10 4EBP1 phosphorylation in young, middle-aged and old subjects, in basal, fed, exercised and fed-plus-exercised conditions, before 
and after RET. Analysis by ANOVA with Tukey post-hoc analysis. **= P<0.05 vs. basal pre; ***= P<0.01 vs. basal pre; ##= P<0.01 vs. basal 
post; = P<0.01 vs. exercise pre; = P<0.001 vs. exercise pre; = P<0.01 vs. exercise post; = P<0.001 vs. exercise post. 
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Neither before or after RET did the young did demonstrate increased 
mTOR phosphorylation in response to any of the anabolic stimuli; 
although they did demonstrate significantly higher phosphorylation in 
response to exercise-plus-feeding after RET than before (1.26±0.06 vs. 
0.92±0.15, P<0.05). The middle-aged group had increased mTOR 
phosphorlyation in response to feeding and exercise-plus-feeding after 
RET (0.94±0.04 vs. 1.08±0.05, P<0.05 and 1.19±0.05, P<0.001 
respectively) when phosphorylation after exercise-plus-feeding was 
significantly higher than after exercise alone (1.19±0.05 vs. 1.02±0.05, 
P<0.01). The old did not respond with increased mTOR phosphorylation to 
any of the stimuli before RET but did display increased phosphorylation in 
response to feeding alone and exercise-plus-feeding after RET (0.98±0.05 
vs. 1.22±0.05 and 1.22±0.06 respectively, P<0.01). At no time point was 
there a significant difference between the age groups (Figure 2.11). 
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Figure 2.11 mTOR phosphorylation in young, middle-aged and old subjects, in basal, fed, exercised and fed-plus-exercised conditions, before 
and after RET. Analysis by ANOVA with Tukey post-hoc analysis. #= P<0.05 vs. basal post;##= P<0.01 vs. basal post; ###= P<0.001 vs. basal 
post;= P<0.01 vs. exercise post; ¶= P<0.05 vs. ex+fed pre. 
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The young group showed a significant depression in EEF2 phosphorylation 
before RET in response to exercise-plus-feeding that was significantly 
lower than phosphorylation at basal and after feeding alone (0.73±0.08 vs. 
1.00±0.00, P<0.01 and 0.94±0.03, P<0.05 respectively). This depression 
also resulted in the phosphorylation of EEF2 after exercise-plus-feeding 
being significantly lower than in the middle-aged and older groups under 
the same stimulated conditions before RET (P<0.001). This depression was 
not apparent after RET resulting in higher phosphorylation in response to 
exercise-plus-feeding after RET when compared to before (0.96±0.06 vs. 
0.73±0.08, P<0.05). Neither the middle-aged nor the older group showed 
increases in EEF2 phosphorylation in response to any of the anabolic 
stimuli either before or after RET. At no time-point was there a significant 
difference between the age groups (Figure 2.12). 
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Figure 2.12 EEF2 phosphorylation in young, middle-aged and old subjects, in basal, fed, exercised and fed-plus-exercised conditions, before 
and after RET. Analysis by ANOVA with Tukey post-KRFDQDO\VLV 3YVEDVDOSUH 3YVIHGSUH 3YVH[IHGSUH 
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2.3.2 Effect of resistance-exercise training on strength 
There were no significant age-related differences in the lean mass of our 
subjects before RET (see chapter 3), but there were substantial age-related 
reductions in strength, assessed as the sum of 6 1RM assessments both 
before (Figure 2.13) and after RET.  
 
Before RET the muscle strength of the young was 5729±405 N which was 
not significantly different to that of the middle-aged group (4921±387 N) 
but was significantly higher than that of the older group whose strength 
was  4082±202 N (P<0.05).  
 
There were no significant differences inrelative strength gains between the 
groups, with the young increasing from 5729±405 N to 7609±377 N 
(+~36%), the middle-aged from 4921±387 N to 6535±460 N (+~35%) and 
the older group from 4082±202 N to 5630±374 N (+~39%). It is interesting 
to note that after RET, following their 39% increase, the strength of the old 
group was not significantly different to that of the young group before RET 
(5630 vs. 5729 N) (Figures 2.13 and 2.14).  
 
In each group males were stronger than females (before training: Y, men 
6472 N vs. females 4392 N; M, males 6309 vs. females 3534 N; O, males 
4680 vs. females 3227 N) but in each group the strength gains made 
between men and women were not significantly different.   
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Figure 2.13 Strength in young, middle-aged and older subjects before 
RET. Values are means±SEM. Statistical analysis via ANOVA with 
Bonferroni post analysis. *=P<0.05 vs. young. 
 
 
Figure 2.14 Strength gains in young, middle-aged and older individuals 
following RET. Values are means±SEM. Statistical analysis via ANOVA 
with Bonferroni post analysis. 
 
The temporal aspect of strength gains was not significantly different 
between the age-groups with all groups displaying the fastest rate of 
strength gains between weeks 8 and 12 (discounting weeks 1-8 where the 
rapid acceleration was likely based on learning and familiarisation as well 
as physiological changes). The rate of increase in the young between 
weeks 8 and 12 was significantly higher than at any other time (P<0.01) 
and greater than the middle-aged and old group (9.8% vs. 6.7% and 6.2% 
respectively) both of whom sustained a greater rate of increase than the 
young in the subsequent four weeks (4.0% vs. 4.9% and 6.0%). Rate of 
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increase in the final four weeks of training was greatest in the old group 
with the middle-aged group demonstrating the least improvement (O, 
4.3%; M, 2.5%; Y, 3.0%) (Figure 2.15), which may suggest that the old 
would have continued to improve had the RET been of a longer duration. 
 
 
Figure 2.15 Strength in young, middle-aged and older individuals during 
the RET. Values are given as the average of 6 1-RM assessments and are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis. 
 
Only in the young group was there a correlation between strength gains 
and increases in lean mass (P<0.05), although there was a trend for this in 
the middle-aged also (P<0.06) (Figure 2.16). This suggests that perhaps in 
the middle-aged, and certainly in the older subjects the mechanism for 
improved strength cannot be explained by increases in lean mass and must 
exist due to changes in alternative mechanisms such as improved neural 
firing or muscle/ tendon architectural properties. 
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Figure 2.16 Relationship between changes in strength and changes in lean body mass in young, middle-aged and older individuals following 
5(76WDWLVWLFDODQDO\VLVE\3HDUVRQ¶VFRUUHODWLRQ 
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2.3.3 Dietary intake with ageing and resistance-exercise training 
Before RET the young consumed significantly more kcal per day 
(2127±156.0 kcal) than both the old (1706.93±84.2 kcal, P<0.01) and the 
middle-aged (1547.52±70.66 kcal, P<0.001) groups. There was no 
difference between the energy intake of the middle-aged and old. During 
RET there were no significant differences between the calorie intakes of 
the age-groups. None of the groups significantly changed their energy 
intake during RET compared to before, although there was a trend for it to 
be lower in the young (2127.71±156.00 vs. 1784.99±109.396 kcal, P=0.07) 
(Figures 2.17 and 2.18). 
 
Figure 2.17 Total energy intakes in young, middle-aged and older subjects 
before RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis. **=P<0.01 vs. young, ***=P<0.001 vs. 
young. 
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Figure 2.18 Total energy intakes in young, middle-aged and older subjects 
during RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis.  
 
Neither before or during RET was the percentage of dietary intake 
composed of protein significantly different between the three age groups. 
Before RET the percentage of intake composed from fats was significantly 
lower in the middle-aged group than in the young (28.65±1.42 vs. 
34.49±1.76%, P<0.05) but was not different to that of the old 
(32.73±1.20%). During RET there were no differences in the percentage 
intake from fat between the age groups. The percentage of intake 
composed from carbohydrates was significantly higher in the middle-aged 
group than in the young or the old (51.17±1.89 vs. 43.26±1.63 and 
44.25±1.44%, respectively, P<0.01) before RET with no significant 
difference between the groups during RET. The middle-aged group had a 
significantly lower percentage intake from carbohydrates during RET 
(51.17±1.89 vs. 46.77±1.65%, P<0.05) when compared to before and this 
may be related to the observed trend for an increase in the percentage of 
energy obtained from fat during RET (28.65±1.42 vs. 31.89±1.14, 
P=0.06). The young did not change their relative percentage intakes from 
protein, fat and carbohydrates during RET although there was a trend 
towards a reduction in percentage intake from fat (34.49±1.76 vs. 
29.56±2.06%, P=0.06). There were no differences in the percentage intake 
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from fat, carbohydrate and protein in the old group during RET when 
compared to before RET (Figures 2.19 and 2.20). 
 
  
Figure 2.19 Percentage of fat, protein and carbohydrate in the diets of 
young, middle-aged and older subjects before RET. Values are means. 
Statistical analysis via ANOVA with Newman-Kelus post analysis.  
 
 
Figure 2.20 Percentage of fat, protein and carbohydrate in the diets of 
young, middle-aged and older subjects during RET. Values are means. 
Statistical analysis via ANOVA with Newman-Kelus post analysis.  
 
Absolute protein intake before RET was significantly higher in the young 
than in the middle-aged (100.04±8.98 vs. 69.96±9.42 g, P<0.05), with a 
trend for it to also be higher than the old (100.04±8.98 vs. 82.03±4.07 g, 
P=0.08). During RET there were no significant differences in absolute 
protein intake between the age groups. There were no differences in the 
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middle-aged and old groups absolute protein intakes during RET when 
compared to before. There was a trend for absolute protein intake to be 
lower in the young during RET (100.04±8.98 vs. 81.46±7.47 g, P=0.07) 
(Figures 2.21 and 2.22). 
 
 
Figure 2.21 Protein intakes in young, middle-aged and older individuals 
before RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis. *=P<0.05 vs. young. 
 
 
Figure 2.22 Protein intakes in young, middle-aged and older individuals 
during RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis.  
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Before RET leucine intake was significantly higher in the young than in 
the middle-aged and the old (3226.69±624.53 vs. 1495.07±206.12 and 
1851.14±187.54 mg, P<0.01, respectively). There was no significant 
difference between the middle-aged and the old. During RET there were no 
significant differences between the three age groups. None of the groups 
showed any differences in leucine intake during RET compared to before 
RET (Figures 2.23 and 2.24). 
 
 
Figure 2.23 Leucine intakes in young, middle-aged and older individuals 
before RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis. **=P<0.01 vs. young. 
 
 
Figure 2.24 Leucine intakes in young, middle-aged and older individuals 
during RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis.  
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Before RET saturated fat intake was significantly higher in the young than 
in the middle-aged and old (31.07±2.93 vs. 16.99±1.55 g, P<0.001 and 
23.53±1.83 g, P<0.05, respectively). The saturated fat intake of the old was 
significantly higher than the middle-aged (P<0.01). During RET there 
were no significant differences between the age-groups. The young group 
consumed significantly lower saturated fats during RET compared to 
before (31.07±2.93 vs. 21.67±2.92 g, P<0.05). There was a trend for 
saturated fat intake to be increased in the middle-aged during RET 
(16.67±1.44 vs. 19.88±1.97 g, P=0.08) with no difference in the old group 
(Figures 2.25 and 2.26). 
 
 
Figure 2.25 Saturated fat intakes in young, middle-aged and older subjects 
before RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis. *=P<0.05 vs. young, ***=P<0.001 vs. 
young, ##=P<0.01 vs. middle-aged. 
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Figure 2.26 Saturated fat intakes in young, middle-aged and older subjects 
during RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis.  
 
Before RET the young consumed significantly more monounsaturates than 
the middle-aged and the old (28.64±3.03 vs. 17.31±1.24 g, P<0.001 and 
21.83±1.13 g, P<0.05, respectively) but there were no significant 
differences between the age groups during RET. In keeping with the 
reduction in saturated fat intake, there was a trend in the young for lower 
monosaturated fat intake during RET when compared to before 
(28.64±3.03 vs. 21.11±2.40 g, P=0.06). Neither the middle-aged nor the 
old group changed their monosaturated fat intake during RET (Figures 
2.27 and 2.28). 
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Figure 2.27 Monounsaturated fat intakes in young, middle-aged and older 
subjects before RET. Values are mean±SEM. Statistical analysis via 
ANOVA with Newman-Kelus post analysis. *=P<0.05 vs. young, 
***=P<0.001 vs. young. 
 
 
Figure 2.28 Monounsaturated fat intakes in young, middle-aged and older 
subjects during RET. Values are mean±SEM. Statistical analysis via 
ANOVA with Newman-Kelus post analysis.  
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Neither before or during RET was intake of polyunsaturates significantly 
different between the three age groups and it was unchanged in all three 
groups when comparing before RET to during RET (Figures 2.29 and 
2.30). 
 
 
Figure 2.29 Polyunsaturated fat intakes in young, middle-aged and older 
subjects before RET. Values are mean±SEM. Statistical analysis via 
ANOVA with Newman-Kelus post analysis.  
 
 
 
Figure 2.30 Polyunsaturated fat intakes in young, middle-aged and older 
subjects during RET. Values are mean±SEM. Statistical analysis via 
ANOVA with Newman-Kelus post analysis.  
 
Cholesterol intake was significantly higher in the young than in the 
middle-aged group before RET (324.85±47.37 vs. 178.93±35.32 mg, 
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P<0.05), although neither group had significantly different cholesterol 
intake to the old (273.58±28.69 mg). During RET there were no significant 
differences in the cholesterol intakes of the three age groups. None of the 
groups displayed a significant reduction in cholesterol intake during RET 
compared to before RET but there was a trend for it to be lower in the 
young (324.85±47.37 vs. 215.66±36.37 mg, P=0.08) (Figures 2.31 and 
2.32). 
 
 
Figure 2.31 Cholesterol intakes in young, middle-aged and older 
individuals before RET. Values are mean±SEM. Statistical analysis via 
ANOVA with Newman-Kelus post analysis. *=P<0.05 vs. young. 
 
 
Figure 2.32 Cholesterol intakes in young, middle-aged and older 
individuals during RET. Values are mean±SEM. Statistical analysis via 
ANOVA with Newman-Kelus post analysis.  
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Sodium intake was not significantly different between the three age groups 
before RET, although during RET the sodium intake of the old was 
significantly higher than both the young and middle-aged groups 
(3148.75±265.14 vs. 2156.29±243.99 and 2341.75±2112.33 mg 
respectively, P<0.05). 
 
The young reduced their sodium intake during RET compared to before 
RET (3129.53±435.301 vs. 2156.29±243.99 mg, P<0.05) while the old 
increased theirs (2511.07±238.731 vs. 3148.75±265.136 mg, P<0.05). 
There was no significant change in the middle-aged group (Figures 2.33 
and 2.34). 
 
 
Figure 2.33 Sodium intakes in young, middle-aged and older individuals 
before RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis.  
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Figure 2.34 Sodium intakes in young, middle-aged and older individuals 
during RET. Values are mean±SEM. Statistical analysis via ANOVA with 
Newman-Kelus post analysis *=P<0.05 vs. old. 
 
There were no significant differences in calcium, potassium or vitamin D 
intake between the three age groups before RET or during RET, although 
the middle-aged group did have significantly higher vitamin D intake 
during RET compared to before (2.29±0.42 vs. 3.57±0.62 µg, P<0.05). 
Iron intake was significantly higher in the young than in the middle aged 
(13.63±1.45 vs. 10.03±0.70 mg, P<0.05), with a trend for it to also be 
higher than the old (11.25±0.79 mg, P=0.08) before RET but it was not 
different between the three age groups during RET due to a significant 
reduction in iron intake in the young during RET compared to before RET 
(13.63±1.45 vs. 10.43±0.68 mg, P<0.05) (Figures 2.35 and 2.36). 
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Figure 2.35 Micronutrient intake in young, middle-aged and older 
individuals before RET. Values are mean±SEM. Statistical analysis via 
ANOVA with Newman-Kelus post analysis. *=P<0.05 vs. young. 
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Figure 2.36 Micronutrient intake in young, middle-aged and older 
individuals during RET. Values are mean±SEM. Statistical analysis via 
ANOVA with Newman-Kelus post analysis. 
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2.3.4 Effect of resistance-exercise training on muscle fibre type 
Before RET the fibre type distribution between the three age groups was 
not significantly different. The young and middle-aged groups had even 
distribution of the three isoforms before RET (Y: I=32.6±0.9, 
IIa=33.3±0.5, IIx=34.2±0.7; M: I=32.6±0.7, IIa=33.1±0.6, 
IIx=34.4±0.5%), while the old had a greater percentage of Type IIx than 
Type I fibres (I=32.0±0.9 vs. IIx=34.9±0.6 P=<0.01 (IIa=33.1±0.6%)).  
 
After RET, the young had a significant reduction in the proportion of Type 
IIa fibres (33.3±0.5 vs. 31.7±0.5%, P<0.05) and a significant increase in 
the proportion of Type IIx fibres (34.2±0.7 vs. 35.3±0.9%, P<0.05). The 
middle-aged group showed a significant increase in the percentage of Type 
I fibres after RET (32.57±0.7 vs. 33.48±0.5%, P<0.05) as did the older 
group (32.0±0.9 vs. 33.2±0.9%, P<0.01) who also demonstrated a 
significant decrease in their percentage of Type IIa fibres (33.1±0.6 vs. 
31.8±1.1%, P<0.05). The changes demonstrated by the old group were 
mirrored by the results for all when the data was grouped together. The 
grouped data showed a significant increase in the proportion of Type I 
fibres from 32.3±0.5 to 33.3±0.4%, P<0.001 and a significant reduction in 
the proportion of Type IIa fibres from 33.1±0.4 to 32.1±0.4%, P<0.01 
(Figure 2.37).  
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Figure 2.37 MHC isoform distribution in young, middle-aged and older 
subjects before and after RET. Values are mean±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis. 
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In the young group, after RET the distribution between the three isoforms 
was no longer even with a significantly higher proportion of Type IIx 
fibres compared to Type IIa (35.3±0.9 vs. 31.7±0.5%, P<0.05). The 
isoform distribution in the middle-aged group remained even after RET. In 
the older group the distribution was still not even after RET but the 
distribution pattern had changed from before RET with the old group 
displaying more Type IIx fibres than Type II a fibres after RET (35.0±0.6 
vs. 31.8±1.1%, P<0.01). 
 
When the data from the three age groups was grouped the distribution 
patterns were the same as that shown by the older group with a 
significantly higher proportion of Type IIx fibres compared to Type I 
before RET (34.5±0.4 vs. 32.3±0.5%, P<0.01) and a significantly higher 
proportion of Type IIx fibres compared to Type IIa (34.6±0.4 vs. 
32.1±0.4%, P<0.001) after RET (Figure 2.38).    
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Figure 2.38 Changes in MHC isoform distribution after RET in young, 
middle-aged and older subjects. Values are mean±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis.*=P<0.05 vs. before RET, 
**=P<0.01 vs. before RET. 
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2.3.5 Effect of resistance-exercise training on RNA: DNA: Protein ratios 
Before RET the protein: tissue ratio was significantly higher in the middle-
aged group than in the young (201.40±9.43 vs. 149.45±7.46, P<0.01). 
None of the groups demonstrated a significant change in their protein: 
tissue ratio after RET, although the ratios of the different age-groups were 
not significantly different after RET (Y, 159.73±11.90; M, 200.86±8.02; 
O, 181.29±10.45) (Figure 2.39). 
 
 
 
Figure 2.39 Protein (µg)/ Tissue (mg) in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis and students t-test.  
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The RNA: tissue ratios were not different between the age-groups either 
before or after RET. RET had no effect on the RNA: tissue ratio in any of 
the age groups (before: Y, 0.66±0.05; M, 0.73±0.04; O, 0.76±0.06, after: 
Y, 0.73±0.05; M, 0.74±0.06; O, 0.79±0.04) (Figure 2.40).  
 
 
 
Figure 2.40 RNA (µg)/Tissue (mg) in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis and students t-test.  
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Before RET the DNA: tissue ratios were not different between the age-
groups (Y, 0.80±0.05; M, 0.77±0.03; O, 0.91±0.04). The young increased 
their DNA: tissue ratio after RET (0.80±0.05 vs. 0.98±0.06, P<0.05) 
resulting in a ratio that was significantly higher than the middle-aged group 
after RET (0.98±0.06 vs. 0.79±0.03, P<0.05). The middle-aged and old 
groups DNA: tissue ratios were not significantly different after RET (M, 
0.79±0.03; O, 0.87±0.05) (Figure 2.41). 
 
 
 
Figure 2.41 DNA (µg)/Tissue (mg) in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis and students t-test. *=P<0.05 
vs. value before training in the same age-group. 
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Before RET the protein: DNA ratio of the middle-aged group was 
significantly higher than that of both the young and older groups 
(262.92±12.50 vs. 191.39±8.33 and 189.00±7.58, respectively, P<0.001). 
After RET the young had a significantly lower protein: DNA ratio 
(191.39±8.33 vs. 164.49±10.88, P<.05) and the old had a significantly 
higher protein: DNA ratio (189.00±7.58 vs. 211.89±12.20, P<0.05). After 
RET the middle-aged still had a higher protein: DNA ratio than both the 
young (259.28±10.82 vs. 164.49±10.88, P<0.001) and old groups 
(259.28±10.82 vs. 211.89±12.20, P<0.05) (Figure 2.42). 
 
 
 
Figure 2.42 Protein (µg)/DNA (µg) in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis and students t-test. *=P<0.05 
vs. value before training in the same age-group. 
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The RNA: protein ratios were not different between the age-groups either 
before or after RET. RET had no effect on the RNA: protein ratio in any of 
the age groups (before: Y, 4.41±0.20; M, 3.73±0.23; O, 4.43±0.35, after: 
Y, 4.70±0.33; M, 3.67±0.26; O, 4.66±0.40) (Figure 2.43). 
  
 
 
Figure 2.43 RNA (µg)/Protein (µg) in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis and students t-test.  
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The RNA: DNA ratios were not different between the age-groups either 
before or after RET. RET had no effect on the RNA: DNA ratio in any of 
the age groups (before: Y, 0.84±0.05; M, 0.95±0.04; O, 0.87±0.07, after: 
Y, 0.76±0.05; M, 0.94±0.07; O, 0.91±0.05) (Figure 2.44). 
 
 
 
Figure 2.44 RNA (µg)/DNA (µg) in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis and students t-test. 
 
2.4 Discussion 
 
We hypothesized that RET would rejuvenate age-related declines in 
muscle protein synthesis in the basal condition and in response to feeding 
and/ or exercise-plus-feeding. However, all groups demonstrated an 
increase in MPS in response to feeding and exercise-plus-feeding both 
before and after RET with no difference in MPS between the age-groups at 
any time, thus not supporting the hypothesis-based assumption of age-
related declines in MPS responses to anabolic stimuli. This data conflicts 
with work showing anabolic blunting with age across a range of EAA 
feeds (Cuthbertson et al., 2005; Volpi et al., 2000b). One possible 
explanation for the lack of differences between the age-groups is that our 
study design may have missed the optimal time-point for anabolic 
responses to be measured due to the ³muscle full´ phenomena recently 
proposed by Atherton (Atherton et al., 2010). This work demonstrated that 
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there is approximately a 90 min window in which anabolic responses 
(increases in MPS and many signalling proteins) are heightened in 
response to AA feeding and that even with continued AA provision 
(extracellular and intracellular availability) the MPS and signalling 
(mostly) responses will return to baseline. Although the feeding strategy 
for this study did involve repeated feeds with the last feed only ~30 min 
before the final muscle biopsy, it may be that the final biopsies being 120 
min after the initial feeding bolus is not truly representative of maximal 
anabolic responses and that studies using a single AA dose or protein meal, 
which do demonstrate anabolic blunting, are more likely to represent 
practicable feeding strategies employed by most individuals in everyday 
life.  
 
Although there were no significant differences between the age-groups 
there was a trend for the fed MPS values before and after training to be 
lower in both of the older groups compared to the young, illustrating subtle 
anabolic blunting with age, although this does not appear to extend to the 
combined stimuli of exercise-plus-feeding. 
 
The issue of timing may also be what prevents us seeing age-related 
differences or RET effects on FSR in response to exercise-plus-feeding. 
Adding exercise to feeding has been shown to not only heighten but also 
prolong the anabolic response (Pennings et al., 2011; Tipton et al., 2001; 
Dreyer et al., 2008; Witard et al., 2009; Moore et al., 2009a; Moore et al., 
2011b), so much so that when measuring FSR for 24 hours after protein 
ingestion and exercise, synthesis rates are heightened compared to basal 
even at the end of the study (Burd et al., 2011). RET may therefore have 
significantly prolonged the duration of increased FSR in response to 
exercise-plus-feeding but with only subtle increases in the amplitude of 
response and this would not have been evidenced in our study design.   
 
The increase in the young groups MPS in response to exercise-plus-feeding 
after RET does suggest positive effects of RET on MPS responses to 
anabolic stimuli. Also, it is interesting to note that this, the most significant 
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effect of RET, occurred only in the young group where the most significant 
increases in muscle hypertrophy occurred (see chapter 3) and where the 
only correlation between strength and lean mass increases was apparent, 
despite almost identical strength gains between the groups. This 
association lends itself to the suggestion that the ability of the young to 
heighten their MPS responses to exercise-plus-feeding after RET may 
partially explain their greater improvements in muscle mass. This would be 
in keeping with the work of some groups who have shown blunted 
hypertrophic responses to RET with age (Greig et al., 2011; Welle et al., 
1996; Dionne et al., 2004; Lemmer et al., 2001), albeit contradicting the 
work of others (Ivey et al., 2000; Hakkinen et al., 2001) who suggest that 
older individuals have the same propensity to gain muscle mass through 
RET as younger subjects. 
 
Another suggestion of the positive benefits of RET comes from the 
additive effect of the dual stimuli compared to feeding alone in the older 
group after RET.  It may be that older individuals require the dual stimuli 
of exercise-plus-feeding, which has been shown to be an optimal 
combination  (Moore et al., 2009a; Staples et al., 2011; Tang et al., 2009) 
to elicit maximal anabolic responses. 
 
Another suggestion for the subtlety of MPS improvements in our older 
group LV WKDW RXU 5(7 ZDV QRW WUXO\ µRSWLPDO¶ IRU WKLV DJH-group. The 
optimal patterns of RET to maximize anabolic responses, especially in the 
elderly still need determining and this represents a major area of study. 
Work from Kumar and colleagues, has cast new light on the role of 
exercise intensity in determining MPS responses to exercise. Kumar has 
shown a sigmoid dose-response to resistance exercise such that, MPS after 
exercise is greatest at intensities above 60% 1-RM; even when repetition 
number was increased at lower intensities to match workload, suggesting 
DQDQDEROLFµFHLOLQJ¶DERYH-RM (Kumar et al., 2009). 
 
Interestingly the intensity of exercise to elicit a robust MPS response can 
be drastically reduced (20% 1-RM) when combined with vascular 
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occlusion (Fry et al., 2010), suggesting that high intensity RET is not 
necessarily a pre-requisite for exercise-induced increases in MPS. In fact, 
increasing the volume of work at a low intensity (30% 1-RM to failure) 
was shown to be more effective than high-intensity, low-volume (90% 1-
RM to failure) resistance exercise in terms of amplitude and duration of 
MPS responses after acute exercise (Burd et al., 2010), although more 
work is required to establish if this would translate into similar training 
adaptations.  
 
The associated anabolic signalling, as with the FSR does not tell a 
conclusive story with regard to the effects of either age or RET but does 
lend itself to some suggestions of improvements with RET. Acute changes 
in MPS are primarily regulated at the mRNA level via increasing 
translational efficiency (Kimball et al., 2002). For example, increasing 
dietary AA alters the phosphorylation state of proteins within the mTOR 
signalling cascade (Moore et al., 2011a) resulting in increases in the 
activity of these proteins, including of P70, 4EBP1 and EEF2 (Cuthbertson 
et al., 2005; Fujita et al., 2007; Glover et al., 2008). It is not only AA 
feeding, but also acute resistance exercise that is known to promote these 
activity increases, with the combination of the two stimuli appearing 
optimal (Karlsson et al., 2004; Witard et al., 2009; Apro & Blomstrand, 
2010). RET also appears to act upon a different pathway, independent of 
mTOR; the MAPK pathway (Williamson et al., 2003). Activation of this 
pathway seems to affect ERK1/2 which can regulate proteins involved in 
initiation and elongation of mRNA translation (Roux et al., 2007) and 
could therefore be involved in post-exercise increases in MPS.  
 
P70 is known for its role in modulating cell-cycle progression, cell size and 
cell-survival (An et al., 2003) and its activation is required for G1 cell 
cycle progression (Lane et al., 1993) (see Figure 2.2). P70 phosphorylation 
only increased in the young in response to exercise-plus-feeding after RET, 
while in the middle-aged group this increase was apparent both before and 
after RET. The old group displayed increased phosphorylation in response 
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to exercise-plus-feeding both before and after RET but increased 
phosphorylation in response to feeding alone only after RET.  
 
4EBP1 mediates the regulation of protein translation by hormones, growth 
factors and other stimuli such as contraction and feeding which signal 
through the P13 kinase pathway (Gingras et al., 1999). 4EBP1 was 
depressed immediately post-exercise in both the young and the older 
groups before and after RET and in the middle-aged group before RET. 
Only in the old group did 4EBP1 phosphorylation increase in response to 
the anabolic stimuli of feeding and exercise-plus-feeding and this was true 
both before and after RET.  
 
mTOR is a serine/threonine protein kinase that regulates cell growth, 
proliferation, motility, survival, protein synthesis and transcription, 
targeting P70, EEF2 and 4EBP1. mTOR phosphorylation was the 
signalling target seemingly most affected by RET. At no time-point were 
there any significant differences between the age-groups before or after 
RET, however mTOR phosphorylation was increased from basal after RET 
in all three age-groups in response to exercise-plus-feeding, a response that 
was not apparent in any of the groups before RET. After RET the middle-
aged and old groups also responded to feeding alone with increased mTOR 
phosphorylation.  
 
EEF2 is essential for protein synthesis by promoting translocation and is 
activated by inhibition of EEF2K by mTOR and p70S6K.  There were no 
significant changes in EEF2 phosphorylation with any of the anabolic 
stimuli in any of the age-groups either before or after RET. The surprising 
depression in EEF2 phosphorylation in response to exercise-plus-feeding 
in the young before RET is likely an artifact of outliners within the data 
(although all data is LOG transformed) that may have been caused by 
possible technique limitations such as mixed tissue (i.e. connective tissue 
infiltration) biopsies and subsequent non-uniform protein loads. 
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Although the lack of demonstratable changes in FSR with RET may seem 
surprising even the most optimal of feeding and/or exercise strategies may 
not elicit substantial effects in all individuals. In a recent study by 
Davidsen et al. (Davidsen et al., 2011), a fully supervised RET program in 
younger individuals elicited strikingly heterogeneous mass and strength 
gains. Based on a continuum, in which the authors categorized the top 20% 
µKLJK¶ UHVSRQGHUV DQG WKH ERWWRP  µORZ¶ UHVSRQGHUV IRXU PL51$
species were associated with training responsiveness; suggesting that these 
PL51$¶VPD\KDYHDUROHWRSOD\LQGHWHUPLQLQJDGDSWLYHKHWHURJHQHLW\ 
On a similar theme, a study by Mayhew et al. (Mayhew et al., 2011), 
determined that increased concentrations of eukaryotic initiation factor 2B 
HSVLORQ H,)%İ SURWHLQ H[SUHVVLRQ DIWHU D VLQJOH H[HUFLVH ERXW ZDV
directly associated with the degree of hypertrophy after RET and that in-
YLWUR RYHU H[SUHVVLRQ RI H,)%İ OHDG WR muscle hypertrophy; suggesting 
that up regulation RIH,)%İPD\SDUWO\XQGHUOLHDGDSWLYHFDSDFLW\ Taken 
together these 2 studies suggest that using biological variability represents 
a powerful approach in terms of both bio-prediction and gaining 
mechanistic insight into human studies and although much more work is 
needed to link measures such as non-coding RNA, mRNA, intracellular 
proteins and MPS in humans, it could be speculated that heterogeneity in 
WKHµPXVFOH-IXOO¶VHW-point may underlie adaptive capacity.  
 
The remaining hypotheses for this chapter all center around strength losses 
with ageing and the effects that nutritional intake and RET may have upon 
these. We hypothesized that RET would improve muscle strength but the 
gains would be less in older individuals. This hypothesis proved incorrect. 
RET did result in significant increases in strength, but these improvements 
were almost identical between the age-groups. The strength improvements 
resulted in the strength of the old group after RET being not different to 
that of the young before; effectively the strength of the old group was 
restored.  
 
There is little argument that older people are able to gain strength with 
RET (Lambert & Evans, 2005) but agreement on whether older people 
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have the ability to achieve the same strength increases as younger people 
has not yet been reached. Some of the literature suggests blunted strength 
gains with ageing (Lemmer et al., 2001; Greig et al., 2011) while other 
groups complement our data showing that older individuals retain their 
ability to gain strength in response to a RET program (Moritani & deVries, 
1980; Hakkinen et al., 2001) and in what seems like a possible explanation 
for the discrepancy in these results, some groups have shown differences in 
response to certain exercises between young and older individuals (Jozsi et 
al., 1999; Welle et al., 1995). 
 
We also hypothesised that there would be age-related declines in muscle 
strength associated with 1. lower dietary protein intake in older individuals 
or 2. a difference in muscle fibre composition. Age-related declines in 
strength are consistently shown within the literature and have also been 
observed in this study. However, these declines in strength are often 
coupled to declines in lean mass, something which we do not see in this 
study and will be discussed in more detail in the next chapter.  
 
Muscle wasting alone cannot therefore account for all decreases in muscle 
strength. This observation means that there must be other factors at play 
leading to the loss of force per unit area seen in ageing individuals. The 
reduction in strength with age, when no apparent reduction in lean mass is 
observed, is commonly explained by differences in tendon properties and a 
decreased efficiency of excitation-contraction coupling with age (Narici & 
Maganaris, 2006). Narici and colleagues suggested that 4 factors, other 
than sarcopenia may contribute to the decreases in strength observed with 
ageing: 1. Muscle architecture, 2. Tendon mechanical properties, 3. 
Reduced agonist and increased antagonist muscle activity and 4. Decreased 
single fibre specific tension. 
 
Numerous groups have demonstrated evidence to support the theories of 
reduced agonist and increased antagonist muscle activity (Harridge et al., 
1999; Scaglioni et al., 2002) and decreased single fibre specific tension 
(D'Antona et al., 2003). Support for changes in muscle architecture and 
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tendon mechanical properties has also been shown with a 25% reduction in 
muscle volume of the plantar flexors associated with a 10% reduction in 
fibre fascicle length, a 13% reduction in pennation angle, and a 10% 
reduction in tendon stiffness (Morse et al., 2004).  
 
In relation the strength changes that we have observed following our RET 
it is interesting that most of the observed changes in muscle architecture 
and tendon mechanical properties are reversible by 14 weeks of RET; fibre 
fascicle length was shown to be increased by 10% and tendon stiffness by 
64% (Reeves et al., 2004). It may therefore be that our RET program 
improved muscle architecture and tendon mechanical properties and these 
contributed to improved strength, especially in the old.  
 
The increases in strength that we observed following our RET may be 
partially due to changes in muscle architecture and tendon mechanical 
properties as discussed above, however as no measures of fascicle length, 
pennation angle or tendon stiffness were made during this study we are 
unable to comment on if these changes occurred.  These changes are 
however highly likely given that they were observed following a 14 week 
RET, also 3 times per week and at a similar intensity (80% 5-RM). 
Changes in these properties may offer great functional benefits to an 
ageing population as a RET induced increase in tendon stiffness has been 
associated with a 25% faster development of joint torque, which may be 
critical in recovering body position from a potential fall, with the risks and 
outcomes of falls in the elderly discussed earlier in this thesis (see chapter 
1). 
 
Another possible explanation for the disconnection between muscle size 
and strength that is seen with ageing is that of reduced neural efficiency. 
The ability of muscles to produce force begins with initiation in the 
nervous system with force production governed by 1. motor unit 
recruitment and  2. the rate of motor unit firing/ central activation (Lambert 
& Evans, 2005). Although there appears to be impairment of muscle 
activation with age for some muscle groups (Jakobi & Rice, 2002; Yue et 
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al., 1999) but not others (Connelly et al., 1999; Kent-Braun & Ng, 1999; 
Roos et al., 1999; Phillips et al., 1992) there is other evidence of impaired 
nervous system muscle activation with ageing, such as increased co-
activation of antagonist muscles (Hakkinen et al., 2001; Izquierdo et al., 
1999; Klein et al., 2001) and reduced foot tapping speed (Kent-Braun & 
Ng, 1999). Using a curvilinear equation Stackhouse and colleagues 
calculated a central activation deficit of 11% in old subjects compared to 
young controls and suggested that this may explain the strength-mass loss 
discrepancy (Stackhouse et al., 2003); with strength declines of 2.0-2.5% 
per year after the age of 65 (Frontera et al., 2000) but mass losses of 0.5-
1.0% per year after the age of 40 (Janssen et al., 2000). 
 
With regard to our hypothesis of reductions in strength with ageing being 
related to lower dietary protein intake in our older group there were very 
few differences in dietary composition between the age groups or with 
RET. The percentage of dietary intake composed of protein was not 
different between the age groups either before or after RET and did not 
change significantly with RET. As hypothesized absolute protein intake 
was significantly higher in the young than in the middle-aged group before 
RET with a trend for it to also be higher than in the old group. However, 
during RET there was a trend for the absolute protein intake of the young 
to be reduced; (corresponding with a reduction in their energy intake) 
which resulted in no significant differences in the absolute protein intakes 
between the age groups during RET. Leucine has been shown to be the 
primary EAA required for increases in MPS (Breen & Phillips, 2011) and 
following the pattern of absolute protein, leucine intake was significantly 
higher in the young than in the middle-aged and old before RET but was 
no different during owing to a small (but not significant) reduction in 
leucine intake in the young and increases of a similar magnitude in the 
middle-aged and old groups. In addition to protein-based intake the young 
group reduced their total kcal intake during RET and this corresponded 
with decreased saturated fat intake, monounsaturated fat intake and sodium 
intake as well as a trend for reduced cholesterol intake, something also 
observed by Bales and colleagues who found that after 8 months RET 
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reduced reported energy and fat intake was observed (Bales et al., 2012). 
These changes resulted in no differences between the age-groups during 
RET as the kcal, saturated fat and monounsaturated fat intakes had all been 
significantly higher in the young group than the middle-aged and old 
groups before RET. The only other significant dietary change was an 
increased sodium intake in the old during RET.   
 
Diet-diary results must however be interpreted with caution as under-
reporting of energy intake (EI) when using diet diaries is common (Biltoft-
Jensen et al., 2009). This is likely to be the case in our results as the 
maximum reported EI is only ~2130 kcal and this was for our young group 
only, with the middle-aged and older groups significantly lower (before 
RET values), averaging an EI of just 1790 kcal if all age-groups were taken 
together. When EI reported by diet diaries were quantified against a 
validated position and motion instrument, reported EI was underestimated 
by 12% on average (Biltoft-Jensen et al., 2009). It is not only EI that is 
misreported in these diet diaries, the quality of the diet is often under-
reported by virtue of underreporting EI and this is seemingly true for all 3 
common methods of dietary recording; diaries, recall and history 
(Livingstone & Black, 2003).  
 
Diet manipulation for the duration of the recording is another problem 
associated with diet diaries. Rebro and colleagues found that people tended 
to reduced their snack intake, number of foods consumed and the 
complexity of their diet during times of monitoring, even if the reporting 
was over non-consecutive days and in subjects deemed as highly motivated 
(Rebro et al., 1998).  
 
The duration and chosen days for the diet diary also seems to affect the 
extent of underreporting, with the highest degrees of underreporting on the 
µZHHNHQG¶ GD\V RI )ULGD\ DQG 6DWXUGD\ (Whybrow et al., 2008), not 
6DWXUGD\ DQG 6XQGD\ ZKLFK DUH WUDGLWLRQDOO\ FODVVLILHG DV µWKH ZHHNHQG¶
when people are requested to include one weekend day in a 3 day diet 
diary. These daily discrepancies support the use of 7-day diaries as 
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superior to 3-day, in that they will catch a complete weekly cycle of human 
feeding behavior and is also allow more days of accurate captures as the 
lowest reported intake occurs on day-1 of a diet diary (Whybrow et al., 
2008). The observation of a trend for reduced reported EI between days 2-
7 of a diet diary may lead some to speculate that a shorter diary would be 
favorable, but this trend was only for a reduction of 49 kJ per day 
(Whybrow et al., 2008) while shorter diaries induce greater between-
subject variability as they may choose different days of the week. Overall, 
the correlation between a 3-day and 7-day diet diary was found to be 
0.860, P<0.001 with the 3-day less effortful for both investigators and 
subjects.  
 
Of course not all people will under-record to the same extent, it has been 
shown that 1. there is a correlation between BMI and degree of 
underreporting, 2. Under reporting is more common in females and 3. 
sugars and fats are the most under-reported (Rasmussen et al., 2007). 
Based on these observations our results should still allow us to assess with 
confidence differences between the age-groups and with RET as there were 
no significant differences between the BMI of our groups and the female: 
male ratio was almost equal in all the groups. Smoking status and 
educational level appear to have little effect on the degree of 
underreporting.  
 
In general it is agreed that dietary intake cannot be estimated without some 
degree of problem (Beaton, 1994). However, stringent guidelines on how 
and when to record may reduce some elements of inaccuracies which is 
key if dietary intake represents a primary endpoint, shorter diaries do 
however seem suitable for recording group trends and changes with an 
intervention.  
 
In relation to our final hypothesis for this chapter we did observe 
differences in myosin heavy chain isoform distribution (representative of 
muscle fibre-type composition) between the age-groups, these do not 
however lend themselves to explaining the loss of strength observed with 
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age. Before RET the old displayed a unique fibre type distribution 
compared to the other age groups, with a higher percentage of Type IIx 
fibres compared to Type I while both the young and middle-aged groups 
showed an even distribution of the three fibre types. This is at odds with 
the work of Lexell and colleagues who reported a greater loss in the 
number and size of Type II fibres with age when compared to Type I fibres 
(Lexell, 1995). This is also at odds with knowledge that the number and 
size of Type II muscle fibres are a primary determinant of muscle force 
production as they produce more force than Type I fibres (Bottinelli et al., 
1996), with a positive relationship between muscle maximal torque 
production and the percentage of Type II fibres in that muscle 
(Thorstensson et al., 1976).  
 
Despite all subjects undertaking the same exercise regime there were 
differences in the fibre type shifts seen with RET. The young group had a 
reduced percentage of Type IIa fibres after RET with increased Type IIx, 
resulting in more Type IIx than Type IIa fibres after RET. The old group 
also showed this profile after RET but in this group was due to a reduction 
in Type IIa fibres after RET without an increase in Type IIx. These shifts, 
in both the young and old group are contrary to the literature where across 
all ages RET has been shown to decrease the percentage of Type IIx fibres 
and increase the percentage of Type IIa (Hikida et al., 2000; Staron & 
Johnson, 1993). The old group did however increase their Type I fibres 
after RET, something which has been shown as the results of RET in 
numerous studies (Hakkinen et al., 2001; Frontera et al., 1988; Trappe et 
al., 2000; Hikida et al., 2000). The middle-aged group also increased their 
proportion of Type I fibres, although the distribution of the three fibre 
types remained even in the middle-aged group after RET, rendering their 
fibre type profile unchanged by the RET. 
 
Overall it seems unlikely that our hypothesis of age-related declines in 
muscle strength would be associated with a difference in muscle fibre 
composition is correct. Both the difference between the groups and the 
changes with RET are very small (yet significant) and it may be that the 
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use of ratios has given greater power to the statistical analysis of this data 
set. If a conclusion was to be drawn about the age-related differences and 
RET-induced changes observed it would be that the young appear to get 
µIDVWHU¶ ZKLOH WKH ROG DSSHDU WR JHW µVORZHU¶ 7\SH ,, ILEUHV KDYH Eeen 
shown to hypertrophy more due to greater recruitment and this may be 
another partial explanation to the greater gains in lean mass shown by our 
young group with RET. 
 
We also measured RNA, DNA and protein content in postabsorptive, pre 
and post RET muscle samples from all of our subjects. Protein: DNA ratio 
gives a sensitive index of muscle protein mass (Crossland et al., 2010) and 
is an indication of the muscle DNA unit size (Cuthbertson et al., 2005); a 
measure of the amount of cytoplasm managed by each nucleus in the 
muscle. Of all the calculated ratios this was most effected by RET with the 
young group showing a decrease in their Protein: DNA ratio after RET 
while the old group had an increased ratio.  
 
Changes in Protein: DNA may be explained by alterations in the DNA: 
Tissue ratio, where the young showed a significant increase after RET and 
the old showed a small (non-significant) decrease. The DNA: Tissue ratio 
is representative of nucleus to fibre ratio and increases may represent 
increased satellite cell proliferation and migration into the cell which in 
turn would support muscle growth and result in a reduced Protein: DNA 
ratio as observed in our young group. Conversely the old groups Protein: 
DNA ratio would be increased as they may not have the ability to increase 
their satellite cell pool within the muscle.  
 
The middle-aged group did not change either Protein: DNA or DNA: 
Tissue with RET but Protein: DNA ratio was higher than both of the other 
groups before and after RET. The spurious results from the middle-age 
group for this data set and others in this work may be due to the large 
³DJHLQJ´ YDULDWLRQ LQ RXU PLGdle aged group; i.e. we have biologically 
µ\RXQJ¶ DQG µROG¶ PLGGOH-aged subjects forming this group; something 
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which could be evidences by using a combination of RNA profiling with 
single-gene DNA marker association (Timmons et al., 2010). 
 
The RNA: Protein and RNA: DNA ratios represent the total capacity of the 
muscle for protein synthesis and in work by Cuthbertson et al were found 
to be lower in elderly compared to young subjects (Cuthbertson et al., 
2005). However, we found no differences in either of these ratios either 
between our age groups or with RET. This discrepancy between our work 
and the work of Cuthbertson is similar to the one observed for the FSR 
data and it may be that subject characteristics explain some of the variation 
observed. This study was promoted aV ³1RWWLQJKDP DQG 'HUE\ $FWLYH
Ageing´ and this in combination with the enticement of 20 weeks free 
personal trainer sessions may have led to a degree of self-selecting bias in 
those who participated in this study. Although our exclusion criteria 
restricted this study to healthy adults, our older age group had a lean 
muscle mass that was not different to that of our younger groups and 
therefore was not representative of the age-related declines in muscle mass 
that can be seen in larger population cohorts.  This discrepancy may offer 
another explanation (alongside the concept of an anabolic window and the 
feeding strategy) as to why we are unable to observe (with statistical 
power) the commonly reported concept of anabolic blunting with age both 
with regard to FSR and the associated anabolic signalling. 
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CHAPTER 3- BODY COMPOSITION 
 
3.1 Introduction to body composition 
 
Maintaining a healthy body weight and level of body fatness is 
fundamental to a healthier and longer life. Overweight or underweight 
individuals with levels of body fat at, or near to the extremes of the body 
fat continuum are likely to have serious health problems that reduce life 
expectancy and threaten quality of life. 
 
Individuals who are overweight or obese have a higher risk of developing 
various cardiovascular, pulmonary and metabolic diseases, as well as 
osteoarthritis and certain types of cancer (US Department of Health and 
Human Services, 2000). 
 
Underweight individuals with extremely low levels of body fat are often 
malnourished and have a higher risk of fluid-electrolyte imbalances, renal 
and reproductive disorders, osteoporosis, osteopenia and muscle wasting 
(Fohlin, 1977; Mazess et al., 1990). 
 
$W SUHVHQW D FRPPRQ WRRO WR DVVHVV VRPHRQH¶V ZHLJKW LV WKH ERG\ PDVV
index (BMI), which is calculated using the following formula: 
 
Weight (kg)      
 Height (m)2 
 
CHAPTER HYPOTHESES: 
i. There are age-related decreases in total body and lean leg mass and 
increases in fat mass. 
ii. Age-related changes in body composition are associated with fat 
distribution linked to increased risk of cardiovascular health risks. 
iii. Resistance-exercise training increases lean mass and improved 
measures of bone quality. 
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With current guidelines classifying: 
x < 18.5 as underweight 
x 18.5 ± 24.9 as healthy 
x 25- 29.9 as overweight  
x >30 as obese, further categories then split those with a BMI over 30 
into levels of obesity (http://www.euro.who.int/nutiriton).  
 
The BMI method does however have limitations. With no accounting for 
the ratio of fat mass (FM): FFM, the BMI can misclassify people with 
extreme musculature into an overweight or obese category based on their 
weight: height ratio when they are in fact carrying very little body fat.  
 
For any given BMI there is considerable variation in body composition, 
often related to age and/ or gender as discussed later in this chapter. Some 
LQGLYLGXDOVZLWK ORZ%0,¶VPD\KDYHDVPXFKUHODWLYHERG\IDWDV WKRVH
ZLWK KLJK %0,¶V EHFDXVH FRPSRVLWLRQ RI DQ LQGLYLGXDO¶V body weight 
cannot be assessed using BMI. 
 
The best model for the assessment of body composition, including 
measurement of muscle mass is magnetic-resonance imaging (MRI). MRI 
is validated against anatomical analysis of cadavers and has been reported 
to display errors of as little as 2% (Engstrom et al., 1991; Mitsiopoulos et 
al., 1998), application of this method is however limited by expense and 
availability. 
 
A slightly less expensive option is computerized tomography (CT), with 
reported errors of ~6% (Janssen & Ross, 2005), this method is limited by 
radiation exposure and also by the lack of readily available composition 
quantification software, meaning that data manipulation using this method 
is often subject to operator variability. 
 
One commonly used method, more accurate than BMI but less so than the 
gold-standard of MRI, WR HVWLPDWH DQ LQGLYLGXDO¶V body composition is 
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DEXA. DEXA is a body composition measurement method used to 
measure total body bone mineral density, bone mineral content, fat and 
lean soft tissue mass. Based on the principle of using the attenuation of X-
rays to identify body tissues, DEXA provides an accurate measure of total 
body bone mineral (TBBM) and BMD, and can provide estimates of bone 
free lean tissue mass (LTM), fat mass (FM), soft-tissue mass (STM) (STM 
= LTM + FM), FFM and % body fat (BF).   
 
The principle underlying DEXA is that the attenuation of X-rays with high 
and low photon energies is measurable and dependent upon the thickness, 
density and chemical composition of the underlying tissue. The attenuation 
of X-ray energies through fat, lean tissue and bone varies due to the 
differences in densities and chemical composition of these tissues. These 
attenuation ratios at two different X-ray energies are thought to be constant 
for all individuals (Pietrobelli et al., 1996). 
 
As with all body composition measurement methods, DEXA is based on 
assumptions, with the main three assumptions for the DEXA method 
being: 
 
1. The amount of fat over bone is the same as the amount of fat over 
bone-free tissue. With DEXA the composition of STM is calculated 
only from pixels that do not contain bone which is approximately 
60-65% of pixels in a whole body scan. This means that STM 
estimates in bony regions may not be as accurate as they are in 
bone-free regions. 
  
2. Measurements are not affected by the anterior-posterior thickness 
of the body. In theory the attenuation of any given substance is 
constant, but these values may change with differences in 
thickness. Calibration of the DEXA machine with a phantom 
attempts to correct this limitation as the quantity and density of the 
phantom is known and can be used to check the accuracy of a 
DEXA scan. 
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3. The hydration and electrolyte content of the LTM is constant. 
Although not exact, research has reported that changes in hydration 
of up to 1kg are not likely to greatly affect the accuracy of DEXA 
measurements (Going et al., 1993; Pietrobelli et al., 1998; 
Pietrobelli et al., 1996) and that a 5% change in the water content 
of FFM will only affect DEXA body fat estimates by 1-2.5% BF 
(Lohman et al., 2000).  
 
All DEXA models and makes are based on the same principles and 
assumptions outlined above. Although often referred to as a three 
compartment (3-C) model of body composition assessment as it provides 
estimates of TBBM, LTM and FM, it is in reality providing two separate 
sets of two compartment assessments (Ellis, 2000), where the first 
distinguishes bone from STM and the second distinguishes lean tissue from 
fat mass. It is the accuracy of the second distinction that has been 
questioned in the past (Milliken et al., 1996; Snead et al., 1993), although 
it has been reported that improvements in software have corrected the 
inaccuracy of this distinction enabling DEXA to accurately measure 
exogenous fat regardless of whether it was centrally or peripherally 
distributed (Kohrt, 1998). One problem that has not yet been overcome is 
that fluid retention increases DEXA reporting of LBM but not FM, with an 
additional limitation of DEXA being that no cross-sectional images can be 
produced. 
 
As well as the limitations and assumptions already discussed a further 
difficulty of the measurement of muscle mass is that determination of 
muscle mass by whichever method does not predict functional muscle 
mass. Alterations or differences in muscle fibre components (i.e. MHC 
isoforms), myofibre function or metabolic characteristics (e.g. creatine 
phosphate content), are not given by any of the body composition 
measurement methods mentioned.  
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3.1.1 Body composition and energy balance 
With levels of obesity and overweight in many westernized countries 
reaching epidemic proportions it has become an issue which all of society 
needs to be aware of as it has high reaching numbers of associated health 
problems. Obesity is clinically characterized by a disproportionately high 
fat mass (Wolfe, 2006) and excessive body fat has the ability to cause 
numerous and serious health problems. Excess body fat not only leads to 
changes in fat tissue development and growth, it also leads to insulin 
resistance and endothelial dysfunction through the pro-inflammatory and 
pro-thrombotic effects of adipokines (McCroskery et al., 2003). Adipose 
tissue is an active endocrine and paracrine organ that releases a large 
number of cytokines and bioactive mediators that influence not only body 
weight homeostasis but also inflammation, coagulation, fibrinolysis, 
insulin resistance, diabetes, atherosclerosis, risk of coronary heart disease 
(CHD) and some forms of cancer (Kopelman, 2000; Lau et al., 1996; Van 
Gaal et al., 2006; Mohamed-Ali et al., 1998). In general, for each unit of 
BMI increment (above 24.9) the risk of CHD increases by 8% (Li et al., 
2006). 
 
The only way in which the homeostasis of body weight can be altered is 
through an imbalance of net energy. Weight gain is inevitable if the energy 
taken up by the body exceeds that expended. Obesity classifications are 
often based on weight: height ratios and although generally thought of and 
defined as excessive accumulation of fat mass, the increased muscle mass 
in obesity is often less appreciated (Hibbert et al., 1994). In obese 
individuals the increased energy expenditure associated with larger muscle 
mass is insufficient to offset the positive net energy balance but may still 
be capitalized upon to facilitate weight loss, especially when combined 
with adequate nutrition. The energy to provide adenosine tri-phosphate 
(ATP) for muscle protein turnover is largely derived from the oxidation of 
fat; the preferred energy substrate of resting muscle (Rasmussen & Wolfe, 
1999. 
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Muscle protein turnover can occur at a greater rate if there is higher amino 
acid availability, possibly through an increase in protein intake (Paddon-
Jones et al., 2005). Studies using testosterone based injections to increase 
MPS have demonstrated that the increase in lean body mass that occurred 
was accompanied by a decrease in fat mass (Ferrando et al., 2002). These 
data lead to the suggestion that a kilocalorie (kcal) restricted diet with a 
high percentage of protein would be expected to alter tissue composition 
favoring the loss of fat and the growth of muscle. This may go some way 
LQDLGLQJREHVHLQGLYLGXDO¶VORVVRIIDWPDVV(Wolfe, 2006).  
 
Although many different factors such as body composition, muscle mass, 
hormonal status, genetic variability and environmental factors will affect 
energy expenditure and therefore energy requirements of an individual, it 
is possible to predict the energy requirements of an individual needed to 
maintain body weight homeostasis based on established regression 
equations. 'HWHUPLQLQJ DQ LQGLYLGXDO¶V EDVDO PHWDEROLF UDWH %05 LV
normally the first step in obtaining an estimate of energy requirements. 
BMR is the minimum rate of expenditure for a conscious person. BMR 
accounts for the energy required to maintain organ and systemic function. 
Level of activity will determine how much of a SHUVRQ¶V energy needs are 
accounted for by their BMR.  
 
The Schofield equations (Schofield, 1985) are one common set of 
regression equations used to establish estimates of BMR values (Table 
3.1). 
 
Table 3.1 Schofield equations for calculating basal metabolic rate (BMR) 
Schofield BMR Equations 
Age Male Female 
10-17 years 17.7 x W + 657 SEE = 105 13.4 x W + 692 SEE = 112 
18-29 years 15.1 x W + 692 SEE = 156 14.8 x W + 487 SEE = 120 
30-59 years 11.5 x W + 873 SEE = 167 8.3 x W + 846 SEE = 112 
W = Body weight in Kilograms; SEE = Standard error of estimation 
Adapted from: (Schofield, 1985) 
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The number achieved from the equations should be altered within the 
standard error range shown. Subjects who are lean and/ or more muscular 
require more kcal than average. Obese subjects require less. Subjects at the 
young end of the age range for a given equation require more kcal. 
Subjects at the high end of the age range for a given equation require fewer 
kcal. 
 
2QFH %05 KDV EHHQ FDOFXODWHG DQ LQGLYLGXDO¶V DFWLYLW\ PXVW DOVR EH
accounted for to determine their energy demands, this is known as their 
physical activity level (PAL). Following a committee meeting in 1991 
(COMA-Committee on Medical Aspects of Food Policy, 1991), the 
following table was produced accounting for leisure time and occupational 
activity on which to base PAL when calculating energy requirements 
(Table 3.2). 
 
Table 3.2 Guide for the prediction of physical activity levels  
Non-
occupational 
activity 
Occupational activity 
Light Moderate Moderate/ Heavy 
M F M F M F 
Non-active 1.4 1.4 1.6 1.5 1.7 1.5 
Moderate 1.5 1.5 1.7 1.6 1.8 1.6 
Very active 1.6 1.6 1.8 1.7 1.9 1.7 
M= Male; F= Female 
Based on: COMA committee meeting (COMA-Committee on Medical Aspects of Food 
Policy, 1991) 
 
BMR is multiplied by PAL to give an estimate of total energy expenditure 
(TEE) and therefore the energy requirement to maintain body weight 
homeostasis. 
 
For example: 
x 25 year old female 
x Body weight 60 kg 
x Moderate occupational activity 
x Very active leisure time 
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BMR = 14.8 x 60 + 487 (with no SEE correction for age or body 
composition) 
BMR = 1375 
PAL = 1.7 
TEE = 1375 x 1.7 
TEE = 2337 kcal/day 
 
Often the roles of muscle in relation to energy balance and/ or the 
prevention of obesity are overlooked. TEE is the sum of resting energy 
expenditure (REE), the thermic effect of food and energy expenditure due 
to activity. Generally REE is the largest component of TEE and it is 
muscle metabolism variation that may alter this considerably as the 
metabolism of other tissues and organs are relatively constant. As large 
variations in muscle mass are possible, often achieved through training, the 
rate of MPS and MPB can vary as well and it is these variations that are 
principally responsible for the energy expenditure of resting muscle.  
 
The average 24 hour FSR of muscle protein is ~0.075%/h-1, including 
response to three mixed-meals (Tipton et al., 1999). With the average 
muscle mass of young healthy males ranging from 35 to 50 kg and elderly 
women often having a muscle mass of <13 kg, calculated muscle protein 
synthesis can range from ~0.23-0.90 kg/d-1 (Tipton et al., 1999). This large 
variation means that because 4 mol of ATP are utilized per mole of amino 
acids incorporated into protein and the hydrolysis of 1 mol ATP releases 
20 kcal energy (Newsholme, 1978), the energy released per day as a result 
of muscle protein synthesis may range from 485 kcal in a well muscled 
young male to only 120 kcal in an active elderly female (Wolfe, 2006). 
 
With regard to weight loss, if the above difference of 365 kcal/ day-1  was 
positive or negative energy balance this would lead to a loss or gain of 47g 
fat mass/ day-1 (as 1kg fat = 7700kcal), which over a sustained period 
would lead to a loss or gain of 1.4 kg fat mass per month. The difference in 
muscle mass need not be as large as shown in the example above to have a 
significant effect on energy balance. A relatively small difference of 5 kg 
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in muscle mass could have a significant effect. An extra 5 kg of muscle 
mass translates to an additional energy expenditure of ~50 kcal.day-1, 
which in turn translates to a loss of 2.35 kg fat mass per year. With obesity 
developing over a time period that is often many years, such a seemingly 
small fat mass loss per year may contribute both to the prevention of 
obesity and aid in the treatment of it where necessary. 
 
3.1.2 Muscle 
For any action the body performs, whether it is movement, digestion or the 
heart beating, muscle is involved. There are three main classifications of 
muscle: cardiac, smooth and skeletal. 
 
Skeletal muscle is the term for the muscles of the body required for every 
conscious coordinated movement of the body. There are more than 600 
skeletal muscles in the body widely varied in size, shape and use. The 
structure of skeletal muscle is based around individual muscle fibers; the 
basic contractile units of skeletal muscles. They are individually 
surrounded by a connective tissue layer known as the endomysium and 
grouped into bundles known as fascicles which are surrounded by a layer 
known as the perimysium (Figure 3.1). 
 
 
Adapted from: 
http://training.seer.cancer.gov/module_anatomy/unit4_2_muscle_structure.html 
Figure 3.1 Skeletal muscle structure 
Bone Perimysium
Blood 
vessel
Muscle 
fiber
Fascicle
EndomysiumEpimysiumTendon
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Individual muscle fibres themselves also house a complex structure (Figure 
3.2). Each individual muscle fibre is surrounded by a plasma membrane 
called the sarcolemma which fuses with the tendon attaching that muscle to 
bone. Within the sarcolemma a muscle fibre is composed of successively 
smaller subunits. The largest of these units are myofibrils. Sarcoplasm 
surrounds the myofibrils and contains dissolved proteins, minerals, 
glycogen, fats and myoglobin. The sarcoplasm also contains a complex 
network of transverse tubules (T tubules); extensions of the sarcolemma 
that pass laterally through the muscle fibre. T tubules are interconnected 
and pass among the myofibrils allowing an action potential to be rapidly 
transmitted to the sarcoplasmic recticulum (SR). These tubules also allow 
substances to be transported into the inner parts of the muscle fiber. The 
SR is a network of tubules than run roughly longitudinally through the 
muscle fibre. These tubules loop around the myofibrils and serve as a 
storage site for calcium which is essential for muscle contraction.  
 
Adapted from: www.mhhe.com/biosci.htm 
Figure 3.2 Skeletal muscle fibre structure 
 
Myofibrils are the contractile components of skeletal muscle composed of 
sarcomeres, the smallest functional units of a muscle. Within each 
myofibril numerous sarcomeres join end to end at the Z-discs. Within each 
sarcomere there is: 
Sarcoplasmic
reticulum Mitochondrion
T Tubule
Sarcolemma
Myosin
Actin
Myofibril
Sarcomere
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x An I band 
x An A band 
x An H zone (in the middle of the A band) 
 
Surrounding the Z-disc towards the end of the sarcomere is the region of 
the isotropic-band (I-band). Following the I-band inwards is the region of 
the anisotropic-band (A-band) and within this band is the (H-zone) (Figure 
3.3).  
 
 
Figure 3.3 Outline of a sarcomere 
 
Actin protein filaments are the major component of the I-band and extend 
into the A-band. Myosin protein filaments extend throughout the A-band 
and overlap into the H-zone. It is the interaction of actin and myosin 
filaments that cause muscle fibres to shorten resulting in muscular 
contraction and movement with myosin being the actual motor. 
 
In addition to being rich in connective tissue, skeletal muscle is highly 
vascularised to provide essential nutrients for muscle function.  
 
3.1.3 Fat 
Adipose tissue is no longer viewed, as it had been previously, as a passive 
organ for triglyceride storage. As developing pre-adipocytes differentiate 
to become mature adipocytes they acquire the ability to secrete various 
proteins, many of which are released as cytokines or adipokines and are 
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discussed later in this chapter. The autocrine and paracrine effect of 
interleukin 6 (IL-6) and tumor necrosis factor-ĮTNF-Į) confirms adipose 
tissue to be a pro-inflammatory organ (Van Gaal et al., 2006). Adipose 
tissue is not only associated with local, but also more generalized systemic 
inflammation, involving circulating pro-inflammatory proteins, although 
these are linked to not only adipocyte but also hepatic origin. These 
findings have further implicated adipose tissue in the progressive 
development of a number of diseases, further supporting the benefits of 
RET as a method by which body composition can be improved. 
 
3.1.4 Bone 
As is true for muscle, bone is a fundamental part of the human body with 
numerous functions to play. Two hundred and six bones make up the 
human skeletal system which provide support and protection for other 
systems of the body and provide attachments for muscles to allow 
movement to occur. Bone is also required to maintain posture and for 
mineral storage and hemopoiesis; blood cell formation in the red bone 
marrow. 
 
Bones can be categorized into 5 main categories: Long bones, short bones, 
flat bones, irregular bones and sesamoid bones. Long bones possess, in 
general features that are typical of all bones (Figure 3.4). 
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Adapted from: www.baileybio.com 
Figure 3.4 Long bone structure 
 
The shaft or diaphysis is the long cylindrical portion of the bone. The 
diaphysis wall is made of hard, dense compact bone and this is known as 
the cortex. The outer surface of the diaphysis is covered by a dense, fibrous 
membrane known as the periosteum and a similar fibrous membrane 
known as the endosteum covers the inside of the cortex. Between the walls 
of the diaphysis lies the medullary cavity, which contains fatty marrow. At 
each end of a long bone is the epiphysis, which is usually specifically 
shaped to join with the epiphysis of an adjacent bone at a joint. The 
epiphysis is formed from trabecular bone. 
 
Cortical (or compact) bone is harder than trabecular (cancellous) bone and 
more compact with only a small proportion of its volume being porous, 
non-mineralized tissue. Because of its make-up cortical bone can withstand 
greater stress but less strain than trabecular bone. In contrast, trabecular 
bone is spongy with up to 90% of its volume being porous meaning that is 
can withstand greater strain than cortical bone before fracturing. 
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Although bones only continue to grow longitudinally until the epiphyseal 
plates close, growth in diameter continues throughout life. Bone is 
continually remodeled to repair micro-damage that occurs as a result of 
activities of daily living. This remodeling occurs as new concentric layers 
are built on top of old layers with new bone being formed by specialist 
cells known as osteoblasts. As we age an imbalance of osteoblasts and 
osteoclasts result in age-related bone losses of ~0.5% per year (Brewer et 
al., 2011). 
 
Bone is made up of calcium carbonate, calcium phosphate, collagen and 
water. About 60-70% of bone weight is made up of calcium with water 
accounting for ~25-30%. The role of collagen in bone is to provide some 
flexibility and also strength in resisting tension. As we age progressive 
losses in collagen occur (Bailey et al., 1999) and these result in an 
increased likelihood of fractures.  
  
3.1.4.1 Osteoporosis 
Osteoporosis is a metabolic bone disease that results in bone fragility and 
increases susceptibility to bone fractures due to a reduction in the density 
of bone tissue. The underlying mechanism of osteoporosis is an imbalance 
between bone resorption and bone formation (Raisz, 2005). Osteoporosis is 
a condition, like sarcopenia which is associated with ageing and effects a 
large proportion of our ageing population; approximately 1 in 2 women 
and 1 in 4 men over the age of 50 years will experience an osteoporosis 
related fracture in their lives (Brewer et al., 2011). Bone remodeling occurs 
in response to physical stress, although conversely physical inactivity can 
lead to significant bone loss. Not all exercise modalities have the same 
positive effects on bone mass; unloaded exercise, such as swimming for 
example, has no impact on bone mass while walking has limited positive 
effects (Guadalupe-Grau et al., 2009). Bone mineral density (BMD) 
determines fracture risk and is most commonly measured by DEXA 
(Brewer et al., 2011). RET has been shown to maintain or even increase 
bone mineral density in older individuals (Bonaiuti et al., 2002; Cochrane 
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et al., 2005; Chilibeck et al., 2005) and the Bone-Estrogen Strength 
Training (BEST) project identified six specific RET exercises that yielded 
the largest improvements in BMD in middle-aged to older females, 4 of 
which were identical to the ones used in this study and 2 of which were 
very similar in the muscle groups used (squat compared to seated leg press 
and military press compared to seated chest press) (Lohman et al., 1995). 
In addition, in the Mediterranean Intensive Oxidant Study (MINOS) 
skeletal muscle mass, improved by RET, was positively correlated with 
BMD and those with the lowest skeletal muscle mass had an increased risk 
of falls due to impaired balance and lower muscular strength (Szulc et al., 
2005).  
 
3.1.5 Body composition and ageing 
Ageing is associated with the loss of FFM and an increase in FM (Cohn et 
al., 1976). The loss of FFM can be attributed to decreases in bone mass 
(Heaney et al., 1982), skeletal muscle mass and body water (Fulop, Jr. et 
al., 1985). Ageing is also associated with the preferential deposition of 
body fat in the trunk region (Borkan et al., 1985), potentially leading to 
android obesity, shown to be associated with CHD and related mortality 
(Donahue et al., 1987). 
 
As we age FM increases and relatively more fat is deposited internally as 
visceral fat. Visceral fat is associated with all diseases linked to a 
centralized pattern of fat distribution, such as CV disease, type 2 diabetes 
and hypertension. The marked decline in FFM that occurs with age is 
primarily due to a loss of skeletal muscle mass (sarcopenia), as already 
mentioned, and a loss in bone mineral (Kuczmarski, 1989; Heymsfield et 
al., 1989; Roubenoff, 2000). Both of these losses increase the risk of 
disability and frailty in an ageing population. 
 
When looking at body composition, especially anthropometry, in an ageing 
population changes in height may need to be accounted for if using tools 
such as BMI. Decreased height with age may be attributable to a loss of 
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muscle tone, alterations in inter-vertebral discs and changes in posture 
(Barbosa et al., 2005) DQGPD\JLYHµIDOVH¶ERG\FRPSRVLWLRQHVWLPDWHV 
 
3.1.6 Body composition and gender 
It is not only age but also gender that has significant effects on body 
composition. However the effect of gender, unlike ageing is present from 
puberty throughout life and is evident in the majority of the population.  
 
Pre-menopausal women frequently develop peripheral (often gynoid) 
obesity with subcutaneous fat accumulation whereas men and post-
menopausal women are more prone to central (android) obesity. Central/ 
android obesity is associated with increased cardiovascular disease 
mortality and the development of type 2 diabetes and is cited as a key 
feature of the metabolic syndrome. Visceral adipocytes which often feature 
in android obesity are a major source of circulating free-fatty acids ())$¶V) 
and cytokines, which may then be directly delivered via the portal vein to 
the liver inducing insulin resistance and an atherogenic lipid profile. 
Inflammation of this nature increases cardiovascular risk particularly when 
present in women (Regitz-Zagrosek et al., 2006).  
 
Waist circumference; a measure of central obesity is recognized as a 
predictor of cardiovascular disease and the National Cholesterol Education 
Program have determined waist circumference measures of >88cm for 
women and >102cm for males predictive of increased risk for CHD and 
metabolic diseases (National Cholesterol Education Programme., 2001). 
Circumference measures allow calculation of the waist: hip ratio, an 
indirect measure of upper and lower-body fat distribution where a high 
ratio indicates greater upper body or central adiposity and is related to risk 
factors associated with cardiovascular and metabolic disease (Ohrvall et 
al., 2000). In 1988 Bray and Gray reported waist: hip ratio values of above 
0.82 for women and 0.94 for men as indicative of high risk for adverse 
health consequences (Bray & Gray, 1988). A heightened waist: hip ratio 
seemingly occurs in both sexes with age.  
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It is not just fat deposition that is different between males and females but 
differences in muscle are also apparent.  In women the decline of muscle 
mass is greatest after menopause, which may be explained by the reduction 
of oestrogen to testosterone (Messier et al., 2011). However, older men 
lose appendicular limb mass more rapidly than women (Zamboni et al., 
2003; Hughes et al., 2002), despite much higher concentrations of 
testosterone. If not testosterone-related, it may be the heightened rates of 
basal MPS in women (~+30%) that account for this sexual dimorphism 
(Smith et al., 2008). Overall the prevalence of sarcopenia is two-fold 
greater in women than in men (Janssen et al., 2004), this is likely related to 
the fact that the risk of morbidity due to muscle loss is greatest in those 
with the lowest pre-morbid muscle mass and women have a smaller peak 
muscle mass. This principle is exemplified by ex-weightlifters who lose 
muscle mass at the same rate as their sedentary age-matched peers but due 
to their higher peak muscle mass, they retain strength for longer and report 
less incidence of disability (Pearson et al., 2002).  
 
Gender differences in body composition are evident throughout adulthood 
with males over 80 years old presenting a greater loss of muscle mass than 
females, while females undergo a greater reduction in subcutaneous fat in 
the decade leading up to this age (Barbosa et al., 2005). 
 
Discussed in more detail later in this thesis adiposity is shown to have a 
strong association with systemic inflammation, this relationship between 
adiposity and certain pro-inflammatory cytokines is significantly stronger 
in women (Thorand et al., 2006) and may indicate that weight reduction 
may be more effective in preventing sub-clinical inflammation in females. 
 
3.1.7 Body composition and resistance-exercise training 
Most forms of exercise training will result in moderate weight loss, 
moderate-to-large losses in body fat and small-to-moderate gains in FFM 
(Wilmore, 1983) 7KH GHJUHH RI DOWHUDWLRQ WR DQ LQGLYLGXDO¶V ERG\
composition will depend on the mode of exercise, frequency, intensity, 
duration and concomitant nutritional status. Training, in particular 
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exercises which involve impact work also have the potential to increase 
BMC and BMD (Mullins et al., 2001). Mechanical force on bone is 
essential for the modeling and re-modeling of bone which in turn increases 
both bone strength and mass (Frost, 1997). Weight bearing exercises (body 
weight and/ or additional weight) provide a direct mechanical force on 
bones but it is muscle contractions that place bones under the largest 
voluntary loads (Frost, 1997). Correlations between hand-grip strength and 
bone area, BMC and BMD in both athletes (Ducher et al., 2005) and 
sedentary individuals (Pang & Eng, 2005) support the notion that muscle 
contractions can significantly benefit bone strength and mass. 
 
Resistance training is a form of strength training; a blanket term for all 
exercise that develops the strength and size of skeletal muscles. Resistance 
training occurs when each effort is performed against a specific opposing 
force. Resistance training may be defined as isotonic if the body is moving 
against set force or isometric if holding still against force at a constant 
tension. Performed properly, following established guidelines based on the 
desired goal resistance training can provide significant functional benefits, 
increase bone, muscle, ligament and tendon strength, improve joint 
function, improve cardiac function and most importantly in relation to 
body composition increase metabolic rate. This increase in metabolic rate 
associated with resistance training is due to an increase in skeletal muscle; 
a metabolically active tissue which requires energy at all times, even at 
rest. At rest skeletal muscle consumes 13.0 kcal/kg per day, considerably 
more than adipose tissue at 4.5 kcal/kg per day (Heymsfield et al., 2002). 
 
As RET increases muscle mass, weight loss will not occur without caloric 
restriction, however even without caloric restriction RET can have 
favorable effects on body composition by reducing fat mass, including 
abdominal fat (Hunter et al., 2002; Tresierras & Balady, 2009). A study 
from over 15 years ago reported that in older women who performed a 
RET regime that involved training three times a week for 16 weeks intra-
abdominal adipose was reduced despite no change in weight due to 
increased muscle mass (Treuth et al., 1995). A more recent study again 
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using a three times per week RET intervention reported no change in body 
weight but decreased fat-mass and increased muscle mass following 12 
weeks of training (Iglay et al., 2007). Decreases in limb fat mass, even 
with no change in limb circumference have also been reported following a 
RET program (Treuth et al., 1994).  
 
Evidence is available that RET increases both regional and total lean tissue 
mass and decreases both regional and total fat tissue mass in people of all 
ages. These changes in BC suggest that RET and the effects it has on BC 
can play an important role in the prevention of age-associated losses in 
strength and muscle mass and may affect fat deposition alleviating the 
decline in functional abilities and health status suffered by many as they 
age (Treuth et al., 1994). 
 
3.2 Methodology 
 
3.2.1 Dual-energy x-ray absorptiometry 
Each subject received two DEXA scans (DEXA; GE LUNAR II), one at 
screening and one when they returned for the second of their two acute 
studies. As well as analyzing whole body estimates of different tissues and 
measuring BMC and BMD (Figure 3.5) DEXA measurements also allowed 
us to obtain data on selected regions of interest (ROI). Subject positioning 
on the DEXA bed was optimized to allow the ROI body compartments to 
be analyzed separately i.e. ensuring a space between the legs and between 
WKH DUPV DQG WRUVR ZKHQHYHU SRVVLEOH 7KH ³upper OHJ´ ROI for body 
composition analysis was selected as the area inferior to the lowest visible 
point of the coccyx to the mid-point of the patella (Figure 3.6a). The ³OHJ´ 
ROI was defined as the area inferior to the lowest visible point of the 
coccyx. )RUDQDO\VLVRIDEGRPLQDOFRPSRVLWLRQWKH³DEGRPLQDO´52,ZDV
selected as the lowest visible point of the coccyx upwards to the highest 
visible point of the pelvic girdle (Figure 3.6E ZLWK WKH ³WUXQN´ 52,
assigned by the DEXA software. 
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 Figure 3.5 Total body standard DEXA report (example) 
 
 
       
A.                                                           B.
 
 Figure 3.6 Customized DEXA regions of interest 
A. Upper Leg region of interest 
B. Abdominal region of interest 
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3.2.2 Anthropometric indexes 
3.2.2.1 Body mass index 
Body mass index (BMI) is commonly used in both clinical and alternative 
settings to RIIHUDQDVVHVVPHQWRIVRPHRQH¶V weight. Calculated using the 
formula of weight (kg)/ height (m)2 the limitations of BMI as an 
assessment tool have already been discussed earlier in this chapter. Used 
mainly in this study as an assessment tool against exclusion criteria we 
have also recorded subject BMI both before and after the RET. 
 
3.2.2.2 Relative skeletal muscle mass index 
The relative skeletal muscle mass index (RSMI) is derived from total lean 
mass (kg) divided by height (m). The RSMI can be an advantageous way 
of assessing lean mass, especially in the elderly as it uses height as one of 
its calculation factors which is known to decrease with advancing age 
(Sorkin et al., 1999; Hirani & Aresu, 2012). The title of relative skeletal 
muscle mass index is slightly misleading in that it is not only lean muscle 
mass that is accounted for as all non-bone lean tissues will feature, 
including organ mass. Nonetheless, decreased RSMI is associated with 
narrower bones, thinner bone cortices, lower bending strength, impaired 
balance and increased risk of falls in the elderly (Szulc et al., 2005).  
 
3.2.2.3 Appendicular lean body mass index 
Appendicular lean body mass index (ALBMI) is a value derived from 
appendicular (arms and legs) lean mass (kg) divided by height (m) and has 
been shown to be more strongly associated with bone mineral content than 
total lean mass (Goulding et al., 2009). As with the RSMI, ALBMI can be 
advantageous in an ageing population due to the inclusion of stature. Age 
has been shown to be an independent determinant of appendicular lean 
body mass when corrected for stature as featured in the ALBMI 
calculations (Gallagher et al., 1997). 
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3.3 Results  
 
3.3.1 Changes in body composition analyzed by dual-energy x-ray 
absorptiometry after resistance-exercise training 
3.3.1.1 Percentage Body Fat 
All three age-groups reduced their percentage body fat following the RET 
(Y, P=<0.05; M, P=<0.001; O, P=<0.01) (Figure 3.7).  
 
 
Figure 3.7 Percentage change in whole-body fat in young, middle-aged 
and older subjects after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis. *=P<0.05 vs. young. 
 
Neither before or after RET was there a significant difference in percentage 
body fat between the age groups even though the young reduced their 
percentage body fat by a greater amount that the old (P=<0.05). When 
dividing the groups by gender the males in all three age groups reduced 
their percentage body fat after RET (Y, P=<0.001; M, P=<0.05; O, 
P=<0.01) whereas only the middle-aged females experienced a reduction 
(P=<0.01). Young males had a lower percentage body fat than young 
females both before and after RET (P=<0.001), and this gender disparity 
was also the case in the middle-aged (P=<0.001) and older groups 
(P=<0.05). Young males had a lower percentage body fat than older males 
before (P=<0.01) and after RET (P=<0.001) that was also lower than 
middle-aged males after RET (P=<0.05). These age differences were not 
apparent in the females where there were no significant differences 
between the three age-groups either before or after RET (Figure 3.8). 
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Figure 3.8 Whole body fat percentages in young, middle-aged and older 
male and female subjects before and after RET. Values are means±SEM. 
Statistical analysis via ANOVA with Bonferroni post analysis. *=P<0.05 
vs. pre-training in the same age-group, **=P<0.01 vs. pre-training in the 
same age-group, ***P<0.001 vs. pre-training in the same age-group. 
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3.3.1.2 Whole-Body Lean Mass 
Whole-body lean mass was increased in the young (P=<0.01) and middle-
aged groups (P=<0.05) after RET and there was a trend for it to increase in 
the older group (P=0.08). The increase in the young tended to be greater 
than in the older group (P=0.1) (Figure 3.9). 
 
 
Figure 3.9 Percentage change in whole body lean mass in young, middle-
aged and older subjects after RET. Values are means±SEM. Statistical 
analysis via ANOVA with Bonferroni post analysis.  
 
There were no significant differences in the whole-body lean mass of the 
three age-groups either before or after RET. When analysing the data 
divided also by gender only the young males increased their whole body 
lean mass following RET (P=<0.01), although there was a trend for an 
increase in the older males (P=0.09). In all three of the ages-groups the 
males had significantly more whole-body lean mass than the females both 
before and after RET (Y, P=<0.01; M, P=<0.001; O, P=<0.001). There 
were no differences between the age groups when divided by gender 
(Figure 3.10). 
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Figure 3.10 Whole body lean mass in young, middle-aged and older male 
and female subjects before and after RET. Values are means±SEM. 
Statistical analysis via ANOVA with Bonferroni post analysis. *=P<0.05 
vs. pre-training in the same age-group, **=P<0.01 vs. pre-training in the 
same age-group. 
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3.3.1.3 Dominant Leg Lean Mass 
As with the whole-body lean mass, there was no significant difference in 
dominant leg lean mass between the age groups either before or after RET. 
When the data was separated by gender both the young males and females 
increased their dominant lean leg mass after RET (P=<0.05). Mirroring the 
trend seen in whole-body lean mass the males in all three age-groups had 
greater dominant lean leg mass than the females (P=0.001) and there were 
no differences between the age groups within gender (Figure 3.11). 
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Figure 3.11 Dominant leg lean mass in young, middle-aged and older male 
and female subjects before and after RET. Values are means±SEM. 
Statistical analysis via ANOVA with Bonferroni post analysis. *=P<0.05 
vs. pre-training in the same age-group, **=P<0.01 vs. pre-training in the 
same age-group. 
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The young were the only group to significantly increase their dominant leg 
lean mass (P=<0.01) although the older group did increase their dominant 
leg lean mass more than the middle-aged (Figure 3.12). 
 
 
Figure 3.12 Percentage change in dominant leg lean mass in young, 
middle-aged and older subjects after RET. Values are means±SEM. 
Statistical analysis via ANOVA with Bonferroni post analysis. #=P<0.05 
vs. middle-aged. 
 
3.3.1.4. Dominant Upper Leg Lean Mass 
Upper dominant leg lean mass was increased in the young (P=<0.01), 
middle-aged (P=<0.01) and older age group (P<0.05) after RET. The 
increase in the young tended to be greater than that in the older group 
(P=0.1) (Figure 3.13). The change in upper leg lean mass did not mirror 
the change shown in whole leg lean mass with no significant differences 
between the age-groups percentage increase.  
 
 
Figure 3.13 Percentage change in upper dominant leg lean mass in young, 
middle-aged and older subjects after RET. Values are means±SEM. 
Statistical analysis via ANOVA with Bonferroni post analysis.  
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There were no significant differences in the upper leg lean mass of the 
three age-groups either before or after RET. When analysing the data 
divided also by gender the young and middle-aged males increased their 
upper leg lean mass following RET (P=<0.05 and <0.01, respectively), 
with a trend for an increase in the older males (P=0.06). In all three of the 
ages-groups the males had significantly more upper leg lean mass than the 
females both before and after RET (P=<0.001). There were still no 
differences in absolute upper lean leg mass between the age groups when 
divided by gender (Figure 3.14). 
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Figure 3.14 Dominant upper leg lean mass in young, middle-aged and 
older male and female subjects before and after RET. Values are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis. *=P<0.05 vs. pre-training in the same age-group, **=P<0.01 vs. 
pre-training in the same age-group. 
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3.3.1.5 Body Mass Index 
BMI was not changed by RET in any age-group and there was no 
significant difference in BMI between the age groups either before or after 
RET. When the data was analysed with the results divided by gender the 
only change following RET was that the young females had a significantly 
higher BMI. Before RET, there was no difference between the BMI of 
young males and females, however after RET the young males BMI was 
significantly lower than that of the young females (P=<0.05). There was no 
gender difference in BMI in the middle-aged and older groups. Young 
males had a significantly lower BMI than middle aged and older males 
both before and after RET (P=<0.001). There was no age difference in the 
females BMI either before or after RET (Figure 3.15). 
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Figure 3.15 Body mass indexes in young, middle-aged and older male and 
female subjects before and after RET. Values are means±SEM. Statistical 
analysis via ANOVA with Bonferroni post analysis. *=P<0.05 vs. pre-
training in the same age-group.  
 
Often cited as poor marker of body composition, comprising only of height 
and weight measurements, BMI is the tool most commonly used in a 
healthcare setting, with many practitioners failing to evaluate its 
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limitations.  Even so despite its seemingly crude method using only height 
and weight as indices of body composition, for the subjects in this study 
there was a significant correlation between BMI and % body fat (Figure 
3.16). 
 
Figure 3.16 Correlation between body fat% and BMI in young, middle-
aged and older subjects before RET. 6WDWLVWLFDO DQDO\VLV YLD 3HDUVRQ¶V
correlation.  
 
3.3.1.6 Trunk Fat Mass 
Trunk fat mass was reduced in young (P=<0.001), middle-aged (P=<0.01) 
and older subjects (P=<0.01) after RET, with no significant difference in 
the level of change experienced by the three age-groups (Figure 3.17).  
 
 
Figure 3.17 Percentage change in trunk fat in young, middle-aged and 
older subjects after RET. Values are means±SEM. Statistical analysis via 
ANOVA with Bonferroni post analysis.  
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Trunk fat mass in the young was lower than that in the older group both 
before and after RET (P=<0.05). When the groups were divided by gender 
the young males had a significant reduction in trunk fat mass after RET 
(P=<0.05) and there was a trend for this reduction in the middle-aged 
(P=0.08) and older males (P=0.1). Only the middle-aged females had 
reduced trunk fat mass after RET (P=<0.01), with no change in the young 
and older females.  Both before and after RET the young males had lower 
trunk fat mass than the young females and both before and after RET they 
had lower trunk fat mass than the middle-aged (P=<0.01 pre and post) and 
older males (P=<0.01 before, P=<0.001 after). There were no differences 
in the trunk fat mass of females in the three different age-groups either 
before or after RET, and in the middle-aged and older groups there were no 
differences between male and females trunk fat mass either before or after 
RET (Figure 3.18). 
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Figure 3.18 Trunk fat in young, middle-aged and older male and female 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis. **=P<0.01 vs. pre-training in 
the same age-group, ***P<0.001 vs. pre-training in the same age-group. 
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3.3.1.7 Bone Mineral Density 
There were no significant differences in the BMD of the three age-groups, 
contrary to what may have been expected, either before or after RET. RET 
did not change the BMD in any of the age groups. When the age-groups 
were also divided by gender there was no difference in the BMD of 
females according to age before RET, however after RET the young and 
middle-aged females had significantly higher BMD than the older females 
(P=<0.05). There was no difference in BMD between the young males and 
females, but in the middle-aged and older groups the males had 
significantly higher BMD than the females both before and after RET 
(P=<0.001) (Figure 3.19). 
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Figure 3.19 Bone mineral density in young, middle-aged and older male 
and female subjects before and after RET. Values are means±SEM. 
Statistical analysis via ANOVA with Bonferroni post analysis.  
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3.3.1.8 Relative Skeletal Mass Index 
There were no significant differences in RSMI between the age-groups 
either before or after RET. The RSMI increased in the young (P=<0.01) 
and middle-aged groups (P=<0.05) after RET, with a trend for it to 
increase in the older group (P=0.1), therefore following the pattern shown 
in whole-body lean mass. When divided by gender only the young males 
increased their RSMI after RET (P=<0.01). The young males had 
significantly higher RSMI after RET than young females (P=<0.05), 
although there were no differences before. The middle-aged males had 
higher RSMI than the middle-aged females both before and after RET 
(P=<0.001) but there were no differences between the older males and 
females either before or after RET. There were no significant differences 
between the age-groups, in either males or females before or after RET 
(Figure 3.20). 
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Figure 3.20 Relative skeletal mass indexes in young, middle-aged and 
older male and female subjects before and after RET. Values are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis. *=P<0.05 vs. pre-training in the same age-group, **=P<0.01 vs. 
pre-training in the same age-group. 
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3.3.1.9 Appendicular Lean Body Mass Index 
The ALBMI, as with the RSMI and the whole-body lean mass was not 
significantly different between the age-groups either before or after RET, 
although the young (P=<0.001), middle-aged (P=<0.05) and older groups 
(P=<0.05) all significantly increased their ALBMI after RET. The ALBMI 
of both the young males and females increased significantly after RET 
(P=<0.01), with no changes in the middle-aged or older males or females 
when the age-groups were also divided by gender which may have been 
due to reduced statistical power when the n was reduced. There was no 
difference between the ALBMI of the young males and females before 
RET, however the males did demonstrate a higher ALBMI after RET 
(P=<0.05). In the middle-aged and older groups the ALBMI was higher in 
males than females both before and after RET (M, P=<0.001; O, P=<0.05). 
There was no difference in ALBMI according to age either before or after 
RET in males or females (Figure 3.21). 
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Figure 3.21 Appendicular lean body mass indexes in young, middle-aged 
and older male and female subjects before and after RET. Values are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis. *=P<0.05 vs. pre-training in the same age-group, **=P<0.01 vs. 
pre-training in the same age-group, ***P<0.001 vs. pre-training in the 
same age-group. 
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3.3.1.10 Android: Gynoid Ratio 
There were no significant differences in android: gynoid (A:G) ratio 
between the age groups before or after RET, although the middle-aged 
group did decrease their A:G ratio after RET (P=<0.05). As a data set that 
in which you would expect to observe gender differences it was surprising 
that there were no differences in the A:G ratios between males and females 
in the young or older age-groups. The middle-aged males had a 
significantly higher A:G ratio than the middle-aged females both before 
and after RET (P=<0.001). The young and middle-aged males both had a 
lower A:G ratio after RET (P=<0.05), while the young females had a 
higher A:G ratio after RET. The young males had a lower A:G ratio than 
the middle-aged (P=<0.001) and older males (P=<0.01) both before and 
after RET. There were no significant differences in the A:G ratios of the 
females from different age-groups either before or after RET (Figure 3.22). 
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Figure 3.22 Android: gynoid ratios in young, middle-aged and older male 
and female subjects before and after RET. Values are means±SEM. 
Statistical analysis via ANOVA with Bonferroni post analysis. *=P<0.05 
vs. pre-training in the same age-group. 
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3.3.1.11 Abdominal Fat Percentage 
The young and the middle-aged group showed a reduction in abdominal fat 
percentage after RET (P<0.01; Figure 3.23).  
 
 
Figure 3.23 Percentage change in abdominal fat in young, middle-aged 
and older subjects after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis. 
 
There were no significant differences in abdominal fat percentage between 
the age groups either before or after RET. When the age-groups were also 
divided by gender, the young and middle-aged males displayed a reduction 
in abdominal fat percentage after RET (Y, P<0.01; M, P<0.05) but the 
older males did not. Only the middle-aged females showed a reduction 
after RET, mirroring what was seen in the female data regarding whole-
body fat percentage. In all three age-groups males had a significantly lower 
abdominal fat percentage than females both before and after RET 
(P<0.001). Young males had a significantly lower abdominal fat 
percentage than older males both before (P<0.05) and after (P<0.01) RET, 
with no difference between the young and middle-aged males or the 
middle-aged and older males. Neither before or after RET were there any 
significant differences in abdominal fat percentage between the females in 
the different age-groups (Figure 3.24). 
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Figure 3.24 Abdominal fat in young, middle-aged and older male and 
female subjects before and after RET. Values are means±SEM. Statistical 
analysis via ANOVA with Bonferroni post analysis. *=P<0.05 vs. pre-
training in the same age-group, **=P<0.01 vs. pre-training in the same 
age-group. 
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3.4 Discussion 
 
Contrary to our hypothesis neither the whole-body lean mass, the total lean 
leg mass nor the upper lean leg mass of our older individuals was 
significantly different to that of our middle-aged or young subjects, 
suggesting that our older individuals were pre-sarcopenic. This may be due 
in some part to a degree of self-selection, in that the older individuals who 
applied to participate in this study (DGYHUWLVHGDV³1RWWLQJKDPDQG'HUE\
Active Ageing´ may likely be a cohort who, although did not participate 
in any formal exercise regime prior to their inclusion in this study, may 
amongst their age-matched peers score highly in ranks of daily physical 
activity and independence, although this is data that we did not collect. 
 
Use of DEXA as our method of body composition analysis may be another 
reason why we were unable to report any significant differences between 
the lean mass of our young and older subjects. In older individuals there 
will be larger proportions of intramuscular fat, also known as myosteatosis 
(Kent-Braun et al., 2000) and connective tissue (Macaluso et al., 2002) 
which the DEXA will not be able to distinguish and may therefore result in 
an over-reporting of lean mass in our older subjects.  
 
Although we were not able to report any significant differences in lean 
mass between our ages groups we did observe a significant increase in 
whole body lean mass of 2.07±0.53% as hypothesized, when all of subjects 
were grouped together, with the increase not significantly different 
between the young (3.94±1.45%), middle-aged (1.72±0.75%) and older 
(1.06±0.58%) groups; although there was a trend for it to be higher in the 
young. There were no significant gender differences in this increase in any 
age-group. The overall increase of 2.07±0.53 % is not too dissimilar to 
other literature which reports 5-17% increases in muscle size with ~4 
months resistance training (Narici & Maganaris, 2006). The 17% value, 
was reported using cross-sectional area via CT after 16 weeks training, 3 
times per week, performing 4 sets of 10-20 repetitions at 70-90 % 1-RM 
(Brown et al., 1990), while the lower value of 5% was obtained after 16 
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weeks training, 3 times per week at 80% 1-RM performing single sets of 
10 repetitions (Ferri et al., 2003) which is closer to our adopted protocol 
although the intensity was still 10% 1-RM higher. 
 
In addition to absolute lean mass values there are also two widely accepted 
indices which can be used for the assessment of lean mass, especially when 
including older individuals, derived from DEXA data. The relative skeletal 
mass index (RSMI) is calculated as total lean mass (kg), divided by height 
(m). The RSMI can be an advantageous way of assessing lean mass, 
especially in the elderly as it uses height as one of its calculation factors 
and this is known to decrease with advancing age (Sorkin et al., 1999; 
Hirani & Aresu, 2012). The title of relative skeletal muscle mass index is 
slightly misleading in that it is not only lean muscle mass that is accounted 
for, but all non-bone lean tissues will feature, including organ mass. 
Nonetheless, decreased RSMI is associated with narrower bones, thinner 
bone cortices, lower bending strength, impaired balance and an increased 
risk of falls in the elderly (Szulc et al., 2005a), all of which when 
combined with the widely reported problems of decreased metabolic rate, 
reduced BMD, decreased insulin sensitivity and lower maximal aerobic 
capacity which are reported with age (Evans, 1995; Dinenno et al., 1999) 
and contribute to age-related health declines. 
 
The appendicular lean body mass index (ALBMI) is calculated as 
appendicular lean mass (kg), divided by height (m). ALBMI has been 
shown to be more strongly associated with bone mineral content than total 
lean mass, making it favorable for assessment of bone health (Goulding et 
al., 2009) and as declines in physical function with age are often 
attributable to losses in muscle mass and strength at the extremities evans 
(Evans, 1995) it may also be favorable for assessing function and 
independence in the elderly (Sugawara et al., 2002). As with the RSMI, the 
ALBMI can be advantageous in an ageing population due to the inclusion 
of stature in the calculation. In older individuals where lean mass and bone 
mass decrease, the ALBMI is frequently used to assess sarcopenia 
(Goulding et al., 2009; Baumgartner et al., 1998) and low values are 
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associated with both muscle weakness and reduced BMD (Waters et al., 
2010). Although age has been shown to be an independent determinant of 
appendicular lean body mass when corrected for stature (Gallagher et al., 
1997), it is still proposed by many groups that strength and muscle 
function are better measure of muscle health with age than lean mass or 
lean mass related indices (Lauretani et al., 2003). 
 
The few but notable discrepancies between the changes observed in RSMI 
and ALBMI demonstrate the importance of method selection when 
assessing BC in a given population. Neither index showed age-related 
differences before nor after RET, but while all age-groups demonstrated 
increases in ALBMI with RET, only the young and middle-aged groups 
showed significant increases in RSMI. When divided into gender groups 
the young males showed an increase in RSMI with RET, placing their 
value significantly higher than that of young females, something that was 
also seen for ALBMI. The RSMI was higher in the middle-aged males 
compared to middle-aged females both before and after RET, as was 
ALBMI which was also higher in the older males compared to age-
matched females.  Only the young males and females showed an increase 
in ALBMI when the gender groups were divided suggesting that this may 
be due to statistical power from a reduced n as all groups showed the 
increase when categorised by age only. Neither index showed an age-
related difference within gender.  
 
With regard to our hypothesis of age-related differences in fat mass this 
proved correct for males but not for females, with young males having a 
lesser percentage body fat than older males both before and after RET and 
also less than the middle-aged males after RET. In all of the age-groups, 
both before and after RET, males had lower body fat percentage than 
females with no differences in body fat percentage between the female age-
groups before or after RET. Only the middle-aged females reduced their 
percentage body fat after RET while all of the male age-groups 
demonstrated a significant reduction. This is similar to the results shown 
by Donges and colleagues in which males showed a significantly greater 
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decrease in FM compared to females and also a greater increase in total 
body FFM. The work of Donges indicated a gender disparity in the 
relationship between functional gains and body composition changes 
following RET as females experienced greater increases in strength than 
males albeit with lesser changes in body composition (Donges & Duffield, 
2012). When the gender sets were grouped together there were no 
significant differences in percentage body fat values between the three age-
groups before or after RET, although all three age-groups showed 
significant reductions in body fat percentage, as has been previously 
demonstrated (Hunter et al., 2002; Cuff et al., 2003; Treuth et al., 1995; 
Tresierras & Balady, 2009); with reductions significantly higher in the 
young than in the old, inversely mirroring the lean mass gains.  
 
The heightened response in the young group both in terms of lean mass 
gains and reductions in body fat percentage may be explained by greater 
total energy expenditure (Carbone et al., 2012). Although all of the 
subjects performed the same relative workload (given as a percentage of 1-
RM) the young group performed work against significantly higher loads 
which would have increased the energy expenditure of their activity above 
that of the other age-groups. Taken in combination with the diet-diary data 
presented in Chapter 2 where the young significantly reduced their 
reported energy intake during RET it is not surprising that they elicited the 
greatest BC changes based on the principle of simple energy balance .This 
theory may also hold true in explaining why the males experienced more 
favorable BC changes compared to the females as for each age-group they 
also performed exercise against a greater resistance. 
 
The small but significant changes in body fat percentage in all three age-
groups highlights the positive role RET can have on body composition, 
especially when taken in combination with the changes in lean mass. The 
gender differences in changes, at least in this study, suggest RET to be 
more effective in altering the BC profile of males but this is independent of 
improvements in functional outcome where females are equal. 
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Another method for assessing body composition changes without the need 
for DEXA, which requires specialist equipment and operators, is that of 
BMI. BMI (RU4XHWHOHW¶V,QGH[DVLWLVVRPHWLPHVNQRZQ) is simply height 
in metres, divided by weight in kilograms squared and derived from a liner 
regression including weight to the power of 1.82 (later was rounded up to 
2). In large-scale epidemiological studies increased BMI has been 
associated with increased all-cause mortality (Calle et al., 1999), although 
it has been questioned if this is true in elderly people or if an ageing-
obesity paradox exists (Allison et al., 1997; Uretsky et al., 2007; Diehr et 
al., 1998). The use of BMI has also been questioned in those with high 
FFM and/ or those with postural deviations (Garrido-Chamorro et al., 
2009; Camhi et al., 2011). Despite the many assumptions made by the use 
of BMI and the limitations, in this study in a group of mixed sex, healthy 
volunteers there is a significant relationship between BMI and percentage 
body fat as measured by DEXA, although no changes in BMI were 
evidenced either with age or RET, despite significant changes in FM and 
FFM being observed. 
 
Regardless of measurement method it is accepted that in all ages central 
adiposity is predictive of negative health outcomes, including morbidities 
and premature mortality. In combination with reduced FFM, increased 
central adiposity is more predictive of future health outcomes in an elderly 
population than BMI (Zamboni et al., 2005; Srikanthan et al., 2009), with 
mortality increasing by 13% for every standard deviation increase in waist 
circumference (Janssen et al., 2000). Based on this knowledge our 
hypothesis surrounding age-related changes in body composition and fat 
distribution being linked to increased risk of cardiovascular health risks 
was developed. We assessed central adiposity by examining both trunk fat 
(given as a pre-defined ROI by the DEXA software) and more specifically 
abdominal fat mass, identified from the lowest visible point of the coccyx 
upwards to the highest visible point of the pelvic girdle. We also assessed 
changes (with RET) and differences (age and gender) in the android: 
gynoid (A:G) ratio, a ratio of fat distribution where a lesser value (ideally 
<1.0) is positive for future health outcomes.  
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Trends in the differences and changes were not greatly different between 
trunk fat and abdominal fat, which is likely expected as the abdominal 
region is part of the trunk ROI, although they were not identical. All age-
groups reduced their trunk fat following RET, while only the young and 
middle-aged groups reduced abdominal fat. Trunk fat only was lower in 
the young compared to the old when males and females were grouped and 
this did support our hypothesis of age-related differences in fat distribution 
being associated with increase CV disease risk.  
 
When the age-groups were divided by gender the young males showed 
reduced trunk fat after RET with a trend for the same in the middle-aged 
and old groups, while the old group showed no change in abdominal fat 
after RET compared to all of their younger male counterparts who did. 
Only middle-aged females reduced either their trunk or abdominal fat. 
Only the young males had less trunk fat than the females, while this was 
true for abdominal fat in all of the age-groups again supporting our 
hypothesis. For both of the measurements the young males had less fat 
than the older males, with no age-related difference in the females, 
suggesting that our hypothesis involving total fat mass was correct in 
hypothesizing age-related fat distribution patterns linked to CV disease in 
males, but not in females.  
 
The greater extent of significant changes in trunk fat compared to 
abdominal fat, especially for the older group where there was no change 
regardless of gender grouping, suggests that the positive changes in trunk 
fat are predominantly a result of changes in the upper trunk and limbs 
opposed to the abdominal region itself. There were very few differences in 
the A:G ratio with RET and those observed were not consistent between 
age and/ or gender groups. Surprisingly the middle-aged group 
demonstrated an increased A:G ratio after RET, as did the young females. 
When divided into gender groups the young and middle-aged males 
showed a reduced A:G ratio after RET, with the young males having a 
lower ratio than the middle-aged and old groups both before and after 
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RET. The lower ratio in the young group is expected as evidence suggests 
that male accumulation of android obesity begins at about 30 years of age. 
This also supports the higher ratio shown in middle-aged males compared 
to females both before and after RET.  
 
AOWKRXJK IHZ VLJQLILFDQW FKDQJHV ZHUH VHHQ LQ WKH µPDUNHUV¶ RI FHQWUDO
obesity, combining the increases in LMM that were seen in all age-groups 
with the reductions in body fat percentage and trunk fat suggests that RET 
can improve BC. Further support for combining information about FM and 
FFM in predicting future health is given by Wannamethee and colleagues 
who found that obesity markers such as waist circumference, BMI and 
waist: hip ratio were only predictive if corrected for a marker of muscle 
mass (Wannamethee et al., 2007). This was also supported by Kim et al 
with data from the Korean Sacropenic Obesity study, where those 
experiencing sarcopenic obesity have a 3.2 times greater prevalence of the 
metabolic syndrome than non-sarcopenic obese subjects and 8.2 times 
more than healthy weight controls (Kim et al., 2010). 
 
It is not only muscle and fat that are affected by age and/ or activity, bone 
health is also a crucial component of healthy independent ageing. We 
hypothesized that RET would improve measures of bone quality, assessed 
as changes in BMD. Although we found no significant difference in BMD 
with age or RET when the age-groups were mixed-sex, we did find in 
females that there was no age-related reduction in BMD before RET but 
the young and middle-aged groups had higher BMD than the old after 
RET, suggesting that younger females have the propensity to improve their 
BMD by RET. An increase in BMD after RET has been previously 
reported by other groups in both males and females, young and old 
(Tsuzuku et al., 1998; Bonaiuti et al., 2002; Chilibeck et al., 2005; 
Sundell, 2011). Both the middle-aged and older males had higher BMD 
than the age-matched female subjects both before and after RET, while this 
gender disparity was not evident in the young. These trends are not 
surprising given previous reports of reduced BMD in post-menopausal 
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female (Raisz, 2005) due to reductions in oestrogen after the onset of 
menopause.  
 
In addition to examining muscle mass, structure and function, fat mass and 
distribution and bone quality, a more complete picture of the benefits of 
RET could have been sought by the inclusion of measurements to assess 
tendon mechanical properties such as tendon length, pennation angle and 
<RXQJ¶VPodulus (Narici & Maffulli, 2010). 
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CHAPTER 4- RISK FACTORS FOR CHRONIC DISEASE 
 
4.1 Introduction to chronic disease 
 
Chronic diseases are defined as diseases that last for a long time; over 3 
months as defined by the US National Centre for disease statistics. In 
general chronic diseases cannot be prevented by vaccination or cured by 
medication. Chronic diseases such as heart disease, stroke, cancer, diabetes 
and arthritis are among the most common, costly and preventable of all 
health problems in the western world (www.cdc.gov.chronicdisease). In 
the USA, 70% of deaths are from chronic diseases, with heart disease, 
cancer and stoke accounting for more than 50%. In 2005, just fewer than 1 
in 2 adults in America had at least one chronic illness with this number 
even higher in an elderly population as the incidence of chronic diseases 
heightens with advancing age (Martin et al., 2010; Moore et al., 2012). 
Approximately 25% of people with chronic disease have at least one daily 
activity that is limited by their condition, with arthritis the most common 
cause (Freedman et al., 2007). Physical activity is commonly cited as one 
RI WKHNH\PRGLILDEOHEHKDYLRUV¶ WKDWFDQ help prevent chronic disease, 
alongside good nutrition, smoking cessation and alcohol limitation. 
 
4.1.1 Chronic disease and resistance-exercise training 
The benefits of physical activity for reducing chronic disease risk are 
plentiful and it is not only body weight and/ or composition that can be 
affected by a net energy imbalance. When energy in exceeds energy out, 
the substrate induced increase in tricarboxylic acid cycle activity generates 
an excess of mitochondrial nicotinamide adenine dinucleotide (NADH) 
CHAPTER HYPOTHESES: 
i. There are age-related declines in insulin sensitivity and glucose 
tolerance which can be improved by resistance-exercise training. 
ii. Bio-markers for cardiovascular disease are increased with age and 
can be reduced by resistance-exercise training.   
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and reactive oxygen species (ROS) causing oxidative stress (Maddux et al., 
2001). Oxidative stress is considered to be one common factor underlying 
insulin-resistance, type 2 diabetes, and CVD and it may also go some way 
to explain the presence of inflammation in all of these conditions (Van 
Gaal et al., 2006). Therefore, RET may be beneficial in maintaining energy 
balance and alleviating this problem. 
 
With the increase in life expectancy occurring in industrialized nations, the 
leading causes of death have shifted dramatically from infectious diseases 
to non-communicable diseases and from younger to older individuals, in 
the main. In developed countries 75% of deaths in persons older than the 
age of 65 are now from CVD and cancer, two of the most common chronic 
diseases (Knoops et al., 2004).  
 
Physical inactivity is a modifiable risk factor for cardiovascular disease 
and a wide variety of other chronic diseases including type 2 diabetes, 
cancer (colon and breast), obesity, hypertension, osteoporosis, 
osteoarthritis and depression (Blair et al., 1989; Lee & Skerrett, 2001; 
Puett & Griffin, 1994; Paffenbarger, Jr. et al., 1986).  
 
6LQFHWKHHDUO\ZRUNVRI0RUULVLQWKH¶V(Morris et al, 1953; Morris 
& Heady, 1953) DQG 3DIIHQEDUJHU DQG FROOHDJXHV LQ WKH ¶V
(Paffenbarger, Jr. et al., 1978; Paffenbarger & Hale, 1975), numerous 
studies have illustrated the decreased relative risk of death, both from all-
cause mortality and from specific diseases, associated with increased 
physical activity (Blair et al., 2001; Macera & Powell, 2001; Macera et al., 
2003; Oguma et al., 2002; Lee & Paffenbarger, Jr., 2000; Lee et al., 1995; 
Kohl, III, 2001). More recently, The HALE  Project, reported increased 
physical activity (as defined by being in the highest tertile for physical 
activity according to the Voorips questionnaire) as lowering the risk of all-
cause mortality by 37%, coronary heart disease by 28%, CVD by 35%, 
cancer by 36% and other causes by 48% (Knoops et al., 2004). 
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Other than just lowering risk factors for chronic disease and other causes of 
PRUWDOLW\ H[HUFLVH PD\ DFWXDOO\ KDYH D µSURWHFWLYH HIIHFW¶ 3HRSOH ZKR
have risk factors for cardiovascular disease yet who are physically active 
may be at lower risk of premature death than sedentary people with no risk 
factors for cardiovascular disease (Warburton et al., 2006) (Figure 4.1).  
 
 
Adapted from: Myers et al, 2002 (Warburton et al., 2006b) 
Figure 4.1 Relative risk of death from any cause among 
participants with risk factors. Chronic obstructive pulmonary 
disease (COPD), High total cholesterol (TC). Comparison of 
subjects who achieved a physical activity level of less than 5 
0(7¶V PHWDEROLF HTXLYDOHQWV - 0(7¶V RU ZKRVH H[HUFLVH
FDSDFLW\ZDVPRUHWKDQ0(7¶V 
 
Physical activity independently acts to reduce the risk of premature death 
and each hour of activity at one metabolic expenditure value (MET; where 
1 MET = 1 kcal.kg body weight-1) higher than normal is associated with an 
8% decrease in CHD risk. 
 
In the pre-face to the USDHHS Surgeons General Report, Dr. A. Manley 
concluded physical activity to be so directly related to preventing disease 
and maintaining a high quality of life, that it should be accorded the same 
level of attention as other physical health practices and join the front ranks 
of essential health objectives (US Department of Health and Human 
Services, 1996). 
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Physical activity also has the ability to have a positive effect on body 
composition which may further reduce this risk. Many studies have 
recognized that physical activity alone can only moderately attenuate, but 
not eliminate the effect of adiposity on health, while at the same time 
demonstrating that being lean cannot counteract the increased disease risk 
associated with physical inactivity, leading to the conclusion that a 
combination of both is required to offset chronic disease risk as much as 
possible (Hu et al., 2004; Stevens et al., 2002; Li et al., 2006; Manson et 
al., 1995).  
 
Increased adiposity is an independent cardiovascular disease risk factor 
and also increases the incidence of other risk factors which may lead to 
CVD or cause premature mortality themselves, notably type 2 diabetes, 
dyslipidaemia, hypertension and inflammation (both local and systemic) 
(Manson et al., 1995). Much of the disease risk associated with increased 
adiposity is related to the link between adipocytes and inflammation. Both 
adipocytes and resident macrophages generate local inflammation, 
synergistically stimulating the inflammatory activity of the other (Lau et 
al., 2005). 
 
It is not however only being overweight that has been associated with 
increased risk of disease and/or premature mortality, extremely low levels 
of body fat have also been found to be detrimental to human health, with 
many associated physical signs, symptoms and abnormalities (Table 4.1): 
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Table 4.1 Physical features of extremely low levels of body fat. 
Physical features of extremely low levels of body fat 
Physical symptoms: 
x heightened sensitivity to cold 
x dizziness and syncope 
x amenorrhea 
x low sexual appetite 
x poor sleep with early morning wakening 
Physical signs: 
x emaciation; stunted growth 
x dry skin 
x cold hands and feet (hypothermia) 
x bradycardia, hypotension and cardiac arrhythmias 
x weak proximal muscles 
Physiological abnormalities: 
Endocrine 
x low concentrations of leutenising and follicle stimulating hormone 
x low concentrations of thyroid stimulating hormone 
x mild increase in plasma cortisol 
x raised growth hormone concentration 
Cardiovascular 
x ECG abnormalities (prolongation of the Q-T interval) 
Gastrointestinal 
x Delayed gastric emptying 
Hematological 
x Moderate anemia 
Metabolic 
x Hypercholesterolaemia 
x Dehydration 
Bone 
x Osteopenia and osteoporosis (due to low bone mineral density) 
Adapted from: Fairburn and Harrison, 2003 (Fairburn & Harrison, 2003) 
  
Although the above table of features associated with extremely low levels 
of body fat may appear vast most are reversed by the restoration of a 
healthy body weight and level of fatness, which is normally achievable 
through healthy eating. The possible exception to this is bone mineral 
density and the associated risk of osteopenia and osteoporosis which if 
caused by sustained periods of malnourishment or extreme underweight 
the damage may be irreversible (Fairburn & Harrison, 2003). 
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Based on fat topography it has been suggested that although visceral fat 
correlates with CV risk factors (Despres et al., 2001) and ectopic fat in 
organs can impair their function (Van Gaal et al., 2006), subcutaneous fat, 
especially gluteal fat may in some circumstances have a protective effect 
against CV disease (Yusuf et al., 2005). 
 
Achieving a healthy body weight through lifestyle interventions is usually 
endorsed as the first step in improving CV health, reinforcing the 
prominent role of obesity in the development of metabolic syndrome and 
CVD. Individuals with a central deposition of adipose tissue can 
experience elevated morbidity and mortality from stroke, congestive heart 
failure, myocardial infarction and CVD (Lakka et al., 2001; Kenchaiah et 
al., 2002). Reduction of total fat mass and/or visceral fat should 
theoretically reverse most, if not all of the metabolic and vascular 
abnormalities that excess adiposity can cause (Lau et al., 2005).  
 
4.1.2 Type 2 diabetes 
Type 2 Diabetes Mellitus (also known as non-insulin dependent diabetes 
(NIDDM) and adult-onset diabetes) is now one of the main threats to 
human health (Zimmet, 2000), accounting for 90-95% of all diabetes and 
affecting an estimated 6% of the adult population in Western society. 
Pronounced changes in the human environment, in human behavior and in 
human lifestyle have accompanied globalization and have resulted in 
escalating rates of both obesity and diabetes (Zimmet et al., 2001). The 
pairing and mirrored increase in both of these health problems led to the 
DGRSWLRQRIWKHWHUPµGLDEHVLW\¶(Astrup & Finer, 2000), first suggested by 
Shafrir in 1996 (Shafrir, 1996).  
 
Insulin sensitivity decreases with ageing (Boirie et al., 2001; Pagano et al., 
1996) and an increase in body fat is often seen as an appealing explanation 
for the decline in insulin sensitivity in both the obese and in elderly 
individuals where body composition changes often see muscle mass 
diminishing and body fat increasing. In general an increase in body fat is 
paired with an increase of non-estrified fatty acids (1()$¶V) in plasma 
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which since thH³JOXFRVH-IDWW\DFLGF\FOH´ZDVSURSRVHGE\5DQGOHLQ
(Randle et al, 1963) has been associated with insulin resistance. New 
UHVHDUFKLVQRZVXJJHVWLQJKRZHYHUWKDWWKH³JOXFRVH-IDWW\DFLGF\FOH´ZDV
inadequate and that alterations in the metabolic function of muscle are 
more likely to affect insulin sensitivity within the muscle. Triacylglycerol 
deposition in muscle has been found to be associated with insulin 
resistance in a variety of subjects (Pan et al., 1997; Ferrannini et al., 1996; 
Goodpaster et al., 2003) and obesity without insulin resistance is not 
associated with increased muscular triacylglycerol deposition suggesting 
that increased triacylglycerol deposition within muscle is likely to be an 
indicator of insulin resistance due to dysfunctional muscle lipid 
metabolism and independent of total body fat mass (Wolfe, 2006). Rather 
than an increase in FFA delivery the increased triacylglycerol deposition is 
more likely to be due to impaired disposal via oxidation, likely due to a 
decline in mitochondrial oxidative function (Petersen et al., 2003). This 
decline may be caused by numerous factors including genetics and/ or 
physical inactivity. 
 
Type 2 Diabetes may occur when not enough insulin is produced and/ or 
when cells of the body are resistant to insulin. Daily environmental and 
GLHWDU\ VWUHVVHV RYHUORDG DQG XOWLPDWHO\ GHVWUR\ WKH ERG\¶V V\VWHPV IRU
regulating blood glucose (Figure 4.2). Insulin resistance correlates with a 
degree of excess adipose tissue, notably abdominal adiposity, and this is a 
strong predictor for the development of type 2 diabetes (Lau et al., 2005). 
As outlined above adipose tissue is not the only precursor for insulin 
resistance and the metabolic function of muscle is central to the 
development of insulin resistance and ultimately type 2 diabetes (Wolfe, 
2006).  
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Adapted from: Saltiel and Kahn, 2001 (Saltiel & Kahn, 2001) 
Figure 4.2 The regulation of glucose metabolism. 
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When adipocytes exceed their storage capacity and the process of fat cell 
proliferation fails, fat begins to accumulate in tissues not suited for lipid 
storage, leading to the formation of specific metabolites that inhibit insulin 
signal transduction (Van Gaal et al., 2006). The majority of these 
metabolites will be ceramides; metabolites of saturated fats and one of the 
three forms of sphingolipids. Composed of one fatty acid and one 
sphingosine, ceramides are found in high concentrations in the lipid bi-
layer of cell membranes. Once thought of as a purely structural element it 
is now known that ceramides can be released from the cell membrane by 
enzymes and act as a signalling molecule. It is in their role as a signalling 
molecule that ceramides have potential to disrupt the insulin signalling 
pathway- crucial in the development of type 2 diabetes (Figure 4.3). It has 
been proposed that ceramides may block insulin stimulated tyrosine 
phosphorylation of insulin receptor substrate-1 (IRS-1) and its subsequent 
activation and recruitment of PI3K (Zundel & Giaccia, 1998), and/ or 
block activation of Akt (Summers & Nelson, 2005). A 1.5-2 fold increase 
in endogenous ceramides is enough to inhibit insulin signalling (Chavez & 
Summers, 2003). 
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Adapted from: www.biocenter.helsinki.fi/bi/piig/research.htm 
Figure 4.3 Basic insulin signalling pathway. 
InR= Insulin receptor, IRS= Insulin receptor substrate, PI3K= 
Phosphoinositide 3-kinases, PTEN= Phosphate tensin homolog, 
PDK1= Phosphoinositide dependent protein kinase-1, FOXO 1= 
Forkhead box subgroup O-1, 4EBP1= 4E Binding protein-1, 
mTOR= Mammalian target of rapamycin. Ļ= activation, ŏ= 
inhibition. 
 
Excess subcutaneous fat and steatosis can cause insulin resistance in the 
liver, muscles and adipose tissue. This leads to an inability for the body to 
suppress hepatic glucose production, impairs glucose uptake and oxidation 
DQG GLVDEOHV WKH ERG\¶V DELOLW\ WR VXSSUHVV WKH UHOHDVH RI 1()$¶V from 
adipose tissue (Van Gaal et al., 2006). 
 
Skeletal muscle is probably the most important tissue for insulin dependent 
glucose disposal in the body (Shulman, 2000). When functioning correctly 
insulin increases glucose uptake in muscle (up to 75% of insulin-dependent 
glucose disposal) and fat cells by stimulating the translocation of the 
glucose transporter, GLUT4 from intracellular sites to the cell surface and 
also inhibits hepatic glucose production, thus serving as a primary 
regulator of blood glucose concentration. Insulin also stimulates cell 
Insulin
InR
FOXO 1
Growth, life-span
4EBP1
IRS 1-4
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mTOR
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PI3K
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growth and differentiation and promotes the storage of substrates in fat, 
liver and muscle by stimulating lipogenesis, glycogen and protein synthesis 
and by inhibiting lipolysis, glycogenolysis, gluconeogenesis and protein 
breakdown (Saltiel & Kahn, 2001). Unfortunately for our ageing 
SRSXODWLRQ WKH SURFHVV¶ RI JOXFRVH WUDQVSRUW JO\FRJHQ V\QWKHVLV DQG
glucose oxidation all appear to be susceptible to dysregulation with age 
(Shulman, 2000) resulting in a higher propensity for hyperglycemia and 
insulin insensitivity. 
 
In normal individuals, despite periods of fasting and feeding, plasma 
glucose remains in a narrow range between 4 and 7 mmol.l-1 (Saltiel & 
Kahn, 2001). If WKH ERG\¶V V\VWHP IRU UHJXODWLQJ EORRG JOXFRVH EHFRPHV
deficient, dysregulation of the above processes can result in elevations of 
both fasting and postprandial glucose and lipid levels above those 
classified as normal. 
 
As well as improving body composition and lowering the obesity-related 
link with insulin-resistance, physical activity can independently improve 
glucose tolerance and sensitivity. Many research groups have reported the 
ability of RET to improve glucose tolerance and insulin action, especially 
in older people (Albright et al., 2000; Miller et al., 1994). This 
improvement may be due to the increased InR and Akt skeletal muscle 
content (Figure 4.3) that occurs with RET (Holten et al., 2004), suggesting 
that RET positively alters the skeletal muscle insulin signalling pathway 
(Iglay et al., 2007). Koopman and colleagues found that a single bout of 
resistance exercise improves insulin sensitivity by ~13% (Koopman et al., 
2005). 
 
By improving non-insulin dependent glucose uptake; physical activity 
improves the ratio between high density lipoprotein (HDL) and low density 
lipoprotein (LDL) cholesterol because it increases the activity of 
lipoprotein lipase, decreases triglycerides, increases fibrinolysis, lowers 
platelet aggregation, increases oxygen uptake in the heart and in peripheral 
tissues, lowers resting heart rate (RHR) by increasing vagal tone and 
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lowers resting blood pressure (Sandvik et al., 1993). Irrelevant to insulin-
sensitivity but important to overall health and well-being, physical activity 
also directly improves myocardial O2 supply, improving myocardial 
contraction and electrical stability (Van Gaal et al., 2006). 
 
Elevated plasma glucose and low HDL levels are just two components of 
WKH FRPSOH[ µPHWDEROLF V\QGURPH¶ 2riginally hypothesized by Reaven 
(Reaven, 1988), it encompasses a common constellation of closely linked 
clinical features (Table 4.2) and is considered a precursor of type 2 
diabetes (Reaven, 2005). 
 
Table 4.2 Features of the metabolic syndrome. 
Metabolic syndrome features 
x Fasting plasma glucose t 1.1g.L-1                 
x Android obesity; waist circumference ! 102cm males 
            ! 88cm females 
x Resting blood pressure t 130/85 mmHg 
x Triglyceride level ! 1.5g. L-1 
x High density lipoprotein cholesterol  0.4g. L-1 males 
                                                                0.5g. L-1 females 
Adapted from: NCEP Report (NCEP-Expert Panel on Detection, 2001) 
 
In America, it has been estimated that the metabolic syndrome affects one 
in four adults, making it the leading public health issue associated with 
increased cardiovascular disease risk (Ford et al., 2002). 
 
In 2001, Roberts and colleagues examined the effects of diet on the clinical 
features which compose the metabolic syndrome in a rodent study 
involving Fischer rats. For 20 months half of the rats were fed a high fat 
diet rich in refined carbohydrates (HFS) while the others were fed a low fat 
diet consisting of mainly complex carbohydrates (LFCC). These diets were 
then switched for two months (Roberts et al., 2001). Although energy 
intake was near to constant between the two diets conversion from LFCC 
to HFS decreased insulin stimulated glucose transport signalling which in 
turn increased levels of plasma insulin, plasma triglycerides, LDL 
cholesterol, very low density lipoprotein (VLDL) cholesterol and total 
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cholesterol (TC). Body weight also increased as did blood pressure and the 
LDL: HDL cholesterol ratio. Conversely, conversion from HFS to LFCC 
led to normalization of glucose transport, blood pressure, plasma insulin 
and VLDL cholesterol. There was also a significant reduction in obesity. 
Similar findings were observed by Roberts and colleagues later, this time 
in human subjects where a ~50% decrease in metabolic syndrome and type 
2 diabetes occurred following treatment albeit without the reduction in 
obesity. The treatment for this study was intense lifestyle and diet 
modification. The LFCC diet was light on fat, medium on protein and high 
in unrefined carbohydrates and fibre although not calorie restricted. 
Exercise was 45-60 minutes per day of treadmill walking at 70-85% of 
maximal heart rate. All of this was undertaken as a residential program 
with adherence essentially 100% (Booth & Chakravarthy, 2006). Results 
RIWKHVHVWXGLHVVXJJHVWµV\QGURPH;¶RUWKHµPHWDEROLFV\QGURPH¶PD\EH
reversed with a LFCC diet when combined with regular exercise even if a 
significant change in body mass does not occur. This may prove a useful 
basis on which to develop treatment for numerous CV and metabolic 
disorder risk factors.     
 
Obesity has been described as the most common cause of insulin 
resistance, and therefore type 2 diabetes in humans (Cavaghan et al., 
2000). In obese subjects, insulin levels typically increase to maintain 
normal glucose tolerance (Bell & Polonsky, 2001). One study observed 24-
hr insulin secretion rates three to four times higher in obese subjects 
compared to lean controls (Cavaghan et al., 2000).  
 
The World Health Organisation (W.H.O) predicts a doubling in the 
incidence of type 2 diabetes in the next two decades, predominantly fuelled 
by affluent modern lifestyles and an increasing incidence of obesity. 
Epidemiological surveys suggest that indolent well-fed populations are two 
to twenty times as likely to develop type 2 diabetes as lean populations of 
the same race (Kumar & Clark, 1994). 
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Diabetes is caused by a failure to maintain a stable level of blood glucose 
in the face of normal fluctuations of supply and demand. Insulin is required 
for the cells to be able to utilize glucose; taking it from the blood into cells. 
Without the transportation of glucose from blood to the cells, the cells may 
be starved of energy and/ or high blood glucose levels may damage the 
eyes, kidneys, nervous system and diabetes-accelerated atherosclerosis 
leads to increased risk of myocardial infarction, stroke and limb 
amputation (Brownlee, 2001). 
 
Insulin resistance, the cause of type 2 diabetes happens when the bodies 
tissues do not respond fully to the actions of insulin, so cannot make use of 
glucose in the blood. The pancreas responds by producing more insulin and 
the liver, where glucose is stored, releases more glucose to try and increase 
the amount of glucose available for the cells. As the cells become more 
resistant to insulin, levels of surplus glucose circulating in the blood 
increase. 
 
Different factors, both sociological and physiological can increase the risk 
of developing type 2 diabetes. These include an android patterning of fat 
distribution, resulting in a high waist: hip ratio, a high BMI, a high body 
fat percentage, elevated blood pressure and high cholesterol levels, all 
factors associated with a sedentary lifestyle (Zimmet, 1999) and obesity 
(Fagot-Campagna et al., 2001). 
 
Apart from heightened genetic susceptibility of certain ethnic groups it is 
clear that environmental and behavioral factors such as a sedentary 
lifestyle, nutrition and obesity are very important risk factors for type 2 
diabetes (Zimmet, 1992). With changes in these factors a new aspect of the 
type 2 diabetes epidemic is emerging; that of its increasing incidence in 
children, teenagers and adolescents (Fagot-Campagna et al., 2001).  Type 2 
diabetes has already been identified in children from Japan, United States, 
Pacific Islands, Hong Kong, Australia and the United Kingdom 
(Rosenbloom et al., 1999;Ehtisham et al., 2000). In Japan, type 2 diabetes 
is now more common than type 1 in children, accounting for 80% of 
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childhood diabetes; an incidence that almost doubled between 1976 and 
1995 (Kitagawa et al., 1998).   
 
The many aetiological determinants and risk factors of type 2 diabetes are 
outlined below (Table 4.3). 
 
Table 4.3 Aetiological determinants and risk factors of type 2 diabetes. 
Aetiological determinants and risk factors of type 2 diabetes 
Genetic factors 
x Genetic markers  
x Family history 
Demographic characteristics 
x Sex 
x Age 
x Ethnicity 
Behavioural and lifestyle related factors 
x Obesity (including duration and fat distribution) 
x Physical inactivity 
x Diet 
x Stress 
x Westernisation/ urbanisation/ modernisation 
Metabolic determinants 
x Impaired glucose tolerance 
x Insulin resistance 
Pregnancy-related determinants 
x Gestational diabetes 
x Diabetes in offspring of women with diabetes during pregnancy 
x Intra-uterine mal or over nutrition 
Adapted from: Zimmet et al, 2001 (Zimmet et al., 2001) 
 
An excellent model of the phenomenon that has accompanied 
modernization exists with the Israeli sand rat (Psammomys obesus). When 
this animal was removed from its natural environment and given an 
abundant high-kcal diet, it developed both type 2 diabetes and obesity 
(Zimmet, 1999). The changed lifestyle experienced by the rat emulates the 
lifestyle that is now experienced by humans as we progress further into the 
21st century, as we now consume diets with an excess of energy, simple 
carbohydrates and saturated fats while at the same time performing less 
physical activity both leisure-based and related to occupation (Dowse & 
Zimmet, 1993). 
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The completed Diabetes Prevention Program (1999) in the United States 
showed that, over three years, lifestyle intervention targeting both diet and 
exercise reduced the risk of progression from impaired glucose tolerance 
(IGT) to type 2 diabetes by 58%. Similar results for other lifestyle 
interventions have also been shown (Pan et al., 1997; Tuomilehto et al., 
2001). Although the results of these studies have been positive, several 
studies have provided evidence that approaches aimed at high risk 
individuals (for example, those with IGT) may not be enough to prevent all 
type 2 diabetes (Zimmet et al., 2001), with data from the UK Prospective 
Diabetes Study Group (UKPDS) indicDWLQJWKDWSDQFUHDWLFȕ-cell function 
is already substantially reduced prior to clinical diagnosis of type 2 
diabetes (UK Prospective Diabetes Study Group, 1995; 1998).  
 
,*7 LV DQ LQWHUPHGLDWH FDWHJRU\ EHWZHHQ µQRUPDO¶ DQG W\SH  GLDEHWHV
relative to glucose levels. This is diagnosed by an oral glucose tolerance 
test where fasting blood glucose is below 6.7 mmol.l-1 and when the 
sample taken 2-hours after ingestion of 75g of glucose is between 6.7 and 
10.0 mmol.l-1. This is compared to the diagnosis of type 2 diabetes where 
the fasting values are over 6.7mmol.l-1 and when the 2-hour value is over 
10.0mmol.l-1 (Kumar & Clark, 1994). 
 
Both aerobic and resistance exercise have been shown to be associated 
with a decreased risk of type 2 diabetes (Helmrich et al., 1994; Manson et 
al., 1992; Helmrich et al., 1991). In one large prospective study (Helmrich 
et al., 1991) each increase of 500kcal in energy expenditure per week was 
associated with a decreased incidence of type 2 diabetes of 6%. This 
benefit was particularly evident in those suffering some of the risk factors 
for type 2 diabetes (Table 4.2). 
 
Resistance training may be of benefit in relation to diabetes as high levels 
RI DGLSRVH WLVVXHDQG ORZVNHOHWDOPXVFOHPDVV ZLOO GHFUHDVH WKHERGLHV¶
ability to handle an exogenous glucose load; potentially diverting glucose 
which could have been oxidized by skeletal muscle into fat and liver 
stores. Resistance exercise training which stimulates skeletal muscle 
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hypertrophy may be able to prevent and/ or reverse this situation allowing 
the body to better cope with exogenous glucose. In a study by Cuff et al., 
the addition of RET to an aerobic training regime enhanced glucose 
disposal (that was not improved by aerobic training alone) and was 
associated with a loss of abdominal subcutaneous and visceral adipose and 
increased muscle density (Cuff et al., 2003). 
 
Glucose deposition in skeletal muscle in older adults is determined by 
decreased amounts and requirement of the GLUT-4 glucose transporters, 
decreased insulin receptors, decreased glycogen synthase activity and 
decreased glucose oxidation. Even a small amount of exercise (endurance 
or resistance training) increases the storage capacity of skeletal muscle and 
the activities of the fore mentioned factors regulating glucose deposition. 
These changes have been associated with increased glucose tolerance, 
meaning the body has a greater ability to metabolize glucose, and 
decreased insulin resistance.  
 
This study may go some way to illustrate the beneficial effect that one type 
of exercise training can have on a primary risk factor for type 2 diabetes, 
however, with the changes in work patterns from heavy labour to 
sedentary, the increase in computerization and mechanics, improved 
transport (Zimmet, 2000), high energy, high-fat diets and the lack of 
leisure time activity there is an urgent need to address these problems both 
socially and politically to aid in the prevention of type 2 diabetes 
(McKinlay & Marceau, 2000). 
 
In conclusion, it must be accepted that type 2 diabetes is not just a disease 
but a symptom of a much larger global problem- the effect environmental 
and lifestyle changes are having on human health (Zimmet, 2000).  
  
4.1.2.1 Pathophysiology of type 2 diabetes 
Skeletal muscle is the tissue responsible for the majority of insulin-
dependent glucose disposal in the body (Shulman, 2000). Glucose 
transport, glycogen synthesis and glucose oxidation all appear to 
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deteriorate with advancing age (Krishnan et al., 2003; Houmard et al., 
1995; Gumbiner et al., 1992), resulting in hyperglycaemia, insulin 
resistance and/ or insulin insensitivity. It is not however ageing per se that 
may be responsible for the age-related decline in insulin-sensitivity that is 
observed, it may be the decreased physical activity (Ryan, 2000), changed 
body composition (Boden et al., 1993) or chronic low-grade inflammation 
(Bruunsgaard & Pedersen, 2003), all of which are related to ageing, that 
contribute the insulin resistance experienced (Festa et al., 2000). 
 
4.1.2.1.1 Glucose 
The importance of glucose in the pathogenesis and development of type 2 
diabetes has been outlined above. As a monosaccharide, glucose is an 
important carbohydrate and is used by living cells as a source of energy 
(Figure 3.2). Commonly referred to as blood sugar in lay literature, blood 
glucose level is normally controlled between 4- 6 mmol.L-1, equating to a 
level in the circulating blood of ~3.3-7g if an average adult blood volume 
of 5 liters is assumed. Insulin is not the only anabolic hormone that can 
affect blood glucose; human growth hormone (HGH), glucagon and 
FDWHFKRODPLQH¶V FDQ DOO LQFUHDVH EORRG JOXFRVH levels. Fasting blood 
glucose levels, especially when combined with fasting insulin levels and 
entered into the homeostasis model assessment (HOMA) equation can 
serve as a good predictor of insulin sensitivity, and even independently can 
serve as a guide to the risk of IGT and/ or type II diabetes. 
 
4.1.2.1.2 Insulin 
Insulin resistance may be calculated using the homeostasis model 
assessment (HOMA) equation (Matthews et al., 1985) and/ or the more 
recent quantitative insulin sensitivity check index (QUICKI) (Katz et al., 
2000) (see below), suitable for use in subjects with no baseline symptoms 
of IGT (i.e. Normal fasting blood glucose levels >4, <7mmol.l-1). QUICKI 
and HOMA have been described as the most accurate surrogate methods of 
assessing insulin sensitivity, with QUICKI described as having excellent 
linear correlation with insulin sensitivity assessed by means of a glucose 
clamp (Chen et al., 2005).  Insulin sensitivity and insulin resistance may be 
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used as precursors of type 2 diabetes, a disease commonly associated with 
adults, and in particular the elderly, but now growing more prevalent in all 
age-spectrums of the population. 
 
HOMA =                                 Glucose (mmol.L-1[,QVXOLQȝ8P/-1) 
                               22.5 
 
QUICKI =                                              1                                             . 
         /RJIDVWLQJLQVXOLQȝ8P/-1) + Log fasting       
glucose (mg.dL-1) 
 
To obtain glucose in mg.dL-1, the conversion from the common 
measurement unit of mmol.L-1 is: 
 
mg.dL-1 x 0.55 = mmol.L-1 
 
HOMA equation values above 2.35 for men and 1.88 for women are 
deemed to be indicative of the metabolic syndrome and therefore 
detrimental to human health (Balkau & Charles, 1999). Lower HOMA 
scores are positive as the score is representing insulin resistance while 
QUICKI scores represent insulin sensitivity so elevated values should be 
interpreted as positive. Hrebicek and colleagues found QUICKI values 
below 0.357 to be distinctly linked to the identification of patients with 
manifestations of the metabolic syndrome and insulin resistance (Hrebicek 
et al., 2002); although they did recommend that values would be lab 
dependent as formal reference values were not available. 
 
4.1.2.2 Implications of type 2 diabetes 
The International Diabetes Federation reports that 366 million people 
worldwide have diabetes (~8.5% of the global population) and that this 
figure will have increased to 522 million by 2030 (www.diabetes.org/). In 
the UK alone, 2.9 million people have been diagnosed as diabetics with an 
HVWLPDWHG¶XQGLDJQRVHGVXIIHUHUV (www.diabetes.org.uk/).  Type 2 
diabetes can have considerable negative effects on the vasculature and can 
lead to devastating microvascular complications (He & King, 2004) such 
as retinopathy (Kempen et al., 2004; Saaddine et al., 2008), nephropathy 
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and neuropathy, which in the most serious of cases may lead to blindness, 
renal disease/ failure and amputation, respectively (Natarajan et al., 2012). 
Type 2 diabetes also increases cardiovascular mortality risk 5 times in 
males and 8 times in females, associated with coronary artery disease, 
atherosclerosis, hypertension and stroke (Beckman et al., 2002) as well as 
being linked to increased infection susceptibility (Natarajan et al., 2012). 
The increased incidence of these complications in type 2 diabetics has been 
linked to hyperglycemia, hyperlipidemia, advanced glycation end products, 
growth factors and pro inflammatory cytokines (Natarajan et al., 2012; 
Natarajan & Nadler, 2004; Brownlee, 2001; Libby, 2002).  
 
4.1.2.3 Resistance-exercise training and type 2 diabetes 
Skeletal muscle is an important determinant of insulin sensitivity 
(Shulman, 2000) and in many studies RET has enhanced insulin sensitivity 
and improved glucose tolerance (Tresierras & Balady, 2009). In a meta-
analysis of 9 randomized control trials containing 372 subjects with type 2 
diabetes, progressive RET led to absolute reductions of HbA1c (Irvine & 
Taylor, 2009), something that was also shown by Bweir et al., (Bweir et 
al., 2009) using a training regime not dramatically different from the one 
used in this study. Many studies assessing the efficacy of different exercise 
regimes use HbA1c as a marker of improvement in diabetic status.  
 
HbA1c is the abbreviation for glycated hemoglobin and is a useful tool for 
assessing average blood glucose in the past 2-3 months (Sigal et al., 2007). 
HbA1c is a form of hemoglobin produced in a non-enzymatic glycation 
pathyway by hemoglobins exposure to plasma glucose. The American 
Diabetes Association define diabetic HbA1c levels as >48mmol/l or 6.5%. 
A 1% increase in HbA1c is associated with a 15-20% increase in major 
cardiovascular events and a 1% decrease with a 37% reduction in 
microvascular complications (Sigal et al., 2007).  
 
Whilst there are no studies that show adverse effects of RET on Type 2 
diabetes the literature is not entirely consistent. Based on the self-scoring 
SF-36 scale RET was found to be better than aerobic training at improving 
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scores of health status in a multi-ethnic Asian diabetic cohort (Ng et al., 
2011) and Minges and colleagues reported reduced obesity and improved 
physical function in diabetics after RET (Minges et al., 2011). Studies 
using the HbA1c marker are less unanimous in their support for RET 
alone. In 2007 Sigal et al reported that 6 months RET significantly reduced 
HbA1c (by 0.38%), waist circumference and abdominal subcutaneous fat 
but concluded that greater results were achieved through a combination of 
RET and aerobic training (Sigal et al., 2007). These results are however 
difficult to interpret as the combined group performed the full aerobic and 
RET regimes, therefore doubling the workload and exercise time of either 
of the single-mode interventions. These improvements in HbA1c were also 
found by Castaneda and colleagues following 16 weeks progressive RET 
where not only was HbA1c reduced by 1.1% but muscle glycogen stores 
were increased by ~20mmol glucose per kg muscle and the prescribed dose 
of diabetic medication was reduced in 72% of exercisers (Castaneda et al., 
2002). Also in agreement with the work of Sigal was an increase in lean 
muscle mass and a decrease in trunk fat mass with a further reported 
benefit of reduced systolic blood pressure. In older diabetics HbA1c was 
also reduced with RET and this was again paired with an increase in lean 
muscle mass, the benefits of which have already been discussed earlier in 
this work (Dunstan et al., 2002). Church and colleagues however, found 
that only a combination of RET and aerobic exercise was able to reduce 
HbA1c and that this combination-training also improved VO2 max. They 
did conclude that in relation to body composition both modes of exercise 
and the combination were equivocal in reducing waist circumference and 
fat mass. 
 
Improved glucose tolerance and/ or uptake after RET appears not to be 
simply a consequence of increased muscle mass but also a result of 
qualitative changes in resistance-trained muscles. A study using a 
unilateral model of RET found that RET enhanced insulin action in both 
type 2 diabetics and healthy subjects independent of increases in lean 
muscle mass. They concluded that increases in GLUT-4 content and 
insulin pathway signalling protein expression were at least part of the 
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mechanism behind improved insulin action following RET (Holten et al., 
2004).  
 
4.1.3 Cardiovascular disease 
Atherosclerotic disease, often cited as the major cause of CVD remains the 
leading cause of death in industrialized nations despite major advances in 
its diagnosis, treatment and prevention. The increasing epidemic of 
obesity, insulin resistance and type 2 diabetes is likely to add to this burden 
if the lifestyle changes associated with westernization are not halted or at 
best reversed (Lau et al., 2005). 
 
Different mechanisms linking adiposity to CVD have been postulated; 
adding support to already established classical risk factors and increasing 
the proposition of less conventional risk factors such as adipokine 
involvement (Van Gaal et al., 2006). 
 
Adipose tissue is an active endocrine and paracrine organ that releases 
large numbers of cytokines such as leptin, adiponectin, IL-6 and TNF-ĮIRU
example. These products not only influence body weight homeostasis but 
also insulin resistance, diabetes, lipid levels, tension, coagulation, 
fibrinolysis, inflammation and atherosclerosis (Lau et al., 2005). 
  
As further examined later in this chapter (Figure 4.5) atherosclerosis is an 
inflammatory process that initially begins with endothelial dysfunction. 
Evidence is beginning to accumulate that suggests that adipokines may 
directly influence endothelial function through their pro-inflammatory 
properties thus suggesting a reason for the link between body composition 
and CVD disease risk (Figure 4.4). 
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Adapted from: (Van Gaal et al., 2006) 
 
Figure 4.4 Mechanisms linking adiposity with CV disease. 
MCP-1: Monocyte chemo attractant protein; NEFA: Non-estrified fatty acid; RBP-4: Retinol binding protein four; IL-6: Interleukin six; 
TNF-Į 7XPRU QHFURVLV IDFWRU DOSKD &53 &-reactive protein; PAI-1: Plasminogen activator inhibitor one; VLDL: Very low density 
lipoprotein; LDL-ox: Low density lipoprotein oxidation; ICAM-1: Intracellular adhesion molecule one; ROS: Reactive oxygen species. 
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Myocardial infarction (MI) (commonly referred to as a heart attack) is 
often an end stage of CVD and nine measurable and modifiable factors 
which could act as predictors have been identified including abdominal 
adiposity and the absence of regular physical activity (Yusuf et al., 2004) 
(Table 4.4). 
 
Table 4.4 Modifiable predictors of myocardial infarction. 
Predictors of Myocardial infarction 
x Low level of exercise/ physical activity 
x Abdominal obesity 
x Hypertension 
x High ApoB: ApoA-1 ratio 
x Diabetes 
x Low dietary intake of fruit/ vegetables 
x High dietary intake of alcohol 
x Smoking 
x Low psychosocial status 
Adapted from: (Yusuf et al., 2004) 
 
4.1.3.1 Cytokines 
Cytokines are a family of proteinaceous substances produced by various 
cells and critical to the functioning of immune responses, including the 
involved inflammatory responses. Chronic inflammation is thought to play 
a role in disease development and in functional decline during ageing 
(Jankord & Jemiolo, 2004).  
 
TNF-Į LV D F\WRNLQH LQYROYHG LQ V\stemic inflammation and the acute 
phase response of the immune process.  TNF-ĮLVUHOHDVHGE\ZKLWHEORRG
cells, endothelial cells and several other cells in the course of damage. Its 
release is stimulated by several other mediators such as IL-1 and it 
generally works with other cytokines such as IL-6 and IL-1 in various 
organ systems. IL-1 is a cytokine that forms part of the inflammatory 
response and increases the expression of adhesion factors on endothelial 
cells. 
 
TNF-Į FDQ VXSSUHVV DSSHWLWHV RIWHQ FDXsing cachexia in times of disease 
states, it can stimulate the liver leading to increased levels of C-Reactive 
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Protein (CRP) and as well as stimulating phagocytosis, TNF-Į FDQ
stimulate macrophages leading to the production of IL-6, oxidants and the 
inflammatory lipid; Prostaglandin-E2 (PGE2). On some tissues TNF-ĮFDQ
lead to an increased insulin resistance, increasing the propensity of affected 
individuals to develop type 2 diabetes (Zhang et al., 2003a). 
 
Ageing is associated with chronic small increases in basal systemic 
circulating levels of inflammatory markers and many pro-inflammatory 
cytokines (Paolisso et al., 1998; Hager et al., 1994; Morin et al., 1997; 
Cohen et al., 1997) with multi-functional cytokines such as TNF-ĮDQG,/-
6 associated with mortality and morbidity in the elderly (Bruunsgaard & 
Pedersen, 2003). In cohorts of frail, older individuals levels of TNF-ĮDQG
IL-6 may be considered as disease markers. Circulating levels of TNF-Į
seem to be the best predictor of mortality in frail, elderly populations with 
a high mortality rate while IL-6 appears a better marker in healthy, elderly 
populations (Hager et al., 1994). 
 
High levels of serum inflammatory mediators have been associated with 
numerous disease states including atherosclerosis, type 2 diabetes, 
hypertension, depression and overall mortality (Kohut et al., 2006). 
Evidence supports the direct role of TNF-Į LQ WKH GHYHORSPHQW RI
atherosclerosis and type 2 diabetes in older individuals (Bruunsgaard & 
Pedersen, 2003). TNF-ĮDOVRLQGXFHVDFDWDEROLFVWDWHWKDWFDXVHVIUDLOW\IRU
which increased levels of circulating IL-6 also seems to be a risk factor. 
Recent research suggests that patients with elevated basal levels of C-
reactive protein (CRP) are at increased risk of hypertension and 
cardiovascular disease. In 2004 Erlinger and colleagues proposed CRP also 
had a role to play in cancer development with significantly higher levels of 
serum CRP in those who went on to develop cancer compared to those 
who did not (Erlinger et al., 2004). 
 
Lifestyle factors such as diet and exercise may modulate levels of 
circulating cytokines and other inflammatory markers such as CRP. 
Exercise has been shown to reduce Toll-like receptor (TLR) expression, 
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which can reduce the release of pro-inflammatory cytokines and depress 
the levels of acute phase proteins (including CRP) released by the liver 
(McFarlin et al., 2004).  IL-6 and TNF-Į DUH WKH PDLQ F\WRNLQHV
responsible for inducing CRP secretion in the liver. CRP is a marker of low 
grade inflammation and has been suggested to play a role in the 
pathogenesis of atherosclerotic lesions in humans (Libby et al., 2002). 
CRP is an acute phase plasma protein produced by the liver and a member 
of the pentraxin family of proteins. Increased levels of serum CRP are 
found in those suffering acute inflammation and measuring serum CRP is a 
recognized method of marking inflammation. Elevation of CRP enhances 
the CHD prognosis in men with four or more features of the metabolic 
syndrome (see Table 4.2) (Libby et al., 2002b). Some research groups have 
shown that aerobic exercise, but not flexibility or resistance training, 
reduces levels of serum TNF-Į IL-6, CRP and IL-8 independent of BMI 
and psychosocial factors in older adults (Kohut et al., 2006), with strength 
training lowering TNF-ĮRQO\7KHVHILQGLQJVDUHKRZHYHUFRQWUDGLFWRU\WR
those of other groups who have shown resistance training to also have an 
effect on lowering serum levels of multiple pro-inflammatory cytokines 
including IL-6, something which is further examined by this study. A 
general consensus does exist to advocate exercise and dietary interventions 
as possible strategies to lessen inflammatory activity and improve the 
health status of the elderly (Bruunsgaard & Pedersen, 2003). 
 
TNF-Į KDV PDUNHG HIIHFWV RQ ZKROH ERG\ OLSLG DQG JOXFRVH PHWDEROLVP
(Zhang et al., 2003a) and over-expression of TNF-ĮLQDGLSRVHWLVVXHDQG
muscle of both humans and animals may contribute to the development of 
insulin resistance. Elevated levels of TNF-ĮP51$DQGSURWHLQKDYHEHHQ
associated with both obesity and insulin resistance (Hotamisligil et al., 
1993) and data is accumulating to suggest that TNF-ĮSOD\VDGLUHFWUROHLQ
the metabolic syndrome (Petersen & Pedersen, 2005). Lowering the active 
levels of TNF-ĮDQGthe deletion of TNF-ĮUHFHSWRUVKDYHERWKEHHQVKRZQ
to improve insulin sensitivity (Hotamisligil, 1999).  
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TNF-ĮLVDQLQIODPPDWRU\F\WRNLQHUHOHDVHGLQJUHDWHUTXDQWLWLHVE\REHVH
human patients and patients with insulin resistance.  TNF-Į QRW RQO\
initiates but also supports atherosclerotic lesion formation, impairs 
endothelium-dependent vasodilation and promotes endothelial dysfunction 
which could lead to impaired blood flow, the consequences of which are 
discussed in detail later. 
  
TNF-Į LV DOVR WKRXJKW WR SOD\ D UROH LQ WKH VNHOHWDO PXVFOH ZDVWLQJ WKDW
occurs with chronic infections, rheumatoid arthritis, cancer, ageing and 
other chronic diseases (Greiwe et al., 2001).  
 
Infusion of TNF-ĮGHFUHDVHVPXVFOHSURWHLQV\QWKHVLV(Garcia-Martinez et 
al., 1993) and in cultured human myoblasts inhibits the increase in protein 
synthesis rate mediated by growth factors (Frost et al., 1997). In vivo, 
TNF-Į VXSSUHVVHV SURWHLQ V\QWKHVLV UDWH LQ GRJV DQG LQGXFHV VNHOHWDO
muscle protein breakdown in rats (Goodman, 1991). 
 
Numerous studies, including one by Greiwe and colleagues have found 
both TNF-ĮP51$DQGOHYHOVRI71)-ĮSURWHLQWREHKLJKHULQWKHHOGHUO\
compared to the young (Greiwe et al., 2001). In the elderly Greiwe showed 
that with resistance training TNF-ĮOHYHOVGHFUHDVHGDQGWKDWERWKVWUHQJWK
and muscle protein synthesis rates in the elderly (aged 81+/-1) were 
inversely related to levels of TNF-Į SURWHLQ (Greiwe et al., 2001). The 
results of this study suggests that TNF-Į contributes to age associated 
muscle wasting and that resistance training may go some way to attenuate 
this process by suppressing skeletal muscle TNF-ĮH[SUHVVLRQ 
 
The mechanism by which TNF-Į PD\ OHDG WR PXVFOH ORVV LV QRW IXOO\
understood, though numerous suggestions have been proposed. One 
proposal is that as TNF-ĮKDVEHHQVKRZQ WRDFWLYDWH WUDQVFULSWLRQ IDFWRU
NF-Ƹ% (Li et al., 1998), which in turn increases inducible nitric oxide 
synthases (iNOS) gene expression, leading to the production of highly 
reactive free radicals that may cause oxidative damage to the muscle. A 
second proposal is that TNF-ĮFDQLWVHOILQGXFHFHOOGHDWK71)-ĮKDVWZR
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ubiquitously expressed cell surface receptors: Tumour necrosis factor 
receptor (TNFR) I and TNFR-II. TNFR-I contains an 80 amino acid 
LQWUDFHOOXODUµGHDWKGRPDLQ¶WKDWLQWHUDFWVZLWKDVHULHVRIDGDSWRUSURWHLQV
capable of triggering either apoptosis or necrosis (Ledgerwood et al., 
1999).  
 
The above suggestions try to explain why TNF-ĮPD\FRQWULEXWHWRPXVFOH
loss with ageing, although it is not obvious why this cytokine is elevated in 
the muscle with age. There is however consensus supporting the notion 
that chronic low-grade inflammation accompanies ageing (Petersen & 
Pedersen, 2005). 
 
Increased skeletal muscle TNF-ĮPD\UHIOHFWDGHFUHDVHGDELOLW\IRUageing 
skeletal muscle to control oxidative stress. In murine studies active NF-Ƹ%
has been shown to be present in the tissues of ageing mice whilst 
correlating with TNF-ĮH[SUHVVLRQ(Spencer et al., 1997). Ageing humans 
may respond the same to oxidative stress and this may affect TNF-ĮOHYHOV
in aged human muscle. 
 
Successful ageing probably cannot occur without exercise, the main 
function of skeletal muscle. Exercise studies have shown that RET 
decreases skeletal muscle TNF-Į DQG LQFUHDVHs protein synthesis, 
suggesting that resistance training may reduce the inhibitory effect of TNF-
ĮRQ WKHSURGXFWLRQRIQHZSURWHLQ LQ WKHHOGHUO\'DWD IURP*UHLZHand 
colleagues showed that TNF-ĮLVWUDQVFULEHGE\KXPDQP\RF\WHVHOHYDWHG
in the muscle of the elderly but decreased by exercise (Greiwe et al., 
2001). This study involved a frail elderly cohort where TNF-Į KDV EHHQ
shown to be the best predictor of mortality (Bruunsgaard & Pedersen, 
2003).  
 
Antagonising the effects of TNF-Į WKURXJK RET may delay some of the 
inevitable decline in skeletal muscle function faced by an ageing 
population. It may also help improve insulin resistance, as shown in 
 211 
rodents (Ventre et al., 1997), although the mechanistic details of how this 
improvement may occur in humans are still debated (Ofei et al., 1996). 
 
IL-6 is one of the cytokines, along with CRP most strongly associated with 
increased CVD risk and the prediction of future CVD or Type 2 diabetes 
(Lau et al., 2005). The release of IL-6 mainly from abdominal adipocytes 
has been suggested to play a pivotal role in the relationship between 
oxidative stress, as discussed earlier in this chapter (see 1.3), and 
endothelial dysfunction (Van Gaal et al., 2006). IL-6 not only contributes 
to CRP elevation and low grade inflammatory states but also has a close 
relationship with coagulation, insulin-resistance, dyslipidaemia and the 
fore mentioned endothelial dysfunction (Van Gaal et al., 2006).  
 
The role of IL-6 with regard to insulin resistance remains controversial; 
infusion of recombinant human IL-6 into resting healthy humans does not 
impair glucose production or uptake (Steensberg et al., 2003), but when 
diabetic patients were given this same infusion, plasma concentrations of 
insulin decreased to levels comparable with age and BMI matched healthy 
controls, suggesting that IL-6 enhanced insulin sensitivity (Petersen et al., 
2005). Again controversially one recent study showed that IL-6 had no 
inhibitory effect on insulin action and glycogen synthesis (Weigert et al., 
2004), while IL-6 knock-out mice developed IGT reversed by IL-6 
infusion (Wallenius et al., 2002).    
 
The majority of cytokine work is related to sepsis/ infection in which the 
cytokine cascade is different to that induced by exercise, especially with 
regard to IL-6 (Table 4.5). In the exercise induced cytokine cascade IL-6 is 
the first cytokine present, followed by an increase in IL-10 and IL-1ra, 
stimulated by IL-6 (Steensberg et al., 2003). IL-6 also stimulates the 
release of soluble TNF-ĮUHFHSWRUVEXWQRW71)-Į(Tilg et al., 1997). 
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Table 4.5 Cytokine cascades in response to sepsis and exercise. 
Cytokine cascades in response to sepsis and exercise 
SEPSIS EXERCISE 
TNF-Į IL-6 
IL-1ȕ IL-1ra 
IL-6 TNF-R 
IL-1ra IL-10 
TNF-R CRP (8-10 hrs later) 
IL-10  
Adapted from: Petersen et al, 2005 (Petersen & Pedersen, 2005) 
 
Not described as a pro or anti-inflammatory cytokine IL-6 responds to 
acute exercise. IL-6 is produced by muscle fibres (Petersen & Pedersen, 
2005), leading it to be defined as a myokine; a cytokine produced and 
released by contracting skeletal muscle fibres and that exerts its effects in 
other organs of the body (Pedersen et al., 2003). The discovery that 
skeletal muscle is a endocrine organ which can produce and release 
cytokines may be of great importance as skeletal muscle is the largest 
organ in the human body (Petersen & Pedersen, 2006). 
 
There is a marked increase in circulating levels of IL-6 after exercise 
(Petersen & Pedersen, 2005), with increases in plasma IL-6 occurring in an 
exponential trend relative to exercise intensity, duration and muscle mass 
recruited (Febbraio & Pedersen, 2002; Pedersen & Hoffman-Goetz, 2000). 
The release of IL-6 post exercise is amplified by the presence of low 
muscle glycogen (Petersen & Pedersen, 2005).  
 
Even moderate exercise can have large effects on IL-6 and the exercise 
induced increase in plasma IL-6 seems greater still in elderly individuals 
(Pedersen et al., 2004). Data suggests that IL-6 has inhibitory effects on 
the previously discussed TNF-ĮSURGXFWLRQDQGWKDWWKHDQWL-inflammatory 
role of IL-6 is continued by its stimulation of IL-10 production (Petersen & 
Pedersen, 2005). 
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IL-10 is often cited as the most important anti-inflammatory cytokine 
found within the human immune response (Opal & DePalo, 2000). 
Synthesized by Cluster of differentiation 4 (CD4+), T-helper 2 (Th2), 
PRQRF\WHV DQG EHWD ȕ FHOOV it acts as an inhibition factor against pro-
inflammatory cytokines and can deactivate monocyte/ macrophage pro-
inflammatory cytokine synthesis; inhibiting cytokine production by 
neutrophils and inhibiting NF-ț% QXFOHDU WUDQVORFDWLRQ (Opal & DePalo, 
2000). IL-10 inhibits the production of IL-Į ,/-ȕ DQG 71)-Į DOO
cytokines which play an important role in the activation of granulocytes, 
monocytes/ macrophages, natural killer cells and T and B cells (Moore et 
al., 1993).   
 
The possibility exists that with regular exercise, the anti-inflammatory 
effects of an acute bout of exercise may act to protect again chronic 
systemic low-grade inflammation. Although this link has not yet been 
proven this would offer one explanation as to how regular exercise protects 
against type II diabetes, atherosclerosis and other clinical conditions 
related to chronic systemic low-grade inflammation (Petersen & Pedersen, 
2005). Decreases in TNF-Į PD\ EH LQGLFDWLYH RI WKLV DQG PD\ DOVR be 
representative of increased IL-10, an anti-inflammatory cytokine. 
 
4.1.3.2 Blood pressure and heart rate 
Blood pressure (or vascular pressure) is the term used to refer to the force 
exerted by circulating blood on the walls of the blood vessels. As 
circulating blood moves away from the heart through the arteries, 
arterioles, capillaries and veins the pressure decreases. In general the term 
blood pressure is referring to the pressure in the arteries and is reported in 
millimeters of mercury (mmHg).  Two values are given to compose a 
blood pressure reading and are scribed as A/B RUSURQRXQFHGDV³$RYHU%´
³A´ refers to the systolic arterial pressure (SBP), sometimes known as the 
peak pressure; this is the pressure occurring near the beginning of the 
cardiac cycle. ³B´ is the diastolic arterial pressure (DBP), and is the lower 
of the two values representing the arterial pressure at the resting phase of 
 214 
the cardiac cycle. A single value, mean arterial pressure is sometimes 
given, this is calculated as: 
 
0HDQ$UWHULDO3UHVVXUH ѿî6%3Ҁî'%3 
 
Typical resting values for a healthy human adult are ~ 120/80, although large 
individual variation occurs and even within an individual this value can 
significantly vary due to numerous factors including circadian rhythm, 
stress, nutrition, and hydration. Those values deemed normal are also age 
GHSHQGHQW ZLWK FKLOGUHQ¶V YDOXHV RIWHQ ORZHU DQG KLJKHU YDOXHV LQ WKH
elderly. 
 
During the actions involved in RET, be they isometric or isotonic 
hemodynamic responses will occur causing an increase in HR, systolic 
blood pressure (SBP) and systolic volume. If high intensity repetitions are 
being performed there is also likely to be an increase in diastolic blood 
pressure (DBP), with these responses greatest during the last repetitions of 
a set that is designed to elicit maximal exertion (Umpierre & Stein, 2007). 
 
Chronic exercise, including RET has however been shown to help in both 
the short term and long term control of BP and has been advocated as a 
mechanism in manageing hypertension (Umpierre & Stein, 2007; Fagard, 
2006). It is not only BP that chronic RET has been shown to have a 
positive effect on, but also on RHR. HR is used to describe the frequency 
of the cardiac cycle and is usually calculated as the number of contractions 
of the heart per minute and expressed as beats per minute (bpm). RHR for 
the average human heart is ~70 bpm, but as with BP this can vary greatly 
between individuals based on age and training status. A recent study found 
that a RET program of 10 weeks in duration had a significant effect on 
lowering RHR (Poelkens et al., 2007).  
 
Resistance training is progressively gaining recognition in CVD prevention 
and rehabilitation (Umpierre & Stein, 2007) and this may be due to directly 
lowering RHR and BP, both risk factors for CVD if elevated, or related to 
 215 
the changes in BC that RT can induce, as visceral fat reduction is directly 
associated with lowered resting blood pressure (BP) (Van Gaal et al., 
2006). 
 
4.1.3.3 Cholesterol  
Dyslipidaemia, often associated with increased adiposity is characterized 
by high levels of VLDL cholesterol, triglycerides and TC. This is normally 
accompanied by an increase in small dense LDL particles and lowered 
HDL cholesterol (Howard et al., 2003). Several mechanisms have been 
proposed as an explanation for the link between increased adiposity and 
low HDL cholesterol: 
 
x Impaired lipolysis of triglyceride-rich lipoproteins (TRL) lowers 
HDL concentration by decreasing transfer of apolipoproteins and 
phospholipids from TRL to HDL. 
x Delayed clearance of TRL facilitates the cholesterol ester transfer 
protein (CETP) mediated exchange between cholesterol esters in 
HDL and triglycerides in VLDL. 
x Increased activity of hepatic lipase in insulin resistance states, such 
as that which occurs with increased adiposity, produces smaller 
HDL particles, leading to HDL elimination (Frenais et al., 2001). 
x Insulin resistance could have a direct affect on the production of 
ApoA-I and/ or secretion of nascent HDL from the liver (Van Gaal 
et al., 2006). 
 
Familial hypercholesterolaemia is generally believed to stand 
independently as a risk factor for CHD and this risk is substantially higher 
if in the presence of insulin resistance caused by abdominal adiposity 
(Gaudet et al., 1998). 
 
In insulin resistant states the dyslipidaemia is characterized by a different 
composition and distribution of LDL particles which results in an increased 
concentration of small dense LDL particles. LDL particles are enriched in 
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triglycerides, which when rapidly lipolysed by hepatic lipase (HL) leave 
smaller, denser LDL particles. It is the activity of both HL and CETP, both 
found to be increased with the metabolic syndrome, that lead to these small 
dense particles which are more prone to oxidation and glycation. These 
small dense LDL particles can move through endothelial fenestrations, 
entering the sub endothelial space where inflammation and transformation 
into plaque can occur (Kwiterovich, Jr., 2002). This modified LDL is then 
mostly taken up by macrophage scavenger receptors, rather than the 
normal LDL receptor (LDLR) pathway and it is this that induces 
atherosclerosis (Van Gaal et al., 2006), for which the process is outlined 
below (Figure 4.5). 
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Adapted from: http://hsc.usf.edu/CLASS/jennifer/atherogenesis.htm 
 
Figure 4.5 The atherogenic process. 
1. Chronic endothelial injury leads to increased permeability and 
adhesion molecules. 
2. Monocytes and later platelets adhere to the injured area. Lipids 
begin to be deposited in the area. 
3. Intimal aggregation of monocytes, macrophages and lipid 
molecules. 
4. Chemotactic and growth factors are released resulting in 
proliferation of smooth muscle cells by which connective tissue 
is formed. 
5. Macrophages and smooth muscle cells engulf lipid particles and 
become laden with them. 
6. Smooth muscle cells proliferate, some foam cells die and lipid 
debris is left within in the plaque. This process results in a much 
decreased lumen diameter. 
 
There is conflicting data regarding the association between serum 
cholesterol levels and mortality from CHD. Although general consensus 
supports the association between high serum TC and the risk of CHD 
(Zhang et al., 2003; Cui et al., 2006; Iso et al., 1989) Russian Lipid 
Research Clinics state that there is no association between the two, while 
US Lipid Research Clinics have stated that they believe there to be a strong 
negative association between HDL cholesterol and CHD mortality (Perova 
et al., 1995). Much US work and policy stems from four prospective 
VWXGLHV FDUULHG RXW LQ WKH ¶V LQ ZKLFK WKH DVVRFLDWLRQ EHWZHHQ +'/
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cholesterol and mortality was inverse and significant (Gordon et al., 1989) 
results which were mirrored by Perova in 1995 when comparing HDL 
cholesterol and CHD in groups of both American and Russian subjects 
over a 12 year period (Perova et al., 1995). In both the Russian and 
American sample of this study Perova found high levels of HDL 
cholesterol to have a negative association with CHD mortality, although 
the association was lower for the Russian sample.  
 
Elevated levels of serum cholesterol have also been found to be associated 
with thromboembolic stroke (Benfante et al., 1994), although this 
association is often underreported because CHD, also associated with high 
serum TC levels, occurs earlier in life and with greater frequency than 
thromboembolic stroke. Although often underreported research has 
determined strong associations between TC and the risk of ischemic, but 
not hemorrhagic stroke (Zhang et al., 2003b). 
 
A recent study demonstrated that 12 weeks of whole-body RET 
significantly decreased total and LDL cholesterol, independent of diet and 
sex (Iglay et al., 2007). 
 
4.1.3.4 Blood Flow 
Declining vascular function is a consequence of ageing which manifests as 
decreased compliance in arteries and arterioles, and ultimately leads to 
chronic high blood pressures and coronary disease (DeSouza et al., 2002; 
Dinenno et al., 1999; Lind & Lithell, 1993). A number of studies have 
reported age-related decrements in large artery blood flow to limbs. For 
instance, elderly humans exhibited 20-30% attenuation in resting PA leg 
blood flow, which was attributed to a 50% increase in leg vascular 
resistance, compared with younger individuals (Donato et al., 2006).  
 
Declines in large arterial blood flow are not only restricted to the PA state 
but are also observed when older individuals are challenged with 
vasodilatory stimuli, such as food intake (Skilton et al., 2005) and exercise 
(Donato et al., 2006; Poole et al., 2003). As adults spend ~40% of their 
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diurnal cycle in the postprandial state deficits in limb blood flow in this 
condition may impact on both glucose transportation/ disposal and also on 
the anabolic responses to feeding as discussed in chapter two. Skilton and 
colleagues demonstrated that meal-related increased in forearm vascular 
reactivity were impaired in both older and diabetic adults with regression 
analysis demonstrating that age was the principal factor in impaired blood 
flow in these groups (Skilton et al., 2005). Furthermore, compromised 
exercise hyperaemia has also been demonstrated, with elderly men 
displaying 20-30% lower leg blood flow (LBF) and leg vascular 
conductance (LVC) than younger men at various exercise workloads 
(Donato et al., 2006) of knee-extensor or whole-body bicycling (Donato et 
al., 2006; Poole et al., 2003).  
 
Both functional and metabolic consequences of declines in LBF responses 
to feeding and exercise have been suggested. First, decreases in LBF 
during/ after exercise may explain decrements in functional performance 
and recovery (e.g. O2 delivery, metabolite clearance etc. (Vincent et al., 
2006)) in ageing skeletal muscles. Second, as LBF regulates delivery of 
insulin and AA for metabolism in skeletal muscles (Clark et al., 2003; 
Timmerman et al., 2010) reduced LBF can contribute to declines in insulin 
sensitivity and muscle protein anabolic responses to feeding and exercise 
with age (Barrett et al., 2009; Clark, 2008; Vincent et al., 2006; Bohe et 
al., 2001; Chesley et al., 1992; Gelfand & Barrett, 1987).   
 
As already mentioned in earlier chapters sarcopenia, and associated 
dynapenia are strong predictors of all cause mortality (Metter et al., 2004) 
and age-related declines in both muscle mass and strength are associated 
with co-morbidities such as falls, fractures and progressive disability 
(Rantanen et al., 1999; Roubenoff, 2000). Although of unknown aetiology, 
there is increasing evidence that age-related declines in vascular function 
may contribute to metabolic dysregulation in skeletal muscles. For 
instance, exercise (Vincent et al., 2006), insulin (Barrett et al., 2009; Clark, 
2008) and mixed-meal feeding (Vincent et al., 2006) have each been 
shown to increase muscle perfusion and each of these stimuli, which are 
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synonymous with MPS (Bohe et al., 2001; Chesley et al., 1992; Gelfand & 
Barrett, 1987) have a blunted effects with ageing. Further evidence for this 
association is shown by increased AA availability during 
hyperinsulinameia, which improved the muscle protein anabolic effect of 
insulin with pharmacological enhancement of muscle perfusion 
(Timmerman et al., 2010).  
 
Exercise is an established intervention for the treatment and prevention of 
many clinical conditions such as cardiovascular disease (CVD), 
sarcopenia, the metabolic syndrome and type 2 diabetes and it may also be 
a promising intervention to prevent the age-related decline in limb blood 
flow (which may be implicated in the aforementioned conditions). 
Improvements in limb blood flow may be beneficial, especially to the 
elderly, who have reduced basal limb blood flow values (Dinenno et al., 
1999). Precise matching of blood flow and metabolism is required for 
virtually all living tissues, especially so for skeletal muscle where activity 
status can alter metabolism considerably (Clifford & Hellsten, 2004). The 
results of a study involving daily aerobic exercise showed that this mode of 
exercise training was unable to attenuate or prevent the age related 
reductions in limb blood flow (Dinenno et al., 2001), but more positive 
results have been found following RET. A cross-sectional study of males 
showed that the decrease in limb blood flow with age was absent in those 
who habitually performed RET (Miyachi et al., 2005). This absence was 
true even when leg blood flow (LBF) was expressed relative to leg muscle 
mass suggesting that RET induces changes other than a larger skeletal 
muscle mass with greater metabolic demands (Anton et al., 2006). 
Evidence for the benefits of exercise on LBF is present even in the young 
as athletes have higher LBF values than inactive age-PDWFKHGLQGLYLGXDO¶V
(Ebeling et al., 1993). 
 
In summary, age-related changes in LBF are purported to contribute to the 
metabolic syndrome, a major precursor to atherosclerotic disease in 
humans that encompasses hyperinsulinaemia, dyslipidaemia and 
hypertension (Lind & Lithell, 1993) and in obese subjects compromised 
 221 
microvascular flow in muscle leads to poor insulin action and therefore 
impaired glucose uptake and storage (Keske et al., 2009; Baron et al., 
1990). Taking all this data together it is likely that methods for maintaining 
ERWKUHVWLQJ3$/%)DQGµDFXWH¶UHVSRQVHVLQ/%)WRYDVRGLODWRU\VWLPXOL
such as exercise and feeding represent an important avenue for preserving 
both muscle and CV health with ageing.  
 
4.2 Methodology 
 
4.2.1 Glucose concentrations 
In keeping with most modern laboratories and recent reports plasma 
glucose levels were measured on a blood glucose analyzer (ILAB 300 Plus 
Clinical Chemistry System, UK). Bloods for this analysis were collected in 
Lithium Heparin tubes and then centrifuged at 4°C at 3200 rpm for 20 min 
before plasma collection.   
 
4.2.2 Insulin concentrations 
Insulin levels were measured using high sensitivity insulin Enzyme-Linked 
ImmunoSorbent Assay (ELISA) systems (Immunodiagnostic systems 
limited (IDS)). Bloods for this analysis were collected in 
Ethylenediaminetetraacetic Acid (EDTA) tubes, and then centrifuged at 
4°C at 3200 rpm for 20 min before plasma collection.  
 
All Enzyme-Linked ImmunoSorbent Assay (ELISA) and Enzyme 
Immunoassay (EIA) systems mentioned in this chapter were processed 
DFFRUGLQJ WR PDQXIDFWXUHU¶V SURWRFRO JXLGDQFH ,Q EULHI PRQRFORQDO
antibodies, directed against distinct epitopes on the test hormone, were pre-
bound to a 96-well plate, to which the calibrators and samples were added 
prior to a secondary antibody labeled with horseradish peroxidase (HRP). 
Any unbound antibody was washed off the plate before a chromogenic 
solution, which reacts with HRP was added. The reaction was stopped with 
hydrochloric acid (HCL) and the optical density read at 450nm against a 
reference filter set at 650nm (Multiskan Ascent plate reader, Ascent 
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software V 2.6, Thermo Scientific, UK) to generate a 4 parameter logistic 
curve from which the sample values could then be read.  
 
4.2.3 Leg blood flow measurements 
Blood flow was measured by Doppler ultrasound (Toshiba Nemio-17). 
Performing Doppler ultrasound measurements on both legs (rested and 
exercised), for the duration of this study at various time-points allowed us 
to observe changes in basal leg blood flow (Basal) before and after the 
RET;  leg blood flow responses to feeding (Fed) and leg blood flow 
response to the combination of exercise-plus-feeding (Ex+Fed). All 
Doppler ultra-sound measurements were taken with the subjects in the 
supine position, with dimmed lighting and no visual or audio stimuli.  A 
single 5 MHz frequency probe (Toshiba Nemio-17) was used to measure 
common femoral artery mean blood velocity (MBV) and arterial lumen 
diameter (Figure 4.6). 
 
Adapted from: http://www.fau.pearlashes.com/anatomy 
Figure 4.6 Artery structure. 
 
The common femoral artery extends from the external iliac artery, the 
artery from where the majority of blood supply to the lower limbs stems 
from with the exception of branches from the internal iliac artery which 
contributes to the supply of the gluteal region. The external iliac artery 
descends from the common iliac artery, which descends from the 
abdominal aorta and passes under the inguinal ligament (Figure 4.7a), at 
the mid-inguinal point to enter the thigh region, where it is re-named the 
femoral artery. The femoral artery lies first in an area known as the 
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µIHPRUDOWULDQJOH¶)LJXUHb), which is defined by the inguinal ligament 
above, the medial border of the sartorius and the medial border of the 
adductor longus. In the femoral triangle the common femoral artery 
bifurcates, giving off a large branch (profunda femoral artery) which arises 
from the back of the femoral artery and then runs distally passing deeply 
between adductor longus and adductor magnus (Figure 4.7c). The deep 
femoral artery forms the principle supply to the thighs giving off medial 
and lateral circumflex arteries and perforating arteries. On leaving the 
µIHPRUDOWULDQJOH¶WKHIHPRUDODUWHU\SDVVHVEHQHDWKsartorius and descends 
along the medial aspect of the thigh lying on adductor magnus and 
adductor longus. The femoral artery then passes through an opening 
between the part of adductor magnus attached to linea aspera and the part 
attached to the adductor tubercle to reach the popliteal fossa at the back of 
the knee where it is renamed the popliteal artery. Throughout its descent 
the femoral artery is accompanied on its medial side by the femoral vein 
(Figure 4.7d). Both lie together within a femoral sheath composed of a 
prolongation of the fascia lining the abdominal cavity.
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Figure 4.7 Femoral artery characteristics. 
 
A. Relative position of the external iliac artery and inguinal ligament; Adapted from: www.maitrise-orthop.com 
B. %RXQGDULHVRIWKHµIHPRUDOWULDQJOH¶; Adapted from: www.gl.ac.uk/ibls/tutorial/anatomy/femoralt.html 
C. A 3-dimensional contrast-enhanced magnetic resonance angiography showing the common femoral artery (CFA) bifurcation to 
superficial femoral artery (SFA) and profunda femoral artery (PFA); Adapted from: www.ensight.com/images/stories.html 
D. An ultrasound image to show the relative proximity of the femoral artery and vein; Adapted from: 
www.altrasonix.com/vascular_04.jpg 
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Measurements were performed ~2-3cm proximal to the bifurcation of the 
femoral artery to minimize turbulence from the bifurcation. The insonation 
angle was <60° to allow a cosine >0 for the calculation of blood flow. 
Arterial lumen diameter was measured by video calipers for each 
measurement and defined as the distance between the media-adventitia 
interface of the near wall and the lumen-intima interface of the far wall of 
the vessel. Ultrasound images were printed (Mitsibushi P93), and 
calculated femoral leg blood flow values were analyzed. Femoral leg blood 
flow (LBF) was calculated as: 
 
LBF (l.min-1) = MBV (cm.sec-1) [ʌ[IHPRUDODUWHU\UDGLXV (mm)) 
2/1000 x 60 
 
Basal LBF measurements using the technique described above were taken 
at 70, 90 and 110 minutes after the study began, with a mean value from 
three measurements taken on each leg uses to obtain the basal value. There 
were no significant differences between the three measurements or 
between the legs. The subjects maintained a supine rested position from the 
beginning of the study until these time points and had been fasted for ~14 
hours with the exception of water. They had not performed any exercise, 
other than activities of daily living in the 72 hrs prior to the study. 
 
Fed blood flow measurements were taken 100, 120 and 140 minutes after 
feeding began. At the first fed blood flow measure subjects had consumed 
5 of the 6 intermittent oral feeds which supplied energy at 4.25 times the 
subjects basal metabolic rate, calculated by standard equations (Schofield, 
1985), with 15% of the total energy being supplied as protein. This 
included a 3-times bolus as the first feed and four further feeds. The leg 
that these measurements were taken from had been completely rested for 
the duration of the study with the exception of having to reposition 
themselves onto the leg extension machine. 
 
Blood flow measurements to assess the response to the combination of 
exercise-plus-feeding were taken at the same time points as those for the 
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response to feeding alone; 100, 120 and 140 minutes after feeding began 
and completion of the exercise; 6 x 8 sets of unilateral leg extensions at 
75% 1-RM, followed by 2 x 10 sets of calf-raises. 
 
Using the Doppler ultrasound technique we found a coefficient of variation 
of 9% for three independent measures under each condition assessed, 
suggesting that we could reliably detect changes of ~18% of the basal 
value.  
 
4.2.4 Muscle protein concentrations by immunoblotting 
Muscle biopsies (~10-20 mg) were homogenized with scissors in ice-cold 
extraction buffer (10 Pl/mg-1) containing 50 mM Tris-HCl (pH 7.4), 0.1% 
Triton X-100, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 0.5 mM activated 
sodium orthovanadate (all Sigma Aldrich, Poole, UK) and a complete 
protease inhibitor cocktail tablet (Roche, West Sussex, UK). Homogenates 
were rotated on a Vibramax for 10 min at 4°C and centrifugeGDW¶J
for 10 min at 4°C before recovery of supernatants representing 
sarcoplasmic fractions. Bradford assays were used to determine 
sarcoplasmic protein concentrations after which samples were standardized 
to 1 mg/ml-1 by dilution with Laemmli loading buffer in order to measure 
relative protein concentrations of our proteins of interest. Samples were 
mixed and heated at 95°C for 5 min before fifteen Pg of protein/lane was 
loaded on to Criterion XT Bis-Tris 12% SDS-PAGE gels (Bio-Rad, Hemel 
Hempstead, UK) for electrophoresis at 200 V for ~60 min. Gels were 
equilibrated in transfer buffer (25 mM Tris, 192 mM glycine, 10% 
methanol) for 30 min before proteins were electroblotted on to 0.2 Pm 
PVDF membranes (Bio-Rad) at 100 V for 30 min. After blocking with 5% 
low-fat milk in TBS-T (Tris Buffered Saline and 0.1% Tween-20; both 
Sigma-Aldrich, Poole, UK) for 1 h, membranes were rotated overnight 
with primary antibody (all AbCam, Cambridge, UK) against our target 
proteins at a concentration of 1:2000 at 4°C. Membranes were washed 
(3×5 min) with TBS-T and incubated for 1 h at room temperature with 
HRP-conjugated anti-rabbit secondary antibody (New England Biolabs, 
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UK), before further washing (3×5 min) with TBS-T and incubation for 5 
min with ECL reagents (enhanced chemiluminescence kit, Immunstar; 
Bio-Rad). Blots were imaged and quantified by assessing peak density 
after ensuring bands were within the linear range of detection using the 
Chemidoc XRS system (Bio-Rad, Hemel Hempstead, UK). Where 
required, phosphorylation of signalling proteins was corrected for loading 
anomalies to an appropriate loading control.  
 
4.2.5 Cytokine concentrations 
Circulating plasma levels of IL-6, IL-10 and TNF-ĮZHUHPHDVXUHGXVLQJ
Luminex xMAP® technology. The Luminex system uses bead-based 
multiplexing to allow up to 100 analytes to be measured from a single 
sample in a traditional 96-well plate. 
 
In brief, 5.6 micron polystyrene microspheres which are internally dyed 
with red and infrared flurophones, are colour coded into 100 distinct sets. 
Each bead set is coated with a reagent specific to a particular bioassay (e.g. 
IL-6), to allow the capture and detection of specific analytes from a 
sample. The Luminex analyser then emits lasers which excite the internal 
dyes that identify each microsphere particle, and also any reporter dye 
captured during the assay. Multiple readings are made on each bead set to 
improve the validity of the results. 
 
4.2.6 Blood pressure and resting heart rate 
Blood pressure and RHR were taken prior to both acute studies. Subjects 
were in a rested state for 20 minutes prior to the measurements and are un-
stimulated throughout. Measurements were taken on an OMRON blood 
pressure machine (OMRON Healthcare Inc), with 3 measurements taken at 
each session and the mean value calculated. Mean arterial blood pressure 
(MAP) was calculated from these values using the formula: 
 
0$3 Ҁ'LDVWROLFEORRGSUHVVXUHѿ6\VWROLF blood pressure) 
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Blood pressure was also recorded during the acute studies at the same time 
as Doppler blood flow measurements were made. MAP calculated from 
blood flow measurements (as shown above) was used to calculate leg 
vascular conductance (LVC) and leg vascular resistance (LVR): 
 
LVC (l.min-1·100mmHg-1) = LBF (l.min-1)/MAP x 100 
LVR (l.min-1·100mmHg-1) = MAP/Q/LBF (l.min-1) 
 
4.2.7 Cholesterol profiles  
Fasted serum cholesterol profiles were produced by the clinical chemistry 
department at Derby City General Hospital, UK by analysis of blood 
samples collected in serum separator tubes (SST).  Bloods for this analysis 
were collected and then centrifuged at 4°C at 3200 rpm for 20 min before 
serum collection. Profile results reported TC, LDL cholesterol and HDL 
cholesterol. 
 
4.3 Results 
 
4.3.1 Risk factors for type 2 diabetes 
4.3.1.1 Glucose handling and uptake 
There were no significant differences in the postprandial plasma glucose 
area under the curve (AUC) between the age groups either before or after 
RET. The young group had a reduced postprandial plasma glucose AUC 
after RET (43.64±1.31 vs. 39.82±1.20, P<0.01). The middle-aged and old 
groups AUC were unaffected by RET (Figure 4.8 and 4.9). 
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Figure 4.8 Time-course of postabsorptive and postprandial plasma glucose 
values in young, middle-aged and older subjects before and after RET. 
Values are means±SEM. Statistical analysis via ANOVA with Bonferroni 
post analysis on AUC values. 
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Figure 4.9 Postprandial glucose AUC in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis and students t-test. **=P<0.01 
vs. the same group before RET. 
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There were no significant differences in fasting glucose values between the 
age-groups either before or after RET. RET did not change the fasting 
glucose values in any of the age-groups (Figure 4.10). 
 
 
Figure 4.10 Fasting glucose values for young, middle-aged and old 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis DQGVWXGHQW¶VW-test. 
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Peak glucose in the postprandial condition was no different between the 
groups before RET (Y, 7.93±0.29; M, 7.56±0.37; O, 8.23±0.40). After 
RET the young group displayed a significant reduction in their peak 
glucose (7.93±0.29 vs. 6.73±0.29, P<0.05), while the middle-aged group 
displayed a significant increase (7.56±0.37 vs. 8.28±0.28, P<0.05). The 
most marked change was in the old who also displayed a significant 
reduction in their peak glucose after RET (8.23±0.40 vs. 7.59±0.32, 
P<0.01). After RET the peak glucose of the young was significantly lower 
than that of the middle-aged (6.73±0.29 vs. 8.28±0.28, P<0.05) (Figure 
4.11).  
 
 
Figure 4.11 Peak glucose values in the postprandial condition for young, 
middle-aged and old subjects before and after RET. Values are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis DQGVWXGHQW¶VW-test. *=P<0.05 vs. pre-training, **=P<0.01 vs. pre-
training. 
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4.3.1.2 Insulin action and sensitivity 
Postprandial plasma insulin AUC was not different between the age groups 
either before or after RET. RET did not significantly affect the 
postprandial plasma insulin AUC in any of the age groups although there 
was a trend for it to be lower in the young after RET (181.95±21.06 vs. 
146.19±17.11, P=0.05) (Figure 4.12 and 4.13). 
 
Figure 4.12 Postprandial insulin AUC in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis and students t-test.  
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Figure 4.13 Time-course of postabsorptive and postprandial plasma 
insulin values in young, middle-aged and older subjects before and after 
RET. Values are means±SEM. Statistical analysis via ANOVA with 
Bonferroni post analysis on AUC values.  
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When all of the subjects were grouped together irrespective of age there 
was a significant reduction in HOMA values after RET (1.32±0.13 vs. 
1.03±0.06, P<0.01) (Figure 4.14). 
 
Figure 4.14 HOMA values for all subjects before and after RET. Values 
DUH PHDQV6(0 6WDWLVWLFDO DQDO\VLV YLD VWXGHQW¶V W-test. **=P<0.01 vs. 
pre-training. 
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Fasting insulin values were not significantly different between the age-
groups before or after RET (before: Y, 4.37±0.47; M, 4.41±0.52; O, 
4.89±0.58; after: Y, 5.08±0.31; M, 3.55±0.37; O, 4.68±0.40 µUnits/ml). 
Only the middle-aged group had a difference in their fasting insulin values 
after RET demonstrating a reduction from 4.41±0.52 to 3.55±0.37 
µUnits/ml (P<0.05) (Figure 4.15).  
 
 
Figure 4.15 Fasting insulin values for young, middle-aged and old subjects 
before and after RET. Values are means±SEM. Statistical analysis via 
ANOVA with Bonferroni post analysis DQGVWXGHQW¶V W-test. *=P<0.05 vs. 
pre-training. 
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Mirroring the results seen with fasting insulin values, only the middle-aged 
group showed a change in their glucose/insulin ratio after RET with it 
increasing from 1.52±0.15 to 1.84±0.17 (P<0.05). There was no difference 
LQ WKH JOXFRVHLQVXOLQ UDWLR¶V EHWZHHQ WKH DJH-groups before RET (Y, 
1.28±0.15; M, 1.52±0.15; O, 1.42±0.17) but the middle-aged was higher 
than the young after RET (1.84±0.17 vs. 1.07±0.06, P<0.01) (Figure 4.16). 
 
Figure 4.16 Glucose: LQVXOLQ UDWLR¶V IRU \RXQJ PLGGOH-aged and old 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via ANOVA with Bonferroni post analysis DQGVWXGHQW¶V W-test. *=P<0.05 
vs. pre-training. 
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Both the middle-aged and the old groups had significantly reduced HOMA 
values after RET (M: 1.13±0.17 vs. 0.88±0.11 ; O: 1.70±0.28 vs. 
1.11±0.12,  P<0.05). Before RET the HOMA value of the old group was 
significanltly higher than the middle-aged and young groups (1.70±0.28 vs. 
1.13±0.17 and 1.12±0.16, respectively, P<0.05), however after RET there 
was no difference in the HOMA values between the age-groups (Figure 
4.17). QUICKI values showed an identical pattern of change. 
 
Figure 4.17 HOMA values for young, middle-aged and old subjects before 
and after RET. Values are means±SEM. Statistical analysis via ANOVA 
with Bonferroni post analysis DQG VWXGHQW¶V W-test. *=P<0.05 vs. pre-
training. 
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Peak fed insulin was not significantly different between the age-groups 
either before or after RET. There was a trend for all three age-groups to 
reduce their peak fed insulin after RET (Y: 68.60±8.77 vs. 53.93±9.04; M: 
47.63±7.40 vs. 39.25±4.61; O: 56.68±9.67 vs. 43.96±4.61, P<0.1) (Figure 
4.18). 
 
 
Figure 4.18 Peak insulin values in the postprandial condition for young, 
middle-aged and old subjects before and after RET. Values are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis and VWXGHQW¶VW-test.  
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4.3.1.2.1 Molecular markers of insulin signalling 
Before RET all three age-groups demonstrated increased AKT 
phosphorylation in response to feeding alone (1.00±0.00 vs. Y: 1.26±0.06, 
P<0.001; M: 1.14±0.04, P<0.01; O: 1.17±0.04, P<0.01) and to the 
combination of exercise-plus-feeding (1.00±0.00 vs. Y: 1.24±0.07; M: 
1.25±0.05; O: 1.20±0.05, all P<0.001). After RET all three groups still 
responded to both feeding alone (Y: 0.97±0.08 vs. 1.19±0.06, P<0.01; M: 
1.00±0.06 vs. 1.21±0.06, P<0.001; O: 0.96±0.04 vs. 1.16±0.05, P<0.001) 
and exercise-plus-feeding (Y: 0.97±0.08 vs. 1.28±0.06; M: 1.00±0.06 vs. 
1.22±0.06; O: 0.96±0.04 vs. 1.29±0.05, all P<0.001), with the old 
displaying an additive effect of exercise-plus-feeding compared to feeding 
alone (1.16±0.05 vs. 1.29±0.05, P<0.05). At no time point was there any 
differences between the age-groups (Figure 4.19). 
 
 
Figure 4.19 Effect of RET on AKT phosphorylation in young, middle-
aged and old subjects. *= P<0.05 vs. basal pre-training; #= P<0.05 vs. 
basal post-WUDLQLQJ Á  3 YV IHG SRVW-training. All via 2-way 
ANOVA with Tukey post-hoc analysis. 
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Before RET only the young demonstrated increased IRS-1 protein 
concentration in response to feeding alone (1.00±0.00 vs. 1.19±0.04, 
P<0.01) or exercise-plus-feeding (1.00±0.00 vs. 1.20±0.07, P<0.01). After 
RET all three age-groups displayed increased IRS-1 protein concentration 
after exercise-plus-feeding when compared to basal values (Y: 1.01±0.06 
vs. 1.27±0.05, P<0.001; M: 0.95±0.04 vs. 1.07±0.05, P<0.05; O: 
1.01±0.03 vs. 1.15±0.04, P<0.01). After RET in response to exercise-plus-
feeding the young had significantly higher levels of IRS-1 than the middle-
aged group (1.27±0.05 vs. 1.07±0.05, P<0.05) (Figure 4.20). 
 
 
Figure 4.20 Effect of RET on Total IRS-1 concentration in young, middle-
aged and old subjects. *= P<0.05 vs. basal pre-training; #= P<0.05 vs. 
basal post-training; a= P<0.05 vs. young in the same condition. All via 2-
way ANOVA with Tukey pos-hoc analysis. 
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Before RET the young and the old groups showed increased PRAS 40 
protein concentration after feeding alone (1.00±0.00 vs. Y: 1.19±0.04; O: 
1.15±0.02, P<0.001) with all three age-groups showing increased PRAS 40 
protein concentration after exercise-plus-feeding (1.00±0.00 vs. Y: 
1.28±0.04, P<0.001; M: 1.10±0.03, P<0.05; O:  1.17±0.04, P<0.001) with 
the concentration significantly higher in the young than in the middle-aged 
after exercise-plus-feeding (1.28±0.04 vs. 1.10±0.03, P<0.01). All three 
age-groups maintained these increases after RET in response to both 
feeding alone (Y: 1.02±0.03 vs. 1.14±0.04; M: 0.92±0.04 vs. 1.06±0.05; O: 
0.98±0.03 vs. 1.13±0.04) and exercise-plus-feeding (Y: 1.02±0.03 vs. 
1.23±0.04; M: 0.92±0.04 vs. 1.09±0.05; O: 0.98±0.03 vs. 1.14±0.05 ) with 
no significant differences between the age-groups after RET (Figure 4.21). 
 
 
Figure 4.21 Effect of RET on Total PRAS-40 concentration in young, 
middle-aged and old subjects. *= P<0.05 vs. basal pre-training; #= P<0.05 
vs. basal post-training; a= P<0.05 vs. young in the same condition. All via 
2-way ANOVA with Tukey post-hoc analysis. 
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Before RET only the middle-aged demonstrated increased AS160 protein 
concentrations in response to feeding alone (1.00±0.00 vs. 1.14±0.04, 
P<0.01) while all three age-groups increased AS160 protein concentrations 
in response to exercise-plus-feeding both before (Y: 1.00±0.00 vs. 
1.15±0.07, P<0.05; M: 1.00±0.00 vs. 1.23±0.07, P<0.001; O: 1.00±0.00 
vs. 1.12±0.04) and after RET (Y: 1.03±0.02 vs. 1.21±0.05, P<0.01; M: 
1.05±0.06 vs. 1.23±0.05, P<0.001; O: 0.90±0.04 vs. 1.04±0.05, P<0.01). 
Before RET the combined stimuli of exercise-plus-feeding had an additive 
effect compared to feeding alone in the old group (1.01±0.05 vs. 
1.12±0.04, P<0.05) while after RET both the middle-aged and the old 
groups increased AS160 protein concentration in response to feeding alone 
(M: 1.05±0.06 vs. 1.16±0.04, P<0.04; O: 0.90±0.04 vs. 1.01±0.04), 
although in the old this may be attributable to the unexpected depression in 
basal values after RET. The AS160 protein concentration was higher in the 
middle-aged than in the old following exercise-plus-feeding after RET 
(1.23±0.05 vs. 1.04±0.05, P<0.05). The basal protein concentration of 
AS160 was significantly lower in the old after RET compared to before 
(1.00±0.00 vs. 0.90±0.04, P<0.05) (Figure 4.22) 
. 
 
Figure 4.22 Effect of RET on Total AS160 concentration in young, 
middle-aged and old subjects. *= P<0.05 vs. basal pre-training; #= P<0.05 
vs. basal post-WUDLQLQJ   3 YV IHG SUH-training; b= P<0.05 vs. 
middle-aged in the same condition. All via 2-way ANOVA with Tukey 
pos-hoc analysis. 
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Before RET only the young showed a greater AKT substrate signature 
after feeding alone (1.00±0.00 vs. 1.13±0.04, P<0.01) while all groups 
demonstrated an increased signature after exercise-plus-feeding (1.00±0.00 
vs. Y: 1.19±0.05, P<0.001; M: 1.15±0.04, P<0.001; O: 1.09±0.3, P<0.05). 
After RET the middle-aged and the old groups responded to feeding alone 
(M: 1.01±0.04 vs. 1.10±0.03, P<0.01; O: 0.93±0.03 vs. 1.02±0.03, 
P<0.05), again with all three groups responding to exercise-plus-feeding 
(Y: 1.03±0.03 vs. 1.19±0.03, P<0.001; M: 1.01±0.04 vs. 1.11±0.04, 
P<0.01; O: 0.93±0.03 vs. 1.03±0.03, P<0.01). Before RET the middle-
aged group showed a greater signature after exercise-plus-feeding 
compared to feeding alone (1.06±0.05 vs. 1.15±0.04, P<0.05) and the AKT 
substrate signature after exercise-plus-feeding was higher in the young 
than in the old after RET (1.19±0.03 vs. 1.03±0.03, P<0.05) (Figure 4.23) 
.  
 
Figure 4.23 Effect of RET on Total AKT substrate concentration in young, 
middle-aged and old subjects. *= P<0.05 vs. basal pre-training; #= P<0.05 
vs. basal post-WUDLQLQJ 3YVIHGSUH-training; a= P<0.05 vs. young 
in the same condition. All via 2-way ANOVA with Tukey post-hoc 
analysis. 
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4.3.1.3 Leg blood flow 
Relationship between basal leg blood flow and age 
LBF was normalized to lean leg mass with results identical to the non-
normalised data presented. 
 
Before and after RET there was no difference in basal LBF between the 
age groups. To determine the true relationship between basal LBF and age, 
we searched for a linear correlation with age (Figure 4.24). We found that 
both before and after RET LBF in the basal state declined with age 
(P<0.05). 
 
Figure 4.24 Relationship between basal femoral artery blood flow and age. 
Statistical aQDO\VLVE\3HDUVRQ¶VFRUUHODWLRQ 
 
 
 
 
 
 
 
 
 
 
 
 246 
 
Effects of feeding and exercise-plus-feeding on leg blood flow before and 
after RET 
Before RET, only the young group demonstrated a significant increase in 
LBF in response to feeding alone (P<0.01). The post-feeding LBF in the 
young was significantly higher than in the middle-aged (P<0.05) and older 
groups (P<0.001) before RET, with no significant difference between the 
values in the middle-aged and older groups.  
 
After RET the young and middle-aged groups demonstrated a significant 
LBF response to feeding alone (P<0.01) and fed LBF values were 
significantly higher in the middle-aged group than before RET (+30%, 
P<0.05).  
 
Before RET the young and middle-aged groups did respond to exercise-
plus-feeding (P<0.001), whereas those in the older group did not. Before 
RET, LBF values after exercise-plus-feeding were significantly higher in 
the young group compared to the older group (1.00±0.10 vs. 0.57±0.04 
l.min-1, P<0.001), with LBF values in the middle-aged group also 
significantly higher than in the older group (0.83±0.06 vs. 0.57±0.04 l.min-
1
, P<0.05) 
  
After RET all three age groups demonstrated a significant increase in LBF 
in response to exercise-plus-feeding (Y: +78.4±10.3%; M: +95.7±14.6%; 
O: +79.8±19.0%, all P<0.001), with LBF values significantly higher after 
exercise-plus-feeding than after feeding alone in all three age-groups 
(P<0.001). After RET, the LBF values in response to exercise-plus-feeding 
were significantly higher in the older group than before RET (+59.5±14%, 
P<0.001) such that the LBF values in the older group were no longer 
significantly different to those in the middle-aged group (Figure 4.25).  
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Figure 4.25 Effect of RET on femoral artery blood flow in young, middle-
aged and older subjects. Values are means±SEM. Statistical analysis via 2-
way ANOVA with Bonferroni post analysis. **= P<0.01 vs. basal pre-
training; ***= P<0.001 vs. basal pre-WUDLQLQJ 3YVEDVDOSRVW-
WUDLQLQJ 3YVEDVDOSRVW-WUDLQLQJÁ 3YVIHHGLQJSUH-
WUDLQLQJ ÁÁ  3 YV IHHGLQJ SUH-WUDLQLQJ ÁÁÁ  3 YV IHHGLQJ
pre-training; ### = P<0.001 vs. feeding post-training; ¶¶¶= P<0.001 vs. 
exercise-plus-feeding pre-training. 
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Relationships between leg blood flow responses to feeding/ exercise-plus-
feeding and age 
When we examined the data for relationships between LBF responses to 
feeding and to exercise-plus-feeding and age we found that before RET the 
responses to feeding and to exercise-plus-feeding were significantly 
blunted with advancing age but these age-related decreases were not 
apparent after RET (Figures 4.26 and 4.27). 
 
 
Figure 4.26 Effect of RET on the relationship between increases in 
femoral artery blood flow after feeding and age. Statistical analysis by 
3HDUVRQ¶VFRUUHODWLRQ 
 
 249 
 
 
Figure 4.27 Effect of RET on the relationship between increases in 
femoral artery blood flow after exercise-plus-feeding and age. Statistical 
DQDO\VLVE\3HDUVRQ¶VFRUUHODWLRQ 
 
4.3.1.4 Leg Vascular Conductance 
Relationships between basal limb vascular conductance and age  
Basal LVC was significantly greater in the young than in the old before 
RET (0.56±0.06 vs. 0.36±0.03 l·min-1·100mmHg-1, P<0.01). After RET, 
basal LVC in the older group was significantly higher (0.36±0.03 vs. 
0.47±0.04 l·min-1·100mmHg-1, P<0.001) and there was a trend for it to also 
be higher in the middle-aged group (0.43±0.05 vs. 0.50±0.04 l·min-
1
·100mmHg-1, P=0.095). After RET there were no significant differences 
in basal LVC between the age-groups (Y: 0.63±0.06, M: 0.50±0.04, O: 
0.47±0.04 l·min-1·100mmHg-1). 
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Limb vascular conductance in response to feeding and exercise-plus-
feeding before and after RET 
Before RET only the young demonstrated an increased LVC in response to 
feeding (0.56±0.06 vs. 0.78±0.10 l·min-1·100mmHg-1, P<0.01), after RET 
the young (0.63±0.06 vs. 0.86±0.08 l·min-1·100mmHg-1, P<0.001) and the 
middle-aged groups (0.50±0.04 vs. 0.67±0.04 l·min-1·100mmHg-1, P<0.01) 
demonstrated increased LVC in response to feeding. All three age-groups 
responded to exercise-plus-feeding with increased LVC both before (Y: 
0.56±0.06 vs. 0.98±0.09, P<0.001, M: 0.43±0.05 vs. 0.77±0.05, P<0.001, 
O: 0.36±0.03 vs. 0.50±0.04 l·min-1·100mmHg-1, P<0.05) and after RET (Y: 
0.63±0.06 vs. 1.12±0.09, M: 0.50±0.04 vs. 0.89±0.05, O: 0.47±0.04 vs. 
0.81±0.08 l·min-1·100mmHg-1, all P<0.001) with the increase in the old 
significantly greater after RET (49±11 vs. 80±19%, P<0.01). Before RET 
the young and middle-aged groups demonstrated a further increase in LVC 
in response to exercise-plus-feeding compared to feeding alone (Y: 
0.78±0.10 vs. 0.98±0.09, P<0.01, M: 0.53±0.04 vs. 0.77±0.05 l·min-
1
·100mmHg-1, P<0.001), an increase that could be seen in all three age-
groups after RET (Y: 0.86±0.08 vs. 1.12±0.09, M: 0.67±0.04 vs. 
0.89±0.05, O: 0.55±0.06 vs. 0.81±0.08 l·min-1·100mmHg-1, all P<0.001). 
LVC in response to feeding was significantly higher in the middle-aged 
and older groups after RET (M: 0.53±0.04 vs. 0.67±0.04, O: 0.41±0.05 vs. 
0.55±0.06 l·min-1·100mmHg-1, both P<0.05). LVC in response to exercise-
plus-feeding was significantly higher in the young and the old after RET 
(Y: 0.98±0.09 vs. 1.12±0.09, P<0.05, O: 0.50±0.04 vs. 0.81±0.08 l·min-
1
·100mmHg-1, P<0.001) such that the LVC in the old after RET was not 
significantly different to that of the young before RET, effectively 
restoring LVC in this condition (Figure 4.28). 
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Figure 4.28 Effect of RET on leg vascular conductance in young, middle-
aged and older subjects. Values are means±SEM. Statistical analysis via 2-
way ANOVA with Bonferroni post analysis. *= P<0.05 vs. basal pre-
training; **= P<0.01 vs. basal pre-training; ***= P<0.001 vs. basal pre-
WUDLQLQJ 3YVEDVDOSRVW-WUDLQLQJ 3YVEDVDOSRVW-
WUDLQLQJÁ 3YV IHHGLQJSUH-WUDLQLQJÁÁ 3YV IHHGLQJSUH-
WUDLQLQJÁÁÁ 3YVIHHGLQJSUH-training; ### = P<0.001 vs. feeding 
post-training; ¶= P<0.05 vs. exercise-plus-feeding pre-training; ¶¶¶= 
P<0.001 vs. exercise-plus-feeding pre-training. 
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4.3.1.5 Leg Peripheral Resistance 
Before RET basal leg peripheral resistance (LPR) was lower in the young 
group that in the old (63.15±5.51 vs. 41.16±4.54, P<0.001) and LPR after 
feeding alone was lower in the young (58.28±5.63 vs. 30.93±3.83, 
P<0.001) and the middle-aged groups (58.28±5.63 vs. 41.80±3.20, P<0.01) 
compared to the old; this was also true after exercise-plus-feeding 
(44.55±3.98 vs. Y: 23.20±2.71 and M: 28.47±1.99, P<0.01). After RET 
there were no significant difference in LPR between the age groups in any 
of the three conditions, effectively restoring the LPR of the old to that of 
younger individuals. 
 
Before RET, in the young, both feeding (41.16±4.54 vs. 30.93±3.83, 
P<0.05) and exercise-plus-feeding (41.16±4.54 vs. 23.20±2.71, P<0.001) 
reduced LPR. After RET only exercise-plus-feeding reduced LPR 
(35.43±3.23 vs. 19.72±2.05, P<0.001) but this may be attributable to the 
lowered (albeit not significantly) basal value (41.16±4.54 vs. 35.43±3.23).  
 
As with the young, before RET the middle-aged group demonstrated 
reduced LPR in response to feeding and exercise-plus-feeding (55.09±4.86 
vs. 41.80±3.20 and 28.47±1.99 respectively, P<0.001). The LPR was 
significantly lower after exercise-plus-feeding compared to feeding alone 
(P<0.001). After RET the middle-aged group displayed reduced basal LPR 
compared to before RET (55.09±4.86 vs. 44.08±3.15, P<0.01) and still 
demonstrated reduced LPR after both feeding alone and exercise-plus-
feeding (44.08±3.15 vs. 31.67±1.70 and 23.94±1.52 respectively, 
P<0.001). The LPR after feeding alone was significantly lower after RET 
(41.80±3.20 vs. 31.67±1.70, P<0.01). 
 
The old group showed reduced LPR only after exercise-plus-feeding 
before RET (63.15±5.51 vs. 44.55±3.98, P<0.001) and this was lower that 
the LPR after feeding alone (58.28±5.63 vs. 44.55±3.98, P<0.001). After 
RET the old group had significantly lower basal LPR than before RET 
(63.15±5.51 vs. 47.14±3.94, P<0.001) and demonstrated a further 
reduction after exercise-plus-feeding (47.14±3.94 vs. 28.42±2.70, 
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P<0.001). After RET the LPR after feeding alone (58.28±5.63 vs. 
43.99±5.21, P<0.01) and after exercise-plus-feeding (44.55±3.98 vs. 
28.42±2.70, P<0.001) was significantly lower compared to the same 
condition before RET (Figure 4.29).   
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Figure 4.29 Effect of RET on leg peripheral resistance in young, middle-
aged and older subjects. Values are means±SEM. Statistical analysis via 2-
way ANOVA with Bonferroni post analysis. *= P<0.05 vs. basal pre-
training; **= P<0.01 vs. basal pre-training; ***= P<0.001 vs. basal pre-
WUDLQLQJ 3YVEDVDOSRVW-WUDLQLQJÁÁ 3YVIHHGLQJSUH-
WUDLQLQJÁÁÁ 3YVIHHGLQJSUH-training; ### = P<0.001 vs. feeding 
post-training; ¶¶¶= P<0.001 vs. exercise-plus-feeding pre-training; = 
P<0.05 vs. old in the same condition; = P<0.01 vs. old in the same 
condition; = P<0.001 vs. .old in the same condition. 
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4.3.1.6 Molecular markers of endothelial capacity and vasodilatory action 
There were no differences in basal muscle concentrations of Alpha-
adrenergic UHFHSWRU  Į-1) between the age groups before or after RET. 
RET had no effect on these protein concentrations (Figure 4.30). 
 
 
Figure 4.30 Protein expression of Alpha-adrenergic receptor 1 in young, 
middle-aged and older subjects before and after RET. Values are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis. 
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There were no differences in basal muscle concentrations of Beta-
DGUHQHUJLF UHFHSWRU  ȕ-1) between the age groups before or after RET. 
RET had no effect on these protein concentrations (Figure 4.31). 
 
 
Figure 4.31 Protein expression of Beta-adrenergic receptor 2 in young, 
middle-aged and older subjects before and after RET. Values are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis. 
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There were no differences in basal muscle concentrations of Platelet 
endothelial cell adhesion molecule-1 (PECAM) between the age groups 
before or after RET. RET had no effect on these protein concentrations 
(Figure 4.32). 
 
 
Figure 4.32 Protein expression of Platelet endothelial-cell adhesion 
molecule in young, middle-aged and older subjects before and after RET. 
Values are means±SEM. Statistical analysis via ANOVA with Bonferroni 
post analysis. 
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Endothelial nitric oxide synthase (eNOS) phosphorylation was unchanged 
by feeding or exercise-plus-feeding before and after RET and was not 
changed in any age-group by RET. Before RET eNOS phosphorylation in 
response to feeding alone was higher in the middle-aged group than the old 
(1.09±0.06 vs. 0.92±0.04, P<0.05) (Figure 4.33). 
 
 
Figure 4.33 Endothelial nitric oxide synthase phosphorylation in young, 
middle-aged and older subjects before and after RET. Values are 
means±SEM. Statistical analysis via 2-way ANOVA with Bonferroni post 
analysis. b=P<0.05 vs. middle-aged in the same condition. 
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PKC-alpha (PKC-Į SKRVSKRU\ODWLRQ ZDV XQFKDQJHG E\ IHHGLQJ RU
exercise-plus-feeding in the young and old groups before and after RET. In 
the middle-aged group feeding alone increased PKC-Į SKRVSKRU\ODWLRQ
before RET (1.00±0.00 vs. 1.05±0.02, P<0.01) and phosphorylation in 
response to exercise-plus-feeding was significantly higher after RET 
compared to before (1.08±0.02 vs. 1.10±0.03, P<0.05). PKC-Į
phosphorylation after exercise-plus-feeding was significantly higher in the 
middle-aged group compared to the old before (1.08±0.02 vs. 0.96±0.02, 
P<0.05) and after (1.10±0.03 vs. 0.99±0.02, P<0.05) RET, this was also 
true in the basal state after RET (1.08±0.02 vs. 0.97±0.02, P<0.05) (Figure 
4.34). 
 
 
Figure 4.34PKC-alpha phosphorylation in young, middle-aged and older 
subjects before and after RET. Values are means±SEM. Statistical analysis 
via 2-way ANOVA with Bonferroni post analysis. *=P<0.05 vs. basal pre; 
¶=P<0.05 vs. the same condition pre-training; b=P<0.05 vs. middle-aged in 
the same condition. 
 
4.3.2 Risk factors for cardiovascular disease 
4.3.2.1 Blood pressure and resting heart rate 
Before RET MAP was significantly lower in the young than in the middle-
aged (105±2 vs. 114±2, P<0.05) and older groups (105±2 vs. 120±2, 
P<0.001). The MAP in both the middle-aged (114±2 vs. 105±2, P<0.001) 
and older groups (120±2 vs. 111±2, P<0.001) were significantly lower 
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after RET; such that there was no difference between the MAP of the three 
groups after RET (Y, 105±2; M, 105±2; O, 111±2).  
 
There was no difference in the RHR between the age groups either before 
(Y, 68±2; M, 64±2; O, 67±3) or after RET (Y, 60±2; M, 57±2; O, 65±2), 
although the RHR of the young and middle-aged groups were significantly 
lower after RET (P<0.001) (Figure 4.35). 
 
Figure 4.35 Mean arterial pressure and resting heart rate in young, middle-
aged and older subjects before and after RET. Values are means±SEM. 
Statistical analysis via ANOVA with Bonferroni post-analysis and 
VWXGHQW¶VW-test. ***=P<0.001 vs. pre-training.   
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4.3.2.2 Cholesterol profiles 
Total cholesterol levels were not significantly different between the age-
groups either before (Y, 4.28±0.44; M, 4.78±0.27; O, 4.87±0.28) or after 
RET (Y, 4.4±0.48; M, 4.59±0.21; O, 5.04±0.25). RET had no effect on the 
total cholesterol levels in any of the age-groups. 
 
Neither LDL nor HDL cholesterol levels were altered after RET in any of 
the age-groups. LDL cholesterol levels were not different between the age 
groups either before (Y, 2.66±0.44; M, 3.0±0.28; O, 3.11±0.23) or after 
RET (Y, 2.86±0.50; M, 2.86±0.20; O, 3.2±0.21). The same was true for 
HDL cholesterol (before: Y, 1.21±0.09; M, 1.25±0.06; O, 1.22±0.09, after: 
Y, 1.18±0.11; M, 1.25±0.06; O, 1.33±0.11) (Figure 4.36). 
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Figure 4.36 Total cholesterol, high density lipoprotein cholesterol and low 
density lipoprotein cholesterol in young, middle-aged and older subjects 
before and after RET. Values are means±SEM. Statistical analysis via 
ANOVA with Bonferroni post analysis and students t-test. 
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Neither total cholesterol: HDL (TC: HDL) ratios nor LDL: HDL 
cholesterol ratios were altered after RET in any of the age-groups. TC: 
HDL ratios were not different between the age groups either before (Y, 
3.70±0.47; M, 3.96±0.28; O, 4.18±0.34) or after RET (Y, 3.47±0.42; M, 
3.79±0.23; O, 4.01±0.33). The same was true for LDL: HDL cholesterol 
ratios (before: Y, 2.35±0.51; M, 2.66±0.25; O, 2.67±0.27, after: Y, 
2.09±0.46; M, 2.52±0.21; O, 2.58±0.28). 
 
Triglyceride levels were significantly lower in the young than the middle-
aged and old both before and after RET (before: 0.88±0.07 vs. 1.14±0.11 
and 1.18±0.14, respectively, after: 0.79±0.09 vs. 1.05±0.08 and 1.12±0.09, 
respectively). Triglyceride levels were not significantly different between 
the middle-aged and old either before or after RET. RET had no effect on 
the triglyceride levels in any of the age-groups (Figure 4.37). 
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Figure 4.37 Total cholesterol: high density lipoprotein cholesterol, low 
density lipoprotein cholesterol: high density lipoprotein cholesterol and 
triglycerides in young, middle-aged and older subjects before and after 
RET. Values are means±SEM. Statistical analysis via ANOVA with 
Bonferroni post analysis and students t-test. *=P<0.05 vs. young pre, 
#=P<0.05 vs. young post. 
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4.3.2.3 Cytokines 
There were no differences in basal plasma concentrations of the classic 
inflammatory markers TNF-Į RU ,/-6 between the age groups before or 
after RET and RET had no effect on these cytokine concentrations. There 
were no significant differences in IL-10 concentrations between the age-
groups before or after RET, although the young did demonstrate 
significantly higher IL-10 after RET (P<0.05) (Figure 4.38).  
 
There were also no differences in basal plasma levels of interleukin-8 (IL-
8), IL-Į, transforming growth factor beta (TGF-ȕ), interferon-gamma 
(IFN-Ȗ), monocyte chemoattractant protein-1 (MCP-1), MCP-2, stromal 
cell-derived factor-1 beta (SDF-ȕ), monokine induced by IFN-gamma 
(MIG) or granulocyte colony-stimulating factor (GCSF) between the age-
groups before or after RET and levels of these cytokines were unchanged 
by RET (Table 4.6). 
 
In addition there were no differences in basal plasma concentrations of IL-
ȕ ,/-16, IL-4, IL-2, IL-12, IL-15, granulocyte-macrophage colony-
stimulating factor (GM-CSF), regulated upon activation, normal T-cell 
expressed and secreted (RANTES), IFN-ȕ PDFURSKDJH LQIODPPDWRU\
protein-1 alpha (MIP-Į RU 0,3-ȕ EHWZHHQ WKH DJH-groups before or 
after RET although at least one of the age-groups did have significantly 
altered levels of these cytokines after RET. GM-CSF was the only cytokine 
increased in all three age-groups following RET (Y, P<0.01; M, P<0.01; 
O, P<0.05). IL-ȕ ,/-16 and IL-2 were significantly higher in the young 
following RET (P<0.01). RANTES (P<0.01), IFN-ȕ P<0.001), IL-15 
(P<0.05) and MIP-ȕP<0.05) were increased only in the old group after 
RET. IL-4 was increased in the middle-aged and old group following RET 
(P<0.001 and <0.05, respectively) while IL-12 and MIP-ĮZHUHKLJKHULQ
both the middle-aged (IL 12, P<0.05; MIP-ĮP<0.01) and old group (IL 
12, P<0.001; MIP-ĮP<0.01) after RET (Table 4.6).  
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Figure 4.38 Plasma concentrations of TNF-Į ,/-6 and IL-10 in young, 
middle-aged and older subjects before and after RET. Values are 
means±SEM. Statistical analysis via ANOVA with Bonferroni post 
analysis and students t-test. *=P<0.05 vs. young pre. 
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Table 4.6 Cytokine concentrations before and after RET  
 
Cytokine Young Middle-aged Old 
pre post pre post Pre post 
TNF-Į 1.6500± 
0.0900 
1.7600± 
0.1100 
1.8200± 
0.0600 
1.8400± 
0.0800 
1.7100± 
0.1200 
1.9400± 
0.1100 
IL-6 0.4200±   
0.1100 
0.3000±     
0.0400 
0.3400±    
0.0200 
0.3600±     
0.0300 
0.3600±    
0.0500 
0.3700±     
0.0500 
IL-10 0.4500± 
0.0300 
0.5600± 
0.0900* 
0.5100± 
0.0500 
0.5000± 
0.0400 
0.5300± 
0.0800 
0.6600± 
0.1200 
IL-8 0.0017± 
0.0002 
0.0019± 
0.0002 
0.0022± 
0.0002 
0.0021± 
0.0002 
0.0020± 
0.0002 
0.0030± 
0.0006 
IL-Į 0.0051± 
0.0003 
0.0055± 
0.0005 
0.0055± 
0.0002 
0.0058± 
0.0002 
0.0055± 
0.0004 
0.0066± 
0.0006 
IL-ȕ 0.0057± 
0.0003 
0.0073± 
0.0006** 
0.0056± 
0.0004 
0.0062± 
0.0003 
0.0060± 
0.0007 
0.0064± 
0.0008 
IL-16 0.3988± 
0.0365  
0.4694± 
0.0505** 
0.3894± 
0.0411 
0.3713± 
0.0373 
0.3734± 
0.0677 
0.3993± 
0.0449 
IL-4 0.2001± 
0.0130 
0.2808± 
0.0214*** 
0.2223± 
0.0121 
0.2403± 
0.0100* 
0.2347± 
0.0184 
0.2682± 
0.0153* 
IL-2 0.0916± 
0.0046 
0.1060± 
0.0053** 
0.1074± 
0.0122 
0.1029± 
0.0045 
0.1109± 
0.0202 
0.1217± 
0.0059 
IL-12 0.0380± 
0.0043 
0.0418± 
0.0056 
0.0377± 
0.0033 
0.0450± 
0.0029* 
0.0384± 
0.0042 
0.0528± 
0.0047*** 
IL-15 0.0146± 
0.0010 
0.0165± 
0.0015 
0.0166± 
0.0008 
0.0165± 
0.0007 
0.0155± 
0.0009 
0.0179± 
0.0018* 
GCSF 0.0668± 
0.0028 
0.0644± 
0.0036 
0.0664± 
0.0026 
0.0735± 
0.0057 
0.0681± 
0.0028 
0.0728± 
0.0032 
MCP-1 0.0450± 
0.0069 
0.0512± 
0.0105 
0.0537± 
0.0066 
0.0693± 
0.0153 
0.0595± 
0.0103 
0.1025± 
0.0224 
MCP-2 0.0038± 
0.0003 
0.0037± 
0.0002 
0.0042± 
0.0003 
0.0039± 
0.0003 
0.0033± 
0.0002 
0.0040± 
0.0003 
GM-CSF 0.0173± 
0.0008 
0.0202± 
0.0012** 
0.0153± 
0.0009 
0.0173± 
0.0006** 
0.0151± 
0.0012 
0.0181± 
0.0012* 
TGF-ȕ 1.3996± 
0.0638 
1.3922± 
0.0659 
1.4644± 
0.0349 
1.5197± 
0.0581 
1.4501± 
0.0706 
1.5209± 
0.0730 
RANTES 0.9984± 
0.2514 
1.1678± 
0.2897 
1.1480± 
0.2609 
1.4827± 
0.2471 
0.8901± 
0.2681 
1.9001± 
0.3295** 
IFN-Ȗ 1.4214± 
0.1078 
1.5560± 
0.1728 
1.5736± 
0.1094  
1.6419± 
0.1043 
1.6038± 
0.1311 
1.8504± 
0.2325 
IFN-ȕ 0.9588± 
0.1165 
0.9354± 
0.1198 
0.9803± 
0.0697 
1.0161± 
0.0554 
0.7238± 
0.0898 
1.1425± 
0.1063*** 
SDF-ȕ 1.7129 
0.1273 
1.8255 
0.1636 
1.8988 
0.0876 
1.8691 
0.1051 
1.9568 
0.1256 
2.0942 
0.1925 
MIG 0.1552 
0.0087 
0.1664 
0.0112 
0.1644 
0.0049 
0.1706 
0.0053 
0.1740 
0.0096 
0.2077 
0.0314 
MIP-Į 0.0757± 
0.0057 
0.0780± 
0.0069 
0.0805± 
0.0045 
0.0888± 
0.0049** 
0.0792± 
0.0063 
0.0975± 
0.0060** 
MIP-ȕ 0.0876± 
0.0072 
0.0905± 
0.0087 
0.0879± 
0.0031 
0.0880± 
0.0076 
0.0912± 
0.0053 
0.1267± 
0.0196* 
Values are means±SEM. Statistical analysis via ANOVA and students t-
test. *=P<0.05 vs. pre RET in the same age-group, **=P<0.01 vs. pre RET 
in the same age-group, ***=P<0.001 vs. pre RET in the same age-group. 
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4.4 Discussion 
 
Effect of RET on LBF 
In summary, we report that age-related dysregulation in LBF in response to 
feeding and exercise-plus-feeding (but not basal) is ameliorated by RET 
which is concomitant with a restoration of LVC. Although we were unable 
to seek a mechanism for our findings in this study, it is evident that RET 
may in some cases reverse age-related declines in LBF/LVC which are 
indicative of pathological changes in vessel structure and/ or vascular tone. 
 
Age-related reductions in basal limb blood flow and vascular conductance 
that occur with advancing age can be associated with the metabolic 
syndrome, functional impairments, osteoporosis and other clinical 
conditions such as CVD and atherosclerosis (Anton et al., 2006). We have 
confirmed previous observations (Miyachi et al., 2005; Dinenno et al., 
2001; Moreau et al., 2003) that there is an age-related decline in basal LBF 
and also in associated LVC. Although we did not observe significant 
differences in LBF between our groups in the basal state, using a 
correlation analysis of all 51 subjects, therefore giving greater statistical 
power, we revealed a relationship that was obscured by comparison of the 
smaller data sets, demonstrating an inverse relationship between advancing 
age and basal LBF. 
 
One of the normal symptoms of ageing is that of impaired glucose 
tolerance, especially insulin mediated glucose uptake (IMGU) which 
occurs primarily in skeletal muscle (Meneilly et al., 1995). This 
impairment may be partly explained by decreased limb blood flow 
experienced by the elderly (Meneilly et al., 1995) causing a decrease in the 
delivery of insulin and glucose to the muscle tissue. Oxygen, hormone and 
nutrient delivery may also be impaired by reduction in LBF and this may 
contribute to decreasing muscle mass maintenance as well as whole±body 
glucose intolerance and hyperinsulinaemia (Lind & Lithell, 1993). 
 269 
 
Arterioles have high compliance, which allows them to respond to stretch 
stimuli and regulate blood flow without damage. Sympathetic fibres of the 
autonomic nervous system  innervate the smooth muscle of blood vessels, 
typically causing the smooth muscle to contract, narrowing the vessel 
lumen. When sympathetic stimulation decreases or in the presence of 
certain receptors (i.e. ȕ-2 adrenoreceptor) the smooth muscle fibres of the 
vessel relax and lumen diameter increases facilitating increases in blood 
flow through the vessel. In healthy young adults the ingestion of food 
induces vasodilation, a response mediated by the vasodilatory actions of 
insulin (Skilton et al., 2005). This postprandial response is significantly 
impaired with increasing age, even when blood flow data is adjusted for 
reduced baseline flow values in the elderly (Skilton et al., 2005).  
 
Although there is little information available concerning acute responses of 
LBF to feeding Fugmann and colleagues (using venous capacitance 
plethysmography) showed a long lasting (<2 h) response to feeding a 
mixed-meal (Fugmann et al., 2003). This was also shown by Hernandez et 
al. who demonstrated a 16-25% increase in LBF in young males 
(Hernandez & Jensen, 1995), although the method used (indocyanine green 
dye dilution) is inherently more variable than either plethysmography or 
Doppler techniques. Combining Doppler ultrasound and contrast enhanced 
ultrasound (CEUS) Vincent and colleagues found a 33% increase in bulk 
brachial artery blood flow 60 min after a mixed meal and also a 50% 
increase in forearm microvascular blood volume (Vincent et al., 2006).  
 
In line with these findings we found that before RET LBF increased in 
response to feeding in our younger subjects (+39.8%) but this increase was 
not apparent in our middle-aged or older subjects. Further age × LBF 
correlation analysis confirmed age-related declines in LBF responses to 
feeding before RET.     
 
The reduced vasodilatory response of decreased postprandial blood flow 
shown with age both by us in this study and by others (Skilton et al., 
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2005), may serve to act as a preclinical marker of vascular health. Ageing 
is a major risk factor for CVD (Lakatta & Yin, 1982) and the reduced 
vasodilatory response in the periphery experienced with age may be 
indicative of an impaired response of the coronary arteries to endothelium 
dependent vasodilators (Gerhard et al., 1996). Due to the large amount of 
time most humans spend in the postprandial state negative changes in 
responses to feeding may have large implications for health.  
 
RET improved the age-related diminutions in LBF responses to feeding 
such that fed LBF responses significantly increased in the middle-aged and 
older groups (when compared to their pre-RET values) and the negative 
relationship between advancing age and fed LBF was ameliorated, 
presumably through enhancement of fed LVC. This restoration of fed LBF 
responses and improved LVC after RET may positively impact age-related 
declines in glucose disposal and amino-acid deposition (Fugmann et al., 
2003; Lind & Lithell, 1993) and may be related to a re-sensitization to 
insulin and its effects on total flow and/ or capillary recruitment- clearly 
this conjecture warrants further investigation. 
 
In this study we elected to measure LBF during the recovery period from 
exercise which reflects the remodeling period (when muscle protein 
turnover is heightened (Kumar et al., 2009)). We also chose to study the 
combined effects of exercise and feeding (rather than exercise hyperaemia 
per se) to maximize practical ramifications of the work. For instance, most 
people would (or would be recommended to) combine resistance exercise 
with feeding to maximize muscle anabolic responses (Moore et al., 2009).  
 
Exercise hyperaemia is evident in active muscles both during, and for 
sustained periods afterwards and is important for performance and ensuing 
recovery and remodeling alike (Sjoberg et al., 2011). Importantly such 
hyperaemic responses also seem to be diminished in age (Donato et al., 
2006; Poole et al., 2003), which may contribute to reduced performance 
and maladaptation to exercise training in older age (Greig et al., 2011).  
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In this study show we evidence of previously undescribed LBF responses 
to the combination of exercise-plus-feeding where LBF in older 
individuals appears to be completely unresponsive to feeding and barely 
responsive to exercise-plus-feeding but is restored after RET; rejuvenating 
these responses in older individuals, even surpassing pre-training values 
seen in middle-aged individuals.  
 
The mechanism for capillary recruitment, and therefore increased blood 
flow, by insulin is early (Vincent et al., 2002), nitric oxide (NO) dependent 
(Clark et al., 2003) and likely to be mediated at the endothelial cells of the 
sphincters. One possible suggestion towards a mechanism for age-related 
reduction and RET induced improvement in LBF surrounds pro-
inflammatory cytokines. Pro-inflammatory cytokines such as TNF-ĮKDYH
been shown to inhibit the insulin stimulated increase in femoral blood 
flow, and supra-physiological levels of insulin were required to recover 
femoral blood flow values (Zhang et al., 2003). We however, observed no 
age-related increases in systemic TNF-Į, IL-6 or any other pro-
inflammatory cytokine nor did we observe a decrease as a result of RET; 
leading to the conclusion that this proposition cannot explain the age-
related reduction in basal femoral blood flow nor the improved blood flow 
responses to feeding and exercise that occurred in this study. 
 
The mechanisms for the age-related declines in LBF and the changes that 
are seen with RET are probably complex and both a decrease in muscle 
mass (Dinenno et al., 2001) and chronic vasodilation (Thijssen et al., 2007; 
Dinenno et al., 2001) have been suggested as possible contributors. 
Although we cannot rule it out we propose that the age-related declines in 
LBF responses to feeding and exercise-plus-feeding are unlikely to be 
related to declines in muscle mass per se, at least in our healthy older 
participants, as using DEXA we did not detect significant differences in 
lean mass between our age-groups and other mechanisms such as chronic 
YDVRGLODWLRQGXH WR LQFUHDVHGĮ-adrenergic tone and/ or lower O2 demand 
are more likely lower candidates than lower muscle mass per se. Our 
findings are consistent with work from other groups showing no significant 
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differences in measures of lean mass between age-groups using DEXA and 
who suggested that reductions in the LBF in the elderly were due to 
reductions in specific oxygen demand independent of total muscle mass 
(Dinenno et al., 1999). Computed tomography (CT) or magnetic resonance 
imaging (MRI) cadaver validation studies have shown these methods to 
have much higher accuracy in quantifying muscle mass than DEXA 
(Mitsiopoulos et al., 1998) and reports describing sarcopenia tend to use 
such methods (Pahor et al., 2009). One explanation for this discrepancy in 
measures may be that CT or MRI can quantify a hallmark of ageing, 
myosteatosis using the Hounsfield unit of lean tissue (Lang et al., 2009) 
but DEXA cannot and this may have lead to an over-estimation of 
functional muscle mass in our older subjects when measured by DEXA. 
Further support for the prior notion of dissociation between muscle mass 
and LBF per se exits as in this study no group demonstrated increases in 
basal LBF despite displaying hypertrophy. 
 
To try and ascertain a greater understanding of the mechanisms related to 
the changes in LBF with age and / or RET we looked at protein expression 
of PECAM-Į-DGUHQRUHFHSWRUDQGȕ-2 adrenoreceptor in the muscle to 
investigate the possibility of alterations in muscle endothelium. It was 
surprising that we saw no differences in the protein concentration of these 
WDUJHWV HLWKHU ZLWK DJH RU 5(7 JLYHQ WKDW FKURQLF Į-adrenergic tone is 
known to be elevated in older individuals (Dinenno et al., 2001; Smith et 
al., 2007a) and that RET has been reported to increase peak vasodilatory 
limb capacity (Rakobowchuk et al., 2005). There were also no differences 
either before or after RET in phosphorylation of eNOS or PKC-Į despite 
their putative role in hyperaemia (Partovian et al., 2005).  
 
RET has been shown to cause muscle hypertrophy (Schoenfeld, 2010) and 
although we did not observe any gains in whole-body lean mass in our 
older group after RET we did see increases in upper lean leg mass which 
may be more pertinent when considering changes in femoral artery blood 
flow. Other studies have demonstrated that older people retain the ability to 
gain muscle mass with RET (Peterson et al., 2011) which suggests that as 
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all of our participants underwent the same training regime it may the use of 
DEXA is a limitation in this study (see above).  As well as promoting 
hypertrophy RET has also been shown to increase basal LBF (Anton et al., 
2006; Tanimoto et al., 2009), somewhat surprisingly given the common 
view of such vascular adaptations being specific to endurance training 
(Thijssen et al., 2007). Tanimoto and colleagues reported that 13 weeks of 
high (85-90% 1-RM) or low-intensity (50-60% 1-RM) RET were equally 
effective in increasing basal LBF (Tanimoto et al., 2009) and it has also 
been shown that basal LBF in resistance trained individuals is better 
maintained with ageing (Miyachi et al., 2005). It was therefore unexpected 
that we saw no increases in basal LBF in any group after RET and the age-
related reduction in postabsorptive LBF was still apparent after RET even 
when data was expressed relative to leg lean muscle mass. This was 
reflected by the fact that increases in basal LVC in our older subjects after 
RET were principally due to decreases in MAP (rather than increases in 
LBF) which may have been due to an amelioration of increased 
sympathetic nerve activity directed to the vascular beds that has been 
reported in ageing (Ng et al., 1993). 
 
Although we have investigated healthy subjects, it may be proposed that 
increased LBF and LVC in the postprandial and post-exercise states after 
RET may benefit individuals with CV or metabolic conditions (Baron et 
al., 1990) and may go some way to alleviate or reverse the anabolic 
blunting sometimes observed in older individuals (Cuthbertson et al., 
2005). The mechanism for these improvements were not discovered during 
this study but were not related to endothelial expansion (indexed by 
endothelial cell markers or androgen receptors in muscle biopsies) or to 
phosphorylation of eNOS (Fleming & Busse, 1999) or PKC-Į(Partovian et 
al., 2005) which are supposed components of the vasodilatory responses in 
the microvascular beds. 
 
Mechanisms to explain the observed positive changes in LBF after RET 
need further exploration as we recognize the limitations of using only these 
markers in muscle biopsies. 'HFUHDVHG Į-adrenergic tone (known to be 
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elevated in older individuals (Dinenno et al., 2001; Smith et al., 2007a) 
and perhaps redistribution of LBF to working muscles (i.e. improved 
functional sympatholysis) are attractive possibilities that may contribute to 
improvements in LBF and corresponding normalization of LVC in 
response to feeding and exercise. Also, to what extent the LBF responses 
to exercise and to exercise-plus-feeding correspond to increases in 
microvascular flow, as observed by Vincent (Vincent et al., 2006) also 
merits further investigation with one assumption that 75% of total femoral 
blood flow goes to the muscle (Newman et al., 2007). If this assumption 
were to be correct the increased leg blood flow shown after RET could 
have very positive implications for an ageing population with regard to 
metabolic and anabolic status (Phillips et al., 2012). 
 
Effect of RET on mean arterial pressure and resting heart rate 
High blood pressure is one of the nine leading risk factors influencing 
cardiovascular disease (Anand et al., 2008) and is estimated to lead to over 
7 million deaths each year; about 13% of total worldwide deaths 
(Chobanian et al., 2003), with a strong independent relationship between 
BP and cardiovascular morbidity and mortality down to 115/75 mmHg 
(Lewington et al., 2002). Physical activity guidelines for hypertension 
traditionally centre aerobic exercise (Mancia, 2007), although as RET 
increases in popularity due to research showing the benefits on bone, 
muscle and metabolism, those interested in CV health are also beginning to 
promote RET as an integral part of an exercise program (Braith & Stewart, 
2006).  
 
Contrary to some negative reports on the effects of RET on BP, we found 
that MAP, which was lower in the young group before RET, was reduced 
in the middle-aged and old groups after RET to the extent that there were 
no differences between the age groups - effectively restoring the MAP of 
the older groups to that of the young. These findings are similar to those 
reported in meta-analyses (Cornelissen et al., 2011; Kelley & Kelley, 
2000) and independent studies (Moraes et al., 2012), showing that both 
moderate intensity progressive, dynamic RET and low intensity isometric 
 275 
RET (Cornelissen et al., 2011) may cause a reduction in systolic and 
diastolic BP (which would equal a reduction in MAP). In one meta-
analysis dynamic RET, as was performed in this study, was also found to 
have other favorable effects on CV risk factors such as an increase in VO2 
max and a reduction in body fat and plasma triglycerides (Cornelissen et 
al., 2011), which complements our findings of lower RHR in our young 
and middle-aged groups after RET, with a trend for this reduction in our 
older group. 
 
Although the reduction in MAP exhibited by our middle-aged and older 
groups after RET may seem numerically small they are significant both 
statistically and clinically. Using information taken from large intervention 
studies (Stamler et al., 1991) it can be suggested that BP reductions as 
small as 3 mmHg can reduce coronary heart disease risk by 5%, stoke by 
8% and all cause mortality by 4% (Whelton et al., 2002). With this 
information our MAP reductions of 9 mmHg in both our middle-aged and 
older group strongly suggest cardiovascular benefits of RET. 
 
While the evidence for the CV benefits of RET are still not as uniform and 
striking as for traditional aerobic exercise, it is gaining favor in the 
literature and it is more widely accepted that RET does not raise resting BP 
(Kelley & Kelley, 2000; Rossi et al., 2012; Fahs et al., 2011). While the 
proposed potential mechanisms for RET increasing BP are multifaceted 
and include 1. concentric hypertrophy due to marked repetitive increases in 
BP during RET, which increased left ventricular wall thickness with 
unchanged left ventricular chamber size 2. larger conduit arteries 3. stiffer 
central conduit arteries (where the mechanoreceptors are located) 
(Sugawara et al., 2012), the major proposed mechanism for RET reducing 
BP is that of reduced peripheral resistance (Kelley & Kelley, 2000), 
aligning perfectly with the results of this study regarding LPF, MAP and 
LVC.  
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Effect of RET on insulin and glucose handling 
It is not only increased LBF and the positive role that it may have in ageing 
with regard to muscle mass maintenance, CVD, atherosclerosis and 
diabetes that has been demonstrated to be improved by RET in this study 
as we have also demonstrated changes in both insulin and glucose 
handling. Glucose tolerance and utilization decline with age because of an 
increase in obesity (central and total) and a decline in physical activity/ 
muscle mass (Coon et al., 1992; Kohrt et al., 1992), although intriguingly 
the most apparent changes in plasma glucose as an index of metabolic 
health were observed in our young group.  
 
Our young group demonstrated reduced postprandial plasma glucose AUC 
in addition to reduced peak plasma glucose and also a trend for reduced 
postprandial plasma insulin AUC. There was a trend in all three groups for 
lower peak plasma insulin after RET and when all subjects were grouped 
HOMA was significantly lower after RET. The older group showed a 
reduction in peak postprandial plasma glucose but not AUC, although 
importantly they, along with the middle-aged group did demonstrate 
reduced HOMA values following RET, restoring their value to a level not 
different to that of the young. HOMA is the abbreviation for homeostasis 
model assessment and together with android obesity, hypertension, 
elevated plasma triglycerides and high HDL cholesterol, can be used to 
diagnose the metabolic syndrome (2001).  
 
Our findings of improvements in HOMA following RET are in keeping 
with those of others who found that in healthy adults (Miller et al., 1994; 
Ryan et al., 1996) and in type 2 diabetics (Kadoglou et al., 2012; Misra et 
al., 2008; Sigal et al., 2007; Ibanez et al., 2005; Castaneda et al., 2002), 
RET improved glycemic control, alleviated insulin resistance (marked by 
HOMA) and reduced HbA1c levels and ApoB: ApoA-I ratio. Increased 
lean mass following RET is commonly cited as one of the key reasons for 
improvements in insulin sensitivity and/ or glucose clearance after RET 
(Ryan et al., 2001), although this cannot explain all of the changes as some 
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groups have found improvements independent of changes in lean mass 
(Holten et al., 2004).  
 
An alternative potential mechanism for these improvements was suggested 
by Holten et al (Holten et al., 2004)  when they found that in healthy 
controls and type 2 diabetics, RET enhances insulin action in skeletal 
muscle. Alongside these findings they also found that RET increased the 
protein contents of GLUT4 insulin receptor, protein kinase B, glycogen 
synthase and also glycogen synthase activity (Holten et al., 2004). These 
signalling changes with RET are not entirely aligned with the changes we 
see after RET as we see no change in basal IRS-1 in any of our age groups 
after RET, although we do see a signalling response after exercise-plus-
feeding in our middle-aged and old groups that was not apparent before 
RET.  
 
Although our results for insulin and glucose handling and the associated 
signalling are not as striking as those found in some studies mentioned our 
volunteers were all healthy individuals, able to perform tasks of everyday 
living and Ryan et al found that in older individuals more insulin resistant 
individuals derived the greatest benefits from RET (Ryan et al., 2001). In 
addition to the beneficial effects on metabolic health that can be achieved 
through RET alone, the combination of aerobic and RET has been shown 
to be superior (Sigal et al., 2007) and therefore combining the approached 
used in this study with regular aerobic training may further enhance the 
health benefits that RET can achieve. 
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CHAPTER 5- DISCUSSION AND OVERVIEW 
 
Ageing is one of the most important social and financial problems facing 
western society and the UK, along with the majority of other countries in 
the western world have an ageing population; in which the rate of ageing 
does not appear to be slowing. With social, clinical and economic 
implications of this ageing population, many to do with the associated 
decline in independence maintenance for these ageing individuals, any 
method which may prevent this decline in health and well-being that 
allows individuals to sustain normal daily activity and functional 
independence must be developed, advocated and promoted. 
 
Although hereditary and other pre-disposing factors to chronic diseases 
cannot be altered, lifestyle choices can be influential in minimizing risk 
factors for chronic disease, especially in the elderly. Because the effects of 
lifestyle choices will be cumulative throughout life it is particularly 
important for older people to adopt diet and lifestyle practices that will 
improve their chances of healthy, active independent ageing. 
 
Sarcopenia, the age-associated loss of muscle mass is a widespread 
syndrome that can cause frailty, decrease mobility, increase the likelihood 
of falls and even have the effect on BC of increasing % body fat, which 
itself is associated with negative health outcomes. RET may be one vehicle 
by which to alleviate progressive sarcopenia and may even go some way to 
reversing the muscle mass losses experienced by a condition that has been 
questionHGWREHGXHWR³WKHSK\VLRORJ\RIGLVXVH´ 
 
Something which is often associated with sarcopenia but can also be an 
independent feature of ageing, and may negatively contribute to risk 
factors for chronic diseases is the redistribution of body fat with ageing. 
Ageing is not only associated with the loss of FFM and an increase in FM 
it is also associated with the preferential deposition of body fat in the trunk 
region which may potentially lead to android obesity; associated with 
heightened CVD and metabolic syndrome risk. Ageing is also associated 
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with a greater proportional deposition of visceral fat which increases the 
risk of all diseases linked to a centralized pattern of fat distribution. 
 
Reduced BMC and BMD which are also associated with ageing may 
increase the risk of bone-related disorders such as osteoporosis and 
osteoarthritis.  
 
Another age associated change is the change in limb blood flow and its 
responses to anabolic stimuli, experienced with age. Although the 
mechanisms behind this are not completely understood it is likely that the 
muscle mass loss experienced with sarcopenia cannot be the only 
explanation as lower limb blood flow is experienced in the elderly even 
when values are expressed relative to lean leg mass.  
 
For the elderly, it is believed that maintenance of muscle mass and strength 
as we age leads to much improved functional capacity and quality of life 
(Tipton, 2001). With exercise seeming more effective at preventing muscle 
loss than restoring lost muscle mass (Wolfe, 2006), the strength gains that 
have been shown in our subjects only serve to show that if these strength 
gains can be made in 20 weeks, then the advocating and promotion of 
habitual RET, especially for those advancing in age may go a long way to 
helping prevent some of the associated muscle loss and associated strength 
and function losses that are experienced by many elderly people. 
 
Sarcopenia can gravely affect quality of life and causes considerable 
morbidity. As skeletal muscle is the primary site for numerous metabolic 
functions, sarcopenia may contribute to negative conditions of peripheral 
insulin resistance, dyslipidaemia and increased adiposity. Any condition 
detrimental to the health of elderly individuals increases their risk of 
hospitalization, need for care and/ or disease impacting on the 
independence maintenance of the elderly individuals in question.  
 
It is not only muscle mass, strength and endurance, but also power output 
that declines with ageing and associated sarcopenia and this may be 
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important in the incidence of falls and the inability to perform weight 
bearing tasks. These tasks may be as simple as raising from a chair or bed, 
something which the majority of healthy people would take for granted, yet 
are crucial for independent living.  
 
For elderly people fear of falling and the potential outcomes of these falls 
are very real, with many elderly people needing hospitalization and/ or 
home-help following a fall. Whipple and colleagues found that the strength 
of elderly people who suffered falls was significantly lower than in elderly 
people who did not fall (Whipple et al., 1987); another reason why the 
promotion of RET in the elderly may have both clinic and social 
implications for an ever growing section of society. 
 
Although some of the risk factors for sarcopenia cannot be altered, such as 
advancing age or female sex, physical inactivity can be and the results of 
this study illustrate the benefits of RET in helping to alleviate sarcopenia in 
the important weight bearing lower limbs. Any method by which 
sarcopenia may be reduced should be embraced and promoted. 
 
RET has been well documented to have health benefits based on 
improvements in muscular strength and positive changes in  BMD, both of 
which can off-set the development of age-related conditions such as 
sarcopenia, osteoporosis and the frailty syndrome.  
 
Our results have shown that a 20 week RET program elicits strength gains 
in all of the major muscle groups trained; a determinant of muscle 
function, bringing the whole-body strength of the old after RET to a level 
not different to the young before RET. As strength has been shown to be 
negatively correlated with premature mortality these strength gains serve 
as an indicator of positive changes in health status following RET. 
 
Decreased trunk fat brought about by a 20 week RET program may lower 
the risk of CVD and associated conditions such as type 2 diabetes and the 
metabolic syndrome. These benefits may be further enhanced by the 
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reduction in whole body % body fat that has been shown to occur with the 
20 week RET program in our completed subjects.  
 
The change in basal leg blood flow and the increased responses to feeding 
and to exercise with feeding shown by our completed subjects suggests 
that a 20 week RET program is associated with positive effects on leg 
blood flow per se and also improves the leg blood flow responses to 
feeding alone and to a single bout of resistance exercise combined with 
feeding. A response to feeding can have significant implications as for the 
average person a relatively large proportion of the waking day is spent in 
the postprandial state. The clinical implications that may be associated 
with increased leg blood flow include: an improved clearance of 
lipoproteins and alleviation of age-associated reductions in muscle glucose 
uptake and insulin sensitivity, which are key features of the metabolic 
syndrome, type 2 diabetes and a factor that potentially contributes to CV 
disease. Delivery of oxygen and nutrients to the muscle are also likely 
increased with improved leg blood flow and this may play a role in 
overcoming the anabolic blunting observed with age.   
 
The results from this study show that 20 weeks RET can lower MAP, a 
risk factor for CVD if elevated and improved fasting metabolic status and 
glucose handling in older individuals. 
 
Significant, novel findings of this study are the positive effects of RET on 
limb blood flow in response to exercise and the combination of exercise-
plus-feeding. The possible advantages that this may have are already 
discussed and knowledge of the distribution of this blood flow i.e. nutritive 
vs. non-nutritive blood flow, would allow us greater insight into the 
possible health benefits of this improved blood flow caused by RET. 
 
There is evidence to support the idea of two vascular routes either within, 
or closely related to skeletal muscle. One route has intimate contact with 
PXVFOHFHOOVDQGLVNQRZQDVµQXWULWLYH¶WKHRWKHUµQRQ-QXWULWLYH¶DFWVDVD
vascular shunt and is thought to be, at least in part, the vessels in closely 
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associated connective tissue that nourishes fat cells attached to the muscle 
(Clark et al., 2000). The presence of these two vascular routes in skeletal 
muscle has two main consequences; 1. In relation to energy balance, the 
proportion of flow between the nutritive and non-nutritive routes sets the 
BMR as an increase in the proportion of total flow that is nutritive 
increases basal energy consumption. 2. The presence of two vascular 
routes effects fuel partitioning within the muscle. As the non-nutritive 
route supplies connective tissue and associated adipocytes and the nutritive 
route the muscle cells, a high nutritive: non-nutritive flow ratio favors 
delivery of nutrients and hormones to the muscle cells. However if a high 
non-nutritive flow remains nutrient delivery reaches the connective tissues 
and fat cells. Although these cells are much less metabolically active than 
muscle cells, nutrients such as glucose, insulin and triglycerides will still 
be utilized enabling fat cell growth (Clark et al., 2000). A study measuring 
leg muscle blood flow using a contrast-enhanced ultra sound (CEUS) 
would allow us to examine the blood flow into the muscle (nutritive flow) 
and if the magnitude of change following RET was the same as for whole 
leg blood flow this may further advocate clinical benefits of RET as 
improved nutritive leg blood flow may be associated with; an improved 
clearance of lipoproteins, alleviation of some of the age-associated 
reductions in muscle glucose uptake and insulin sensitivity and improve 
nutrient and oxygen delivery to the muscle which may be key for MPS. 
 
Any positive changes in health-related markers measured in this study can 
only serve to act as evidence for the benefits of physical activity, 
specifically RET. The economic, clinical and social implications of 
physical inactivity are well known and positive results of physical activity 
based research can only act to drive forward the concept of physical 
activity for health. 
 
Based on the results of this study there is scope for future work to alter the 
length and/ or the intensity of the RET intervention, to establish what is the 
minimum time-frame or intensity needed to obtain the positive outcomes 
that we observed. Although advocating habitual RET would be optimal, to 
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try and maximize reduction in risk factors for chronic disease and the 
maintenance of independence in the elderly there may be clinical situations 
(i.e. pre-operative or post-fall) in which it would be beneficial to have 
knowledge of the minimum time-scale or work intensity needed to elicit 
these gains in the elderly. 
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